<!DOCTYPE html>
 <!--[if lt IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8 lt-ie7"> <![endif]--> <!--[if IE 7]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9 lt-ie8"> <![endif]--> <!--[if IE 8]> <html dir="ltr" lang="en-US" class="aui ltr no-js lt-ie9"> <![endif]--> <!--[if gt IE 8]><!--> <html class="aui ltr" dir="ltr" lang="en-US" prefix="og: http://ogp.me/ns#"> <!--<![endif]--> <head> <title>Medical treatment for early fetal death (less than 24 weeks) - Lemmers, M - 2019 | Cochrane Library</title> <meta content="Medical treatment for early fetal death (less than 24 weeks) - Lemmers, M - 2019 | Cochrane Library" property="og:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002253.pub4/full" property="og:url"/> <meta content="article" property="og:type"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" property="og:image"/> <meta content="summary_large_image" name="twitter:card"/> <meta content="Medical treatment for early fetal death (less than 24 weeks) - Lemmers, M - 2019 | Cochrane Library" name="twitter:title"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002253.pub4/full" name="twitter:url"/> <meta content="https://www.cochranelibrary.com/cochrane-theme/images/cochrane_circulargraphic.png" name="twitter:image"/> <meta content="initial-scale=1.0, width=device-width" name="viewport"/> <meta content="10.1002/14651858.CD002253.pub4" name="dc.identifier" scheme="DOI"/> <meta content="Medical treatment for early fetal death (less than 24 weeks)" name="citation_title"/> <meta content="Marike Lemmers" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Marianne AC Verschoor" name="citation_author"/> <meta content="Academic Medical Center" name="citation_author_institution"/> <meta content="Bobae Veronica Kim" name="citation_author"/> <meta content="School of Medicine, The University of Adelaide" name="citation_author_institution"/> <meta content="Martha Hickey" name="citation_author"/> <meta content="The Royal Women's Hospital" name="citation_author_institution"/> <meta content="Juan C Vazquez" name="citation_author"/> <meta content="Instituto Nacional de Endocrinologia (INEN)" name="citation_author_institution"/> <meta content="Ben Willem J Mol" name="citation_author"/> <meta content="Monash University" name="citation_author_institution"/> <meta content="James P Neilson" name="citation_author"/> <meta content="The University of Liverpool" name="citation_author_institution"/> <meta content="jneilson@liverpool.ac.uk" name="citation_author_email"/> <meta content="Cochrane Database of Systematic Reviews" name="citation_journal_title"/> <meta content="John Wiley &amp; Sons, Ltd" name="citation_publisher"/> <meta content="6" name="citation_issue"/> <meta content="10.1002/14651858.CD002253.pub4" name="citation_doi"/> <meta content="2019" name="citation_date"/> <meta content="2019/06/17" name="citation_online_date"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002253.pub4/abstract" name="citation_abstract_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002253.pub4/full" name="citation_fulltext_html_url"/> <meta content="https://www.cochranelibrary.com/cdsr/doi/10.1002/14651858.CD002253.pub4/pdf/full" name="citation_pdf_url"/> <meta content="1465-1858" name="citation_issn"/> <meta content="en" name="citation_language"/> <meta content="Delivery, Obstetric; *Fetal Death; *Mifepristone [administration &amp; dosage]; *Misoprostol [administration &amp; dosage]; *Oxytocics [administration &amp; dosage]; Pregnancy Trimester, First; Randomized Controlled Trials as Topic" name="citation_keywords"/> <link href="https://fonts.googleapis.com/css?family=Source+Sans+Pro:400,700,600,900" rel="stylesheet"/> <script src="https://cmp.osano.com/AzZdRbSORDOOzF9W/d594efc1-9663-477d-9528-6576640e64fd/osano.js"></script> <style> .osano-cm-widget{display: none;} </style> <script src="https://static.addtoany.com/menu/page.js"></script> <script async="" charset="utf-8" src="https://platform.twitter.com/widgets.js"></script> <script async="async" src="//script.crazyegg.com/pages/scripts/0056/6375.js" type="text/javascript"></script> <script type="text/javascript">window.dataLayer={};var xtend=function(){var a={};var b=false;var c=0;var d=arguments.length;if(Object.prototype.toString.call(arguments[0])==="[object Boolean]"){b=arguments[0];c++}var f=function(g){for(var h in g){if(Object.prototype.hasOwnProperty.call(g,h)){if(b&&Object.prototype.toString.call(g[h])==="[object Object]"){a[h]=xtend(true,a[h],g[h])}else{a[h]=g[h]}}}};for(;c<d;c++){var e=arguments[c];f(e)}return a};</script> <!-- Global site tag (gtag.js) - Google Analytics --> <script src="https://www.googletagmanager.com/gtag/js?id=UA-189672-63&amp;l=gDataLayer"></script> <script>window.gDataLayer=window.gDataLayer||[];function gtag(){gDataLayer.push(arguments)}gtag("js",new Date());gtag("config","UA-189672-63");</script> <script type="text/javascript">var o={auth:{customerIds:[],individualId:null,brandedCustomer:null,roles:["Guest"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <script type="text/javascript">var o={page:{siteSection:"Content",languageCode:"en",cms:{pageTitle:"Content"}}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <meta content="text/html; charset=utf-8" http-equiv="content-type"/> <link href="https://www.cochranelibrary.com/cochrane-theme/images/favicon.ico" rel="Shortcut Icon"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" rel="canonical"/> <link href="https://www.cochranelibrary.com/zh/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANS" rel="alternate"/> <link href="https://www.cochranelibrary.com/zh_HANT/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="zh-HANT" rel="alternate"/> <link href="https://www.cochranelibrary.com/hr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hr-HR" rel="alternate"/> <link href="https://www.cochranelibrary.com/nl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="nl-NL" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="x-default" rel="alternate"/> <link href="https://www.cochranelibrary.com/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="en-US" rel="alternate"/> <link href="https://www.cochranelibrary.com/fr/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fr-FR" rel="alternate"/> <link href="https://www.cochranelibrary.com/de/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="de-DE" rel="alternate"/> <link href="https://www.cochranelibrary.com/hi/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hi-HI" rel="alternate"/> <link href="https://www.cochranelibrary.com/hu/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="hu-HU" rel="alternate"/> <link href="https://www.cochranelibrary.com/in/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="in-ID" rel="alternate"/> <link href="https://www.cochranelibrary.com/ja/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ja-JP" rel="alternate"/> <link href="https://www.cochranelibrary.com/ko/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ko-KR" rel="alternate"/> <link href="https://www.cochranelibrary.com/ms/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ms-MY" rel="alternate"/> <link href="https://www.cochranelibrary.com/fa/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="fa-IR" rel="alternate"/> <link href="https://www.cochranelibrary.com/pl/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pl-PL" rel="alternate"/> <link href="https://www.cochranelibrary.com/pt/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="pt-PT" rel="alternate"/> <link href="https://www.cochranelibrary.com/ro/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ro-RO" rel="alternate"/> <link href="https://www.cochranelibrary.com/ru/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ru-RU" rel="alternate"/> <link href="https://www.cochranelibrary.com/es/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="es-ES" rel="alternate"/> <link href="https://www.cochranelibrary.com/ta/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="ta-IN" rel="alternate"/> <link href="https://www.cochranelibrary.com/th/web/cochrane/content?templateType=full&amp;urlTitle=/cdsr/doi/10.1002/14651858.CD002253.pub4&amp;doi=10.1002/14651858.CD002253.pub4&amp;type=cdsr&amp;contentLanguage=" hreflang="th-TH" rel="alternate"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/aui.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <link href="/html/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773519000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/scolaris-content-display/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/notifications-portlet/notifications/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" rel="stylesheet" type="text/css"/> <link href="https://www.cochranelibrary.com/html/portlet/login/css/main.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1739773548000" rel="stylesheet" type="text/css"/> <script type="text/javascript">var Liferay={Browser:{acceptsGzip:function(){return false},getMajorVersion:function(){return 80},getRevision:function(){return"537.36"},getVersion:function(){return"80.0"},isAir:function(){return false},isChrome:function(){return true},isFirefox:function(){return false},isGecko:function(){return true},isIe:function(){return false},isIphone:function(){return false},isLinux:function(){return true},isMac:function(){return false},isMobile:function(){return false},isMozilla:function(){return false},isOpera:function(){return false},isRtf:function(){return true},isSafari:function(){return true},isSun:function(){return false},isWap:function(){return false},isWapXhtml:function(){return false},isWebKit:function(){return true},isWindows:function(){return false},isWml:function(){return false}},Data:{NAV_SELECTOR:"#navigation",isCustomizationView:function(){return false},notices:[null]},ThemeDisplay:{getLayoutId:function(){return"7"},getLayoutURL:function(){return"https://www.cochranelibrary.com/en/content"},getParentLayoutId:function(){return"0"},isPrivateLayout:function(){return"false"},isVirtualLayout:function(){return false},getBCP47LanguageId:function(){return"en-US"},getCDNBaseURL:function(){return"https://www.cochranelibrary.com"},getCDNDynamicResourcesHost:function(){return""},getCDNHost:function(){return""},getCompanyId:function(){return"20155"},getCompanyGroupId:function(){return"20195"},getDefaultLanguageId:function(){return"en_US"},getDoAsUserIdEncoded:function(){return""},getLanguageId:function(){return"en_US"},getParentGroupId:function(){return"20182"},getPathContext:function(){return""},getPathImage:function(){return"/image"},getPathJavaScript:function(){return"/html/js"},getPathMain:function(){return"/en/c"},getPathThemeImages:function(){return"https://www.cochranelibrary.com/cochrane-theme/images"},getPathThemeRoot:function(){return"/cochrane-theme"},getPlid:function(){return"20757"},getPortalURL:function(){return"https://www.cochranelibrary.com"},getPortletSetupShowBordersDefault:function(){return true},getScopeGroupId:function(){return"20182"},getScopeGroupIdOrLiveGroupId:function(){return"20182"},getSessionId:function(){return""},getSiteGroupId:function(){return"20182"},getURLControlPanel:function(){return"/group/control_panel?refererPlid=20757"},getURLHome:function(){return"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane"},getUserId:function(){return"20159"},getUserName:function(){return""},isAddSessionIdToURL:function(){return false},isFreeformLayout:function(){return false},isImpersonated:function(){return false},isSignedIn:function(){return false},isStateExclusive:function(){return false},isStateMaximized:function(){return false},isStatePopUp:function(){return false}},PropsValues:{NTLM_AUTH_ENABLED:false}};var themeDisplay=Liferay.ThemeDisplay;Liferay.AUI={getAvailableLangPath:function(){return"available_languages.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getCombine:function(){return true},getComboPath:function(){return"/combo/?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000&"},getFilter:function(){return"min"},getJavaScriptRootPath:function(){return"/html/js"},getLangPath:function(){return"aui_lang.jsp?browserId=other&themeId=cochrane_WAR_cochranetheme&colorSchemeId=01&minifierType=js&languageId=en_US&b=6210&t=1513680837000"},getStaticResourceURLParams:function(){return"?browserId=other&minifierType=&languageId=en_US&b=6210&t=1513680837000"}};Liferay.authToken="EBp84H4P";Liferay.currentURL="\x2fweb\x2fcochrane\x2fcontent\x3ftemplateType\x3dfull\x26urlTitle\x3d\x2fcdsr\x2fdoi\x2f10\x2e1002\x2f14651858\x2eCD002253\x2epub4\x26doi\x3d10\x2e1002\x2f14651858\x2eCD002253\x2epub4\x26type\x3dcdsr\x26contentLanguage\x3d";Liferay.currentURLEncoded="\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D";</script> <script src="/html/js/barebone.jsp?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;colorSchemeId=01&amp;minifierType=js&amp;minifierBundleId=javascript.barebone.files&amp;languageId=en_US&amp;b=6210&amp;t=1513680837000" type="text/javascript"></script> <script type="text/javascript"></script> <script type="text/javascript">var o={database:"CDSR",page:{pageType:"Article Full Text HTML"},article:{availableLanguage:["en","es","zh_HANS","fr","de","fa","th","ms","ja","zh_HANT"],languageCode:"en",accessStatus:"delayed-free",doi:"10.1002/14651858.CD002253.pub4",title:"Medical treatment for early fetal death (less than 24 weeks)",firstPublishedDate:"Jun 17, 2019 12:00:00 AM",isCurrentVersion:true,editorialGroup:"Cochrane Pregnancy and Childbirth Group",availableParts:["PDF Full","PDF Standard","PDF Abstract","HTML","Comments","Information","References","Stats","Related Content"]}};window.dataLayer=xtend(true,window.dataLayer,o);</script> <link class="lfr-css-file" href="https://www.cochranelibrary.com/cochrane-theme/css/custom.css?browserId=other&amp;themeId=cochrane_WAR_cochranetheme&amp;minifierType=css&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" rel="stylesheet" type="text/css"/> <style type="text/css"></style> <script async="" src="https://assets.adobedtm.com/59640f9fa510/7cad07cf7779/launch-a215d9c51521.min.js"></script> <!--[if lt IE 9]> <script src="/cochrane-theme/vendor/respond/dest/respond.min.js?t=1738734739000" type="text/javascript"></script> <![endif]--> </head> <body class="yui3-skin-sam controls-visible guest-site signed-out public-page site"> <div class="site-container"> <a href="#main-content" id="skip-to-content">Skip to Content</a> <div class="cookie-message cookie-message--hidden system-message-container" id="js-cookie-message"> <div class="container"> <a aria-label="Close cookies message" class="fa fa-times js-cookie-close pull-right" href="#"></a> <div class="system-message-wrapper container"> <i aria-hidden="true" class="fa fa-exclamation-triangle"></i> <div class="system-message-title">Cookies</div> <div class="system-message-description"> <p> Our site uses cookies to improve your experience. You can find out more about our use of cookies in About Cookies, including instructions on how to turn off cookies if you wish to do so. By continuing to browse this site you agree to us using cookies as described in <a href="http://olabout.wiley.com/WileyCDA/Section/id-813473.html">About Cookies</a>. </p> <a class="btn secondary js-cookie-close js-cookie-accept" href="#">I accept</a> </div> </div> </div> </div> <script>document.body.className=document.body.className+" js_enabled";</script><header> <div class="container"> <div class="branding"> <h1 class="brand-container"> <a href="https://www.cochranelibrary.com/en/"> <span class="brand-name">The Cochrane Library</span> <img alt="Cochrane Library logo" class="brand-logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_logo.png" title="Cochrane Library"/> </a> </h1> <span class="additional-branding"> <p class="brand-message"> <em>Trusted evidence.</em> <em>Informed decisions.</em> <em>Better health.</em> </p> </span> </div> <div class="desktop-search basic-search-container"> <div class="desktop-search-form"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="owel__null__null" src="/scolaris-search/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"/> <input name="facetDisplayName" type="hidden" value=""/> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002253.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002253.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<div class="search-tools-nav">
<a class="btn secondary" href="/en/browse-by-topic">Browse</a>
<a class="btn primary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
</div>
<a class="toggle-menu-switch" href="#"><i aria-hidden="true" class="fa fa-bars"></i> <div class="toggle-menu-text">Open menu</div></a>
</div>
<div class="auxiliary-container">
<div class="container">
<div class="header-auxiliary-menu">
<div class="auxiliary-menu-item language-selector">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="bvrs__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> Review language : English </a> <a class="open-language-modal" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> Website language : English </a> </div> <div class="language-selector-modal-content" data-modal-title="Language selection" data-size="large" style="display: none;"> <div class="form-content language-selector-modal"> <div class="row-fluid"> <div> <table class="mytable" style="border: 1px solid #f0f0f0" width="90%"> <tbody> <tr class="row-box"> <td><i class="fa fa-file-text icon-size"></i></td> <td><h3>Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> </td> <td> <div> <select id="contentLanguageSelector" onchange="updateLang(this.value)"> <option class="content-language-option" data-languagecode="de" value="de"> Deutsch </option> <option class="content-language-option" data-languagecode="en" selected="" value="en"> English </option> <option class="content-language-option" data-languagecode="es" value="es"> Español </option> <option class="content-language-option" data-languagecode="fa" value="fa"> فارسی </option> <option class="content-language-option" data-languagecode="fr" value="fr"> Français </option> <option class="content-language-option" data-languagecode="hi" value="hi"> हिन्दी </option> <option class="content-language-option" data-languagecode="hr" value="hr"> Hrvatski </option> <option class="content-language-option" data-languagecode="id" value="id"> Bahasa Indonesia </option> <option class="content-language-option" data-languagecode="ja" value="ja"> 日本語 </option> <option class="content-language-option" data-languagecode="ko" value="ko"> 한국어 </option> <option class="content-language-option" data-languagecode="hu" value="hu"> Magyar </option> <option class="content-language-option" data-languagecode="ms" value="ms"> Bahasa Malaysia </option> <option class="content-language-option" data-languagecode="nl" value="nl"> Nederlands </option> <option class="content-language-option" data-languagecode="pl" value="pl"> Polski </option> <option class="content-language-option" data-languagecode="pt" value="pt"> Português </option> <option class="content-language-option" data-languagecode="ru" value="ru"> Русский </option> <option class="content-language-option" data-languagecode="ro" value="ro"> Română </option> <option class="content-language-option" data-languagecode="ta" value="ta"> தமிழ் </option> <option class="content-language-option" data-languagecode="th" value="th"> ภาษาไทย </option> <option class="content-language-option" data-languagecode="zh_HANT" value="zh_HANT"> 繁體中文 </option> <option class="content-language-option" data-languagecode="zh_HANS" value="zh_HANS"> 简体中文 </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> <tr class="row-box"> <td><i class="fa fa-globe icon-size"></i></td> <td> <div class="language-info"> <h3>Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> </div> </td> <td> <div class="language-dropdown"> <select id="portalLanguageSelector"> <option class="portal-language-selector" data-portallanguage="en" selected="" value="/en/cdsr/doi/10.1002/14651858.CD002253.pub4/full/en"> English </option> <option class="portal-language-selector" data-portallanguage="es" value="/es/cdsr/doi/10.1002/14651858.CD002253.pub4/full/es"> Español </option> </select> </div> </td> </tr> <tr> <td colspan="1" style="height: 10px"></td> </tr> </tbody> </table> </div> </div> <div style="text-align: right;"> <button class="btn primary btn-cancel" style="margin-left: 10px;" type="button">Cancel</button> <a class="btn secondary ok-btn" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
<a class="auxiliary-menu-item signin last" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002253.pub4%2Ffull" rel="nofollow">
<i class="icon fa fa-user"></i> Sign In
    </a>
<span class="auxiliary-container-extended"></span>
</div>
</div>
</div>
</header>
<div class="main-nav-wrapper">
<span class="main-nav-left-extended"></span>
<nav class="main container">
<ul>
<li class="nav-root-item parent">
<a href="#">Cochrane reviews<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_14" role="presentation">
<a aria-labelledby="layout_14" href="https://www.cochranelibrary.com/en/cdsr/reviews" role="menuitem">
            Search reviews (CDSR)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_15" role="presentation">
<a aria-labelledby="layout_15" href="https://www.cochranelibrary.com/en/cdsr/reviews/topics" role="menuitem">
            Browse reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_18" role="presentation">
<a aria-labelledby="layout_18" href="https://www.cochranelibrary.com/en/cdsr/table-of-contents" role="menuitem">
            Issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_17" role="presentation">
<a aria-labelledby="layout_17" href="https://www.cochranelibrary.com/en/cdsr/editorials" role="menuitem">
            Editorials
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_19" role="presentation">
<a aria-labelledby="layout_19" href="https://www.cochranelibrary.com/en/special-collections" role="menuitem">
            Special Collections
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_20" role="presentation">
<a aria-labelledby="layout_20" href="https://www.cochranelibrary.com/en/cdsr/supplements" role="menuitem">
            Supplements
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_121" role="presentation">
<a aria-labelledby="layout_121" href="https://www.cochranelibrary.com/en/about/about-cochrane-reviews" role="menuitem">
            About Cochrane reviews
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Searching for trials<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_254" role="presentation">
<a aria-labelledby="layout_254" href="https://www.cochranelibrary.com/en/search/releases" role="menuitem">
            What's new (search and CENTRAL)
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_266" role="presentation">
<a aria-labelledby="layout_266" href="https://www.cochranelibrary.com/en/search-help" role="menuitem">
            Search help
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_252" role="presentation">
<a aria-labelledby="layout_252" href="https://www.cochranelibrary.com/en/search-help-quick-guides" role="menuitem">
            Search help quick guides
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_251" role="presentation">
<a aria-labelledby="layout_251" href="https://www.cochranelibrary.com/en/search-faqs" role="menuitem">
            Search FAQs
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_114" role="presentation">
<a aria-labelledby="layout_114" href="https://www.cochranelibrary.com/en/central/about-central" role="menuitem">
            About CENTRAL
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_115" role="presentation">
<a aria-labelledby="layout_115" href="https://www.cochranelibrary.com/en/central/central-creation" role="menuitem">
            How CENTRAL is created
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_241" role="presentation">
<a aria-labelledby="layout_241" href="https://www.cochranelibrary.com/en/retracted-trials" role="menuitem">
            Retracted publications in CENTRAL
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Clinical Answers<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_29" role="presentation">
<a aria-labelledby="layout_29" href="https://www.cochranelibrary.com/en/cca" role="menuitem">
            Browse Clinical Answers
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_91" role="presentation">
<a aria-labelledby="layout_91" href="https://www.cochranelibrary.com/en/cca/about" role="menuitem">
            About Clinical Answers
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">About<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_116" role="presentation">
<a aria-labelledby="layout_116" href="https://www.cochranelibrary.com/en/about/about-cochrane-library" role="menuitem">
            About the Cochrane Library
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_13" role="presentation">
<a aria-labelledby="layout_13" href="https://www.cochranelibrary.com/en/cdsr/about-cdsr" role="menuitem">
            Cochrane Database of Systematic reviews
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_198" role="presentation">
<a aria-labelledby="layout_198" href="https://www.cochranelibrary.com/en/cdsr/editorial-policies" role="menuitem">
            Editorial policies
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_92" role="presentation">
<a aria-labelledby="layout_92" href="https://www.cochranelibrary.com/en/about/author-information" role="menuitem">
            Information for authors
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_212" role="presentation">
<a aria-labelledby="layout_212" href="https://www.cochranelibrary.com/en/about-pico" role="menuitem">
            About PICO
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_207" role="presentation">
<a aria-labelledby="layout_207" href="https://www.cochranelibrary.com/en/about/about-translations" role="menuitem">
            About translations
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_188" role="presentation">
<a aria-labelledby="layout_188" href="https://www.cochranelibrary.com/en/about/releases" role="menuitem">
            What's new
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_216" role="presentation">
<a aria-labelledby="layout_216" href="https://www.cochranelibrary.com/en/data" role="menuitem">
            Data reuse
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_235" role="presentation">
<a aria-labelledby="layout_235" href="https://www.cochranelibrary.com/en/about/about-cochrane-library/editorial-board" role="menuitem">
            Cochrane Library Editorial Board
        </a>
</li>
</ul>
</li>
<li class="nav-root-item parent">
<a href="#">Help<span class="icon fa fa-caret-down"></span></a>
<ul class="child">
<li class="child-nav-item" id="layout_nav_child_attr_259" role="presentation">
<a aria-labelledby="layout_259" href="https://m.info.wiley.com/webApp/cochranenewsletter?id=0" role="menuitem">
            Newsletter
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_177" role="presentation">
<a aria-labelledby="layout_177" href="https://www.wiley.com/en-us/customer-success/cochrane-library-training-hub" role="menuitem">
            Cochrane Library Training
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_44" role="presentation">
<a aria-labelledby="layout_44" href="https://www.cochranelibrary.com/en/help/access" role="menuitem">
            Access
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_150" role="presentation">
<a aria-labelledby="layout_150" href="https://www.cochranelibrary.com/en/help/permissions" role="menuitem">
            Permissions and reprints
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_93" role="presentation">
<a aria-labelledby="layout_93" href="https://www.cochranelibrary.com/en/help/media" role="menuitem">
            Media information
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_97" role="presentation">
<a aria-labelledby="layout_97" href="https://www.cochranelibrary.com/en/help/contact-us" role="menuitem">
            Contact us
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_125" role="presentation">
<a aria-labelledby="layout_125" href="https://www.cochranelibrary.com/en/about/terms-and-conditions" role="menuitem">
            Terms and conditions
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_176" role="presentation">
<a aria-labelledby="layout_176" href="https://cochranesupport.wiley.com/s/article/cochrane-library-known-issues" role="menuitem">
            Known issues
        </a>
</li>
<li class="child-nav-item" id="layout_nav_child_attr_270" role="presentation">
<a aria-labelledby="layout_270" href="https://www.cochranelibrary.com/search-help" role="menuitem">
            Search help
        </a>
</li>
</ul>
</li>
<li class="about-link"><a href="https://www.cochrane.org/about-us" target="_blank"><span>About Cochrane</span><i class="fa fa-caret-right"></i></a></li>
</ul>
</nav>
</div>
<div class="portlet-boundary portlet-boundary_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_">
<span id="p_scolariscontentlanguagebanner_WAR_scolarislanguageportlet"></span>
<section class="portlet" id="portlet_scolariscontentlanguagebanner_WAR_scolarislanguageportlet">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Language\x20Banner\x20Portlet')">
<img alt="" id="etlj__null__null" src="/scolaris-language-portlet/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Language Banner Portlet</span> </span> <span class="portlet-title-text">Scolaris Content Language Banner Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentlanguagebanner_WAR_scolarislanguageportlet" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="" id="content">
<div class="columns-1" id="main-content" role="main">
<div class="portlet-layout row-fluid">
<div class="portlet-column portlet-column-only span12" id="column-1">
<div class="portlet-dropzone portlet-column-content portlet-column-content-only" id="layout-column_column-1">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="rjus__column1__0" src="/scolaris-content-display/icon.png"/> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="publication cdsr container"> <div class="article-navigation-container" id="cdsr-nav"> <nav class="article-navigation"> <ul class="tools-row"> <li> <li class="tools pdf pulldown-menu readcube-menu closed en_US"> <a class="pulldown-menu-trigger" href="#0"> <span class="pdf-icon"> <i class="icon fa fa-file-pdf-o"></i> <span>Download PDF</span> </span> <i aria-hidden="true" class="fa fa-caret-down"></i> </a> <ul class="pulldown-menu-items"> <li class=""> <a class="download media pdf-link-full pdf-link" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/pdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> <a class="download media pdf-link-full readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/epdf/full/en" title="Article in PDF format"> <span class="readcube-label"> Full </span> <span class="readcube-description"> All content </span> </a> </li> <li class=""> <a class="download media pdf-link-abstract pdf-link" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/pdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> <a class="download media pdf-link-abstract readcube-epdf-link" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/epdf/abstract/en" title="Article in PDF format"> <span class="readcube-label"> Summary </span> <span class="readcube-description"> Abstract and plain language summary only </span> </a> </li> </ul> </li> <li class="tools cite cite-article-link" data-article-id="CD002253.PUB4" data-modal-title="Cite this review"> <span><i aria-hidden="true" class="icon fa fa-share"></i></span> <span>Cite this review</span> </li> </li> </ul> <ul class="tools-row tools-secondary"> <li> <li class="tools print print-cdsr-link" data-content-language="en" data-indicator-tooltip="scolaris.print.modal.language.tooltip.en" data-print-options="[{&quot;param&quot;: &quot;abstract&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Abstract&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;چکیده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé scientifique&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;บทคัดย่อ&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Abstract&quot;}]},{&quot;param&quot;: &quot;pls&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;de&quot;,&quot;title&quot;:&quot;Zusammenfassung in einfacher Sprache&quot;},{&quot;language&quot;:&quot;es&quot;,&quot;title&quot;:&quot;Resumen en términos sencillos&quot;},{&quot;language&quot;:&quot;fa&quot;,&quot;title&quot;:&quot;خلاصه به زبان ساده&quot;},{&quot;language&quot;:&quot;fr&quot;,&quot;title&quot;:&quot;Résumé simplifié&quot;},{&quot;language&quot;:&quot;ja&quot;,&quot;title&quot;:&quot;一般語訳&quot;},{&quot;language&quot;:&quot;ms&quot;,&quot;title&quot;:&quot;Ringkasan bahasa mudah&quot;},{&quot;language&quot;:&quot;th&quot;,&quot;title&quot;:&quot;ข้้อสรุปภาษาธรรมดา&quot;},{&quot;language&quot;:&quot;zh_HANS&quot;,&quot;title&quot;:&quot;Plain language summary&quot;},{&quot;language&quot;:&quot;zh_HANT&quot;,&quot;title&quot;:&quot;淺顯易懂的口語結論&quot;}]},{&quot;param&quot;: &quot;conclusions&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors' conclusions&quot;}]},{&quot;param&quot;: &quot;summaryOfFindings&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Summary of findings&quot;}]},{&quot;param&quot;: &quot;background&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Background&quot;}]},{&quot;param&quot;: &quot;objectives&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Objectives&quot;}]},{&quot;param&quot;: &quot;methods&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Methods&quot;}]},{&quot;param&quot;: &quot;results&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Results&quot;}]},{&quot;param&quot;: &quot;discussion&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Discussion&quot;}]},{&quot;param&quot;: &quot;references&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;References&quot;}]},{&quot;param&quot;: &quot;appendices&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Appendices&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Search strategies&quot;}]},{&quot;param&quot;: &quot;characteristics&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Characteristics of studies&quot;}]},{&quot;param&quot;: &quot;data&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Analyses&quot;}]},{&quot;param&quot;: &quot;information&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Information&quot;}]},{&quot;param&quot;: &quot;authors&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;Authors&quot;}]},{&quot;param&quot;: &quot;history&quot;,&quot;titles&quot;:[{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;},{&quot;language&quot;:&quot;en&quot;,&quot;title&quot;:&quot;History&quot;}]}]" data-print-urlbase="/cdsr/doi/10.1002/14651858.CD002253.pub4/print"> <span><i class="icon fa fa-print"></i></span> <span>Print</span> </li> <li class="js-old-version-modal-trigger tools comments comment-on-review" data-article-id="CD002253.PUB4" data-english-only-message="Please note, that commenting is available in English only. Apologies for any inconvenience." data-href="/cdsr/doi/10.1002/14651858.CD002253.pub4/read-comments" data-new-version="" id="comment-on-review"> <span class="comment-icon"><i class="icon fa fa-comment"></i></span> <span class="comments-count">0</span> <span>Comment</span> </li> <li class="tools share-cdsr-link" data-share-url="/cdsr/doi/10.1002/14651858.CD002253.pub4/full"> <span><i class="icon fa fa-share-alt"></i></span> <span>Share</span> </li> <li class="tools follow"> <span class="article-not-followed cochrane-link signin follow-wrapper"> <span> <i class="icon fa fa-plus"></i> </span> <span> Follow </span> </span> </li> </li> </ul> <div class="metrics-wrapper"> <div class="metrics-count"> <span>Full text views: </span> <span>6519 <i class="icon fa fa-info-circle custom-tooltip" style="padding-left: 2px;color: #962d91;" title="Usage represents full text views on Cochrane Library since January 2022 or 2023. For articles published after this date, the usage represents views since the article was first published on Cochrane Library."> </i> </span> </div> </div> <div class="metrics-wrapper nav-link-section"> <div class="altmetric-embed" data-badge-type="1" data-condensed="true" data-doi="10.1002/14651858.CD002253.pub4" data-link-target="_blank"></div> <div class="inline-status-wrapper guidelines-count" data-count-plural="Cited in $1 guidelines" data-count-single="Cited in 1 guideline"> <a href="related-content#guidelines_data" title="Guidelines"></a> </div> </div> <ul class="nav-section-header"> <li> <h3>Contents</h3> </li> </ul> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full"> Abstract </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#pico"> PICOs </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-abs-0005"> Plain language summary </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0177"> Authors' conclusions </a> </li> <li class="cdsr-nav-link bold-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0043"> Summary of findings </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0044"> Background </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0049"> Objectives </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0050"> Methods </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0087"> Results </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-sec-0171"> Discussion </a> </li> <li class="cdsr-nav-link"> <a class="figures-and-tables-link" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/#"> Figures and tables </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references"> References </a> </li> </ul> <div class="nav-section-header"> <h3>Supplementary materials</h3> </div> <ul class="nav-long-form nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/appendices#CD002253-sec-0182"> Search strategies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#characteristicStudies"> Characteristics of studies </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#dataAndAnalyses"> Analyses </a> </li> <li class="cdsr-nav-link download-stats-data-link" data-download-href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/table_n/CD002253StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/table_n/CD002253StatsDataOnly.rm5?content-disposition=attachment&amp;mime-type=application/octet-stream"> Download data </a> </li> </ul> <ul class="tools-row"> <li> </li> </ul> <ul class="nav-section-header"> <li><h3>Related</h3></li> </ul> <ul class="linked-content linked-content-dropdown" id="linked-content-articles" tabindex="0"> <li class="linked-cca" data-type="cca"> <div class="linked-content-section"> <span class="linked-type">Cochrane Clinical Answers<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-editorials" data-type="editorial"> <div class="linked-content-section"> <span class="linked-type">Editorials<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-podcasts" data-type="podcast"> <div class="linked-content-section"> <span class="linked-type">Podcasts<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> <li class="linked-sc" data-type="sc"> <div class="linked-content-section"> <span class="linked-type">Special Collections<span class="count"></span></span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="articles"></div> </li> </ul> <div class="nav-section-header"> <h3>About this review</h3> </div> <ul class="nav-long-form nav-info nav-link-section"> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information"> <i> <svg viewbox="0 0 24 24"> <path d="M11,9H13V7H11M12,20C7.59,20 4,16.41 4,12C4,7.59 7.59,4 12,4C16.41,4 20,7.59 20,12C20,16.41 16.41,20 12,20M12,2A10,10 0 0,0 2,12A10,10 0 0,0 12,22A10,10 0 0,0 22,12A10,10 0 0,0 12,2M11,17H13V11H11V17Z"></path> </svg> </i> Information </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#authors"> <i> <svg viewbox="0 0 24 24"> <path d="M12,5.5A3.5,3.5 0 0,1 15.5,9A3.5,3.5 0 0,1 12,12.5A3.5,3.5 0 0,1 8.5,9A3.5,3.5 0 0,1 12,5.5M5,8C5.56,8 6.08,8.15 6.53,8.42C6.38,9.85 6.8,11.27 7.66,12.38C7.16,13.34 6.16,14 5,14A3,3 0 0,1 2,11A3,3 0 0,1 5,8M19,8A3,3 0 0,1 22,11A3,3 0 0,1 19,14C17.84,14 16.84,13.34 16.34,12.38C17.2,11.27 17.62,9.85 17.47,8.42C17.92,8.15 18.44,8 19,8M5.5,18.25C5.5,16.18 8.41,14.5 12,14.5C15.59,14.5 18.5,16.18 18.5,18.25V20H5.5V18.25M0,20V18.5C0,17.11 1.89,15.94 4.45,15.6C3.86,16.28 3.5,17.22 3.5,18.25V20H0M24,20H20.5V18.25C20.5,17.22 20.14,16.28 19.55,15.6C22.11,15.94 24,17.11 24,18.5V20Z"></path> </svg> </i> Authors </a> </li> <li class="cdsr-nav-link" lang="en"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#history"> <i> <svg viewbox="0 0 24 24"> <path d="M13.5,8H12V13L16.28,15.54L17,14.33L13.5,12.25V8M13,3A9,9 0 0,0 4,12H1L4.96,16.03L9,12H6A7,7 0 0,1 13,5A7,7 0 0,1 20,12A7,7 0 0,1 13,19C11.07,19 9.32,18.21 8.06,16.94L6.64,18.36C8.27,20 10.5,21 13,21A9,9 0 0,0 22,12A9,9 0 0,0 13,3"></path> </svg> </i> Version history </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#keywords"> <i> <svg viewbox="0 0 24 24"> <path d="M11 3C10.18 3 9.44 3.5 9.14 4.27L3.64 18.27C3.12 19.58 4.09 21 5.5 21H7.75C8.59 21 9.33 20.5 9.62 19.7L10.26 18H13.74L14.38 19.7C14.67 20.5 15.42 21 16.25 21H18.5C19.91 21 20.88 19.58 20.36 18.27L14.86 4.27C14.56 3.5 13.82 3 13 3M11 5H13L18.5 19H16.25L15.12 16H8.87L7.75 19H5.5M12 7.67L9.62 14H14.37Z"></path> </svg> </i> Keywords (MeSH, PICOs) </a> </li> <li class="cdsr-nav-link"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/related-content"> <i class="icon fa fa-sitemap fa-rotate-270"></i> Related content </a> </li> <li class="cdsr-nav-link translation-notes-link"> <a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/#"> <i> <svg viewbox="0 0 24 24"> <path d="M12.87,15.07L10.33,12.56L10.36,12.53C12.1,10.59 13.34,8.36 14.07,6H17V4H10V2H8V4H1V6H12.17C11.5,7.92 10.44,9.75 9,11.35C8.07,10.32 7.3,9.19 6.69,8H4.69C5.42,9.63 6.42,11.17 7.67,12.56L2.58,17.58L4,19L9,14L12.11,17.11L12.87,15.07M18.5,10H16.5L12,22H14L15.12,19H19.87L21,22H23L18.5,10M15.88,17L17.5,12.67L19.12,17H15.88Z"></path> </svg> </i> Translation notes </a> </li> <li class="cdsr-nav-link"> <a class="request-permissions" data-copyright="Copyright © 2019 The Cochrane Collaboration. Published by John Wiley &amp; Sons, Ltd." data-creative-commons="false" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/#"> <span class="request-permissions-icon"></span> Request permissions </a> </li> <li class="cdsr-nav-link"> <a href="/data"> <i class="icon fa fa-database"></i> Request data reuse </a> </li> </ul> </nav> </div> <article> <div class="cdsr-header-top"> <div class="cdsr-header-left"> <a class="publish-database" href="/">Cochrane Database of Systematic reviews</a> <span class="publish-type">Review - Intervention</span> </div> <div class="cdsr-header-right"> <div class="inline-status-wrapper"> <ul class="cochrane-status"> <li aria-label="A new search for studies has been conducted." class="status-item up-to-date custom-tooltip" data-status="newsearch" title="A new search for studies has been conducted."> <a class="btn secondary" href="information#history">New search</a> </li> </ul> </div> </div> </div> <header class="publication-header"> <h1 class="publication-title" lang="en">Medical treatment for early fetal death (less than 24 weeks)</h1> <div class="publication-metadata-block"> <div class="publication-authors"> <div class="publish-meta-wrapper"> <ul class="authors"> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0002">Marike Lemmers</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0003">Marianne AC Verschoor</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0004">Bobae Veronica Kim</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0005">Martha Hickey</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0006">Juan C Vazquez</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0007">Ben Willem J Mol</a></li> <li class="author"><a href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information#CD002253-cr-0008"><i class="icon corresponding-author fa fa-envelope"></i>James P Neilson</a></li> </ul> <span class="author declaration"> <a class="declarationsOfInterestLink" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information/en#CD002253-sec-0187">Authors' declarations of interest</a> </span> </div> </div> </div> <div class="publication-metadata-block"> <p> <span class="publish-date">Version published: 17 June 2019 </span> <a class="whatsNewLink" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/information/en#versionTable">Version history</a> </p> <div class="doi-header"> <a href="https://doi.org/10.1002/14651858.CD002253.pub4">https://doi.org/10.1002/14651858.CD002253.pub4</a> </div> </div> </header> <div class="publication-control-bar"> <span class="publication-control-button publication-control-collapse"> Collapse all </span> <span class="publication-control-button publication-control-expand"> Expand all </span> </div> <section class="abstract"> <div class="section-header section-collapse-header" id="CD002253-abs-0001" lang="en"> <h2 class="title section-collapse-title"> Abstract <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002253-abs-0001">English</a> </li> <li class="section-language"> <a class="" href="full/es#CD002253-abs-0004">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002253-abs-0010">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002253-abs-0003">Français</a> </li> <li class="section-language"> <a class="" href="full/th#CD002253-abs-0012">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002253-abs-0002">简体中文</a> </li> </nav> </div> </div> <div class="abstract full_abstract" id="CD002253-abs-0001" lang="en"> <section id="CD002253-sec-0001"> <h3 class="title" id="CD002253-sec-0001">Background</h3> <p>In most pregnancies that miscarry, arrest of embryonic or fetal development occurs some time (often weeks) before the miscarriage occurs. Ultrasound examination can reveal abnormal findings during this phase by demonstrating anembryonic pregnancies or embryonic or fetal death. Treatment has traditionally been surgical but medical treatments may be effective, safe, and acceptable, as may be waiting for spontaneous miscarriage. This is an update of a review first published in 2006. </p> </section> <section id="CD002253-sec-0002"> <h3 class="title" id="CD002253-sec-0002">Objectives</h3> <p>To assess, from clinical trials, the effectiveness and safety of different medical treatments for the termination of non‐viable pregnancies. </p> </section> <section id="CD002253-sec-0003"> <h3 class="title" id="CD002253-sec-0003">Search methods</h3> <p>For this update, we searched Cochrane Pregnancy and Childbirth's Trials Register, <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a>, the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (24 October 2018) and reference lists of retrieved studies. </p> </section> <section id="CD002253-sec-0004"> <h3 class="title" id="CD002253-sec-0004">Selection criteria</h3> <p>Randomised trials comparing medical treatment with another treatment (e.g. surgical evacuation), or placebo, or no treatment for early pregnancy failure. Quasi‐randomised studies were excluded. Cluster‐randomised trials were eligible for inclusion, as were studies reported in abstract form, if sufficient information was available to assess eligibility. </p> </section> <section id="CD002253-sec-0005"> <h3 class="title" id="CD002253-sec-0005">Data collection and analysis</h3> <p>Two review authors independently assessed trials for inclusion and risk of bias, extracted data and checked them for accuracy. We assessed the quality of the evidence using the GRADE approach. </p> </section> <section id="CD002253-sec-0006"> <h3 class="title" id="CD002253-sec-0006">Main results</h3> <p>Forty‐three studies (4966 women) were included. The main interventions examined were vaginal, sublingual, oral and buccal misoprostol, mifepristone and vaginal gemeprost. These were compared with surgical management, expectant management, placebo, or different types of medical interventions were compared with each other. The review includes a wide variety of different interventions which have been analysed across 23 different comparisons. Many of the comparisons consist of single studies. We limited the grading of the quality of evidence to two main comparisons: vaginal misoprostol versus placebo and vaginal misoprostol versus surgical evacuation of the uterus. Risk of bias varied widely among the included trials. The quality of the evidence varied between the different comparisons, but was mainly found to be very‐low or low quality. </p> <p><b>Vaginal misoprostol versus placebo</b> </p> <p>Vaginal misoprostol may hasten miscarriage when compared with placebo: e.g. complete miscarriage (5 trials, 305 women, risk ratio (RR) 4.23, 95% confidence interval (CI) 3.01 to 5.94; low‐quality evidence). No trial reported on pelvic infection rate for this comparison. Vaginal misoprostol made little difference to rates of nausea (2 trials, 88 women, RR 1.38, 95% CI 0.43 to 4.40; low‐quality evidence), diarrhoea (2 trials, 88 women, RR 2.21, 95% CI 0.35 to 14.06; low‐quality evidence) or to whether women were satisfied with the acceptability of the method (1 trial, 32 women, RR 1.17, 95% CI 0.83 to 1.64; low‐quality evidence). It is uncertain whether vaginal misoprostol reduces blood loss (haemoglobin difference &gt; 10 g/L) (1 trial, 50 women, RR 1.25, 95% CI 0.38 to 4.12; very‐low quality) or pain (opiate use) (1 trial, 84 women, RR 5.00, 95% CI 0.25 to 101.11; very‐low quality), because the quality of the evidence for these outcomes was found to be very low. </p> <p><b>Vaginal misoprostol versus surgical evacuation</b> </p> <p>Vaginal misoprostol may be less effective in accomplishing a complete miscarriage compared to surgical management (6 trials, 943 women, average RR 0.40, 95% CI 0.32 to 0.50; Heterogeneity: Tau² = 0.03, I² = 46%; low‐quality evidence) and may be associated with more nausea (1 trial, 154 women, RR 21.85, 95% CI 1.31 to 364.37; low‐quality evidence) and diarrhoea (1 trial, 154 women, RR 40.85, 95% CI 2.52 to 662.57; low‐quality evidence). There may be little or no difference between vaginal misoprostol and surgical evacuation for pelvic infection (1 trial, 618 women, RR 0.73, 95% CI 0.39 to 1.37; low‐quality evidence), blood loss (post‐treatment haematocrit (%) (1 trial, 50 women, mean difference (MD) 1.40%, 95% CI ‐3.51 to 0.71; low‐quality evidence), pain relief (1 trial, 154 women, RR 1.42, 95% CI 0.82 to 2.46; low‐quality evidence) or women's satisfaction/acceptability of method (1 trial, 45 women, RR 0.67, 95% CI 0.40 to 1.11; low‐quality evidence). </p> <p><b>Other comparisons</b> </p> <p>Based on findings from a single trial, vaginal misoprostol was more effective at accomplishing complete miscarriage than expectant management (614 women, RR 1.25, 95% CI 1.09 to 1.45). There was little difference between vaginal misoprostol and sublingual misoprostol (5 trials, 513 women, average RR 0.84, 95% CI 0.61 to 1.16; Heterogeneity: Tau² = 0.10, I² = 871%; or between oral and vaginal misoprostol in terms of complete miscarriage at less than 13 weeks (4 trials, 418 women), average RR 0.68, 95% CI 0.45 to 1.03; Heterogeneity: Tau² = 0.13, I² = 90%). However, there was less abdominal pain with vaginal misoprostol in comparison to sublingual (3 trials, 392 women, RR 0.58, 95% CI 0.46 to 0.74). A single study (46 women) found mifepristone to be more effective than placebo: miscarriage complete by day five after treatment (46 women, RR 9.50, 95% CI 2.49 to 36.19). However the quality of this evidence is very low: there is a very serious risk of bias with signs of incomplete data and no proper intention‐to‐treat analysis in the included study; and serious imprecision with wide confidence intervals. Mifepristone did not appear to further hasten miscarriage when added to a misoprostol regimen (3 trials, 447 women, RR 1.18, 95% CI 0.95 to 1.47). </p> </section> <section id="CD002253-sec-0007"> <h3 class="title" id="CD002253-sec-0007">Authors' conclusions</h3> <p>Available evidence from randomised trials suggests that medical treatment with vaginal misoprostol may be an acceptable alternative to surgical evacuation or expectant management. In general, side effects of medical treatment were minor, consisting mainly of nausea and diarrhoea. There were no major differences in effectiveness between different routes of administration. Treatment satisfaction was addressed in only a few studies, in which the majority of women were satisfied with the received intervention. Since the quality of evidence is low or very low for several comparisons, mainly because they included only one or two (small) trials; further research is necessary to assess the effectiveness, safety and side effects, optimal route of administration and dose of different medical treatments for early fetal death. </p> </section> </div> </section> <section class="pico-section" id="pico"> <h2 class="title section-collapse-title">PICOs <i class="icon fa fa-info-circle" title="The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome."></i> <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-content" style="display: block;"> <h3 class="keyword-heading">PICOs</h3> <div class="pico-table"> <div class="pico-column Population"> <h6>Population<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Intervention"> <h6>Intervention<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Comparison"> <h6>Comparison<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> <div class="pico-column Outcome"> <h6>Outcome<span class="pico-count"></span></h6> <ul class="pico-terms"> </ul> </div> </div> <div class="pico-information"> <p><i class="icon fa fa-info-circle"></i> The PICO model is widely used and taught in evidence-based health care as a strategy for formulating questions and search strategies and for characterizing clinical studies or meta-analyses. PICO stands for four different potential components of a clinical question: Patient, Population or Problem; Intervention; Comparison; Outcome.</p> <p>See more on using PICO in the <a href="https://training.cochrane.org/handbook/current/chapter-02#section-2-3">Cochrane Handbook</a>.</p> </div> </div> </section> <section class="pls"> <div class="section-header section-collapse-header" id="CD002253-abs-0005" lang="en"> <h2 class="title section-collapse-title"> Plain language summary <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> <div class="section-language-toggles"> <span class="section-languages-legend">available in</span> <nav class="section-languages"> <li class="section-language"> <a class="is-active" href="full/en#CD002253-abs-0005">English</a> </li> <li class="section-language"> <a class="" href="full/de#CD002253-abs-0009">Deutsch</a> </li> <li class="section-language"> <a class="" href="full/es#CD002253-abs-0008">Español</a> </li> <li class="section-language"> <a class="" href="full/fa#CD002253-abs-0011">فارسی</a> </li> <li class="section-language"> <a class="" href="full/fr#CD002253-abs-0007">Français</a> </li> <li class="section-language"> <a class="" href="full/ja#CD002253-abs-0015">日本語</a> </li> <li class="section-language"> <a class="" href="full/ms#CD002253-abs-0014">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="full/th#CD002253-abs-0013">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="full/zh_HANS#CD002253-abs-0006">简体中文</a> </li> <li class="section-language"> <a class="" href="full/zh_HANT#CD002253-abs-0016">繁體中文</a> </li> </nav> </div> </div> <div class="abstract abstract_plainLanguageSummary" id="CD002253-abs-0005" lang="en"> <h3>Medical treatment for early fetal death (less than 24 weeks)</h3> <p><b>What is the issue?</b> </p> <p>A miscarriage is the spontaneous death and/or expulsion of an embryo or fetus from the uterus before it is able to survive on its own. This natural death of an embryo or fetus ('non‐viable pregnancy' or 'intrauterine fetal death', depending on the duration of pregnancy) can be identified by ultrasound before symptoms like blood loss and abdominal pain occur. Sometimes an embryo may not have even developed ('empty sac'). In the past, treatment for a deceived embryo/fetus, has usually been by dilatation and curettage (D&amp;C) surgery, but drugs have now been developed to replace the need for surgery which may be helpful for the expulsion to happen. Misoprostol and gemeprost are synthetic prostaglandin E analogues that can stimulate expulsion of the embryo/fetus from the uterus. Mifepristone blocks the activity of progesterone, a hormone that supports pregnancy. These and similar drugs may be useful in bringing on expulsion in women with a non‐viable pregnancy and can be used before 24 weeks' gestation. </p> <p>Waiting for spontaneous expulsion is also possible. Women who retain the dead embryo/fetus can experience severe blood loss or develop an infection of the womb. These are rare complications. Gastro‐intestinal side effects such as nausea and diarrhoea, cramping or abdominal pain and fever have been reported with misoprostol. </p> <p><b>Why is this important?</b> </p> <p>Surgical treatment has the disadvantage of requiring anaesthesia. It carries risks of damage to the uterus or cervix and possible development of fibrous tissue in the inner lining of the uterus. These can be avoided if the non‐viable pregnancy is treated with medication, or if the woman is able to wait for a spontaneous expulsion. </p> <p>We set out to determine if medical treatment is as good as, or better than, surgical treatment or expectant management (waiting for the expulsion to happen). Furthermore, we compared different doses and administration routes in order to detect which regimen most often induces a complete miscarriage with the fewest side effects. </p> <p><b>What evidence did we find?</b> </p> <p>For this updated review, 43 randomised clinical trials involving 4966 women with non‐viable pregnancies at less than 24 weeks' gestation were included. The main interventions examined were vaginal, sublingual, oral and buccal misoprostol, mifepristone and vaginal gemeprost. These were compared with surgical management, expectant management, placebo, or different types of medical interventions were compared with each other. Fourteen comparisons had only one trial. The studies varied in risk of bias. The quality of the evidence ranged from very low or low for most comparisons. </p> <p>Vaginal misoprostol may hasten miscarriage when compared with placebo but made little difference to rates of nausea, diarrhoea or to whether women were satisfied with the acceptability of the method. It is uncertain whether vaginal misoprostol when compared to placebo reduces blood loss or pain because the quality of the evidence for these outcomes was found to be very low. </p> <p>Vaginal misoprostol was less effective in accomplishing a complete miscarriage compared to surgical management and may be associated with more nausea and diarrhoea. Vaginal misoprostol made little difference to pelvic infection, blood loss, pain or women's satisfaction/acceptability of method when compared to surgical management. </p> <p>There was little difference between different routes of giving misoprostol when trials compared the vaginal route with placing it under the tongue or between oral and vaginal misoprostol. Single studies found mifepristone to be more effective than placebo and vaginal misoprostol to be more effective than expectant management. However the quality of this evidence was found to be very low and so we are not convinced of these findings. Mifepristone did not appear to provide any additional benefit when added to misoprostol. </p> <p><b>What does this mean?</b> </p> <p>Using misoprostol as an alternative to surgical treatment may decrease the need for surgery for women with an early fetal death. The use of misoprostol can have some side effects such as nausea and diarrhoea, but risks of severe blood loss or pelvic infection were not higher compared to surgical treatment or expectant management. Further research is needed on drug doses, routes of administration and potential adverse effects, including future fertility, and also on women's views of drug treatment, surgery and waiting for spontaneous miscarriage. </p> </div> </section> <section id="vls" style="display: none"> <div class="section-header section-collapse-header"> <h2 class="title section-collapse-title">Visual summary<i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i></h2> </div> <a href="" target="_blank"><img alt="visual summary" src=""/></a> </section> <section class="conclusions"> <div class="section-header section-collapse-header" id="CD002253-sec-0177" lang="en"> <h2 class="title section-collapse-title"> Authors' conclusions <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="authorsConclusions" lang="en"> <div class="section-header" id="CD002253-sec-0177"></div> <h3 class="title" id="CD002253-sec-0178">Implications for practice</h3> <section id="CD002253-sec-0178"> <p>Available evidence from randomised trials supports the use of misoprostol as one possible option for the treatment of non‐viable pregnancies before 24 weeks. In general, side effects of medical treatment were minor. There were no major differences in effectiveness between different routes of administration. Treatment satisfaction was addressed in only a few studies, in which the majority of women were satisfied with the received intervention. </p> <p>There is intense interest in the reproductive uses of misoprostol because it appears a potent method for pregnancy interruption as well as being cheap and stable at room temperature. Using misoprostol as an alternative to surgical treatment for early fetal death could decrease the number of curettages, thus preventing women from the specific risks that are related to surgical intervention. </p> </section> <h3 class="title" id="CD002253-sec-0179">Implications for research</h3> <section id="CD002253-sec-0179"> <p>Ultrasound demonstration of early pregnancy failure before 14 weeks is a common problem that merits greater research effort than has occurred to date. Further research to assess the effectiveness, safety and side effects of misoprostol, including optimal route of administration and dose, should focus on the dose regimens that tend to be most effective according to our review results: vaginal or sublingual misoprostol in higher dosages. Women's views about the acceptability of medical treatment, surgical treatment and expectant management could be integral to future research protocols, as could economic assessments. Long‐term outcomes, notably subsequent fertility, deserves further study in appropriately powered randomised controlled studies. </p> </section> </section> </section> <section class="summaryOfFindings"> <div class="section-header section-collapse-header" id="CD002253-sec-0043" lang="en"> <h2 class="title section-collapse-title"> Summary of findings <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="summaryOfFindings" lang="en"> <div class="section-header" id="CD002253-sec-0043"></div> <div class="table" id="CD002253-tbl-0001"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> early fetal death (less than 24 weeks)<br/> <b>Setting:</b> worldwide<br/> <b>Intervention:</b> vaginal misoprostol<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complete miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.23<br/> (3.01 to 5.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>305 women<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were differences in timing of outcome measurement: after 24 hours (2 studies), after 48 hours (2 studies) or after 7 days (1 study). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1.000<br/> (569 to 1.000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pelvic infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.38<br/> (0.43 to 4.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 women<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>128 per 1.000<br/> (40 to 409) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.21<br/> (0.35 to 14.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 women<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1.000<br/> (8 to 327) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood loss: haemoglobin difference &gt; 10 g/L</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/> (0.38 to 4.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1.000<br/> (61 to 659) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain (opiate use)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 5.00<br/> (0.25 to 101.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>84 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<sup>4 6</sup> </p> <p>VERY LOW</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Woman’s satisfaction/acceptability of method</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (0.83 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>878 per 1.000<br/> (622 to 1.000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Serious indirectness: differences in medication regimens used between the included studies. However: very strong association; dose‐response relation (‐1). </p> <p><sup>2</sup> Serious risk of bias: problems with blinding in various studies, downgraded because of limitation in study design (‐1). </p> <p><sup>3</sup> Serious imprecision: only two studies with relatively few patients (‐1). </p> <p><sup>4</sup> Serious risk of bias: unclear allocation concealment (‐1). </p> <p><sup>5</sup> Serious risk of indirect evidence: haematocrit difference was used to estimate the amount of blood loss (‐1). </p> <p><sup>6</sup> Serious imprecision: only one study included, wide confidence interval (‐2). </p> </div> </td> </tr> </tfoot> </table> </div> <div class="table" id="CD002253-tbl-0002"> <table class="summary-of-findings framed"><a class="open-table-viewer open-in-figure-viewer" href="#0">Open in table viewer</a><div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> early fetal death (less than 24 weeks)<br/> <b>Setting:</b> worldwide<br/> <b>Intervention:</b> vaginal misoprostol<br/> <b>Comparison:</b> surgical evacuation of uterus </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with surgical evacuation of uterus</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complete miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.32 to 0.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>943 women<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blinding of patients and treating personnel was impossible due to the nature of the interventions. All studies used the same dosage of misoprostol (800 mcg). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>921 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1.000<br/> (295 to 460) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pelvic infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.39 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>618 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 study included but with relatively large patient numbers.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1.000<br/> (28 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 21.85<br/> (1.31 to 364.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1.000<br/> (1 to 364) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 40.85<br/> (2.52 to 662.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1.000<br/> (3 to 663) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss: post‐treatment haematocrit (%)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean blood loss: post‐treatment haematocrit (%) was 35.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>mean 1.40 lower<br/> (3.51 lower to 0.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain relief</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.42 (0.82 t0 2.46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>303 per 1.000<br/> (175 to 525) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Woman’s satisfaction/acceptability of method</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67 (0.40 to 1.11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>45 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>536 per 1.000<br/> (320 to 888) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Serious risk of bias: only one study blinded the outcome assessors. All other studies were not blinded (‐1). </p> <p><sup>2</sup> Serious inconsistency: varied sampling, different medication regimes, I<sup>2</sup> = 46% (‐1). </p> <p><sup>3</sup> Serious risk of bias: no blinding of outcome assessors (‐1). </p> <p><sup>4</sup> Serious imprecision: only one study with relatively few patients, small number of events and wide confidence intervals (‐1). </p> <p><sup>5</sup> Serious risk of bias: high risk of selective reporting and unclear allocation concealment (‐1). </p> <p><sup>6</sup> Serious risk of bias: high risk of bias for blinding and attrition (‐1). </p> <p><sup>7</sup> Serious imprecision: only one study with relatively few patients (‐1). </p> </div> </td> </tr> </tfoot> </table> </div> </section> </section> <section class="background"> <div class="section-header section-collapse-header" id="CD002253-sec-0044" lang="en"> <h2 class="title section-collapse-title"> Background <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="background" lang="en"> <div class="section-header" id="CD002253-sec-0044"></div> <p>Miscarriage is the most frequent pregnancy complication with an incidence of at least 10% to 15% of all pregnancies (<a href="./references#CD002253-bbs2-0219" title="GrudzinskasJG . Endocrinological and metabolical assessment of early pregnancy. In: ChamberlainG editor(s). Turnbull's Obstetrics. London: Pearson Professional Ltd, 1995:185‐93. ">Grudzinskas 1995</a>; <a href="./references#CD002253-bbs2-0222" title="HowiePG . Abortion and ectopic pregnancy. In: WhitfieldCR editor(s). Dewhurst's Textbook of Obstetrics and Gynecology for Postgraduates. Oxford: Blackwell Science Ltd, 1995:140‐63. ">Howie 1995</a>; <a href="https://cc3khmdk4ijcp2vv2zihhwd7rm.sec.amc.nl/doi/10.1002/14651858.CD002253.pub3/full#CD002253-bbs2-0200#CD002253-bbs2-0200" target="_blank">Simpson 1991</a>). Traditionally, early non‐viable pregnancies (less than 14 weeks) have been terminated by surgical evacuation. However, the use of medical treatment for early non‐viable pregnancies is increasing. Later pregnancies (14 to 24 weeks) have been ended by medical induction of miscarriage (<a href="./references#CD002253-bbs2-0231" title="SayL , KulierR , GulmezogluAM , CampanaA . Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2] ">Say 2002</a>). </p> <section id="CD002253-sec-0045"> <h3 class="title" id="CD002253-sec-0045">Description of the condition</h3> <p>A miscarriage is defined as an intrauterine pregnancy demise confirmed by ultrasound or histology up to 13 weeks of gestation. There are different forms of non‐viable pregnancies such as 'anembryonic pregnancies' (formerly called 'blighted ova') if no embryo has developed within the gestational sac, or 'missed abortions' if an embryo or fetus is present, but is dead. When fetal death occurs in later pregnancy (14 to 24 weeks of gestation) it is called intrauterine fetal demise. </p> <p>The widespread use of ultrasound in early pregnancy for either specific reasons (for example, vaginal bleeding) or as a routine examination (<a href="./references#CD002253-bbs2-0233" title="WhitworthM , BrickerL , MullanC . Ultrasound for fetal assessment in early pregnancy. Cochrane Database of Systematic Reviews2015, Issue 7. [DOI: 10.1002/14651858.CD007058.pub3] ">Whitworth 2015</a>) reveals 'non‐viable pregnancies' destined inevitably to miscarry in due course. </p> </section> <section id="CD002253-sec-0046"> <h3 class="title" id="CD002253-sec-0046">Description of the intervention</h3> <p>Traditionally, early non‐viable pregnancies (less than 14 weeks) have been terminated by surgical evacuation. Later pregnancies (14 to 24 weeks) have been ended by medical induction of miscarriage (<a href="./references#CD002253-bbs2-0231" title="SayL , KulierR , GulmezogluAM , CampanaA . Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2] ">Say 2002</a>). Although clotting problems occasionally occur in women with prolonged retention of a dead fetus, this is rare and does not usually happen within the first month after fetal death. There are, therefore, not pressing medical reasons to terminate non‐viable pregnancies. Although, anecdotally, many women favour early termination, so‐called 'expectant management' (that is, awaiting spontaneous miscarriage) is a legitimate alternative and this policy should be considered in clinical care and in planning trials (<a href="./references#CD002253-bbs2-0228" title="NandaK , LopezLM , GrimesDA , PeloggiaA , NandaG . Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD003518.pub3] ">Nanda 2012</a>; <a href="./references#CD002253-bbs2-0234" title="Wieringa‐de WaardM , VosJ , BonselGJ , BindelsPJ , AnkumWM . Management of miscarriage: a randomized controlled trial of expectant management versus surgical evacuation. Human Reproduction2002;17(9):2445‐50. ">Wieringa 2002</a>). More recently, medical treatment is used as an alternative to surgical termination of non‐viable pregnancies. There are various types of medical treatment that could be used as alternatives to surgical treatment; misoprostol, mifepristone, gemeprost, methotrexate or oxytocin. The drug most frequently investigated and now used is misoprostol. This drug can be administered via several different routes; oral, sublingual, vaginal and extra amniotic, and as a single drug therapy or combined with other types of medication such as mifepristone, methotrexate or oxytocin. Furthermore, the optimal dose of misoprostol is not known, and therefore different doses are used ranging from 100 mg up to 800 mg per dose. </p> </section> <section id="CD002253-sec-0047"> <h3 class="title" id="CD002253-sec-0047">How the intervention might work</h3> <p>Misoprostol is a synthetic prostaglandin E1 analogue. It is a type of medication that was first registered as treatment for peptic ulcers. It is also used as medical treatment for terminating an unwanted or non‐viable pregnancy. Misoprostol ripens the cervix and causes uterine contractions. Furthermore, it is cost‐effective (<a href="./references#CD002253-bbs2-0217" title="CostaSH , VesseyMP . Misoprostol and illegal abortion in Rio de Janeiro, Brazil. Lancet1993;341:1258‐61. [PUBMED: 8098402] ">Costa 1993</a>; <a href="./references#CD002253-bbs2-0218" title="GraziosiGC , van derSteegJW , ReuwerPJ , DrogtropA , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2005</a>; <a href="https://cc3khmdk4ijcp2vv2zihhwd7rm.sec.amc.nl/doi/10.1002/14651858.CD002253.pub3/full#CD002253-bbs2-0197#CD002253-bbs2-0197" target="_blank">Norman 1991</a>). Misoprostol could be especially useful in low‐income countries, where transport and storage facilities are inadequate and the availability of uterotonic agents and blood is limited. Its use in obstetrics and gynaecology has been explored, especially to induce first and second trimester abortion (<a href="./references#CD002253-bbs2-0213" title="AshokPW , PenneyGC , FlettGM , TempletonA . An effective regimen for early medical abortion: a report of 2000 consecutive cases. Human Reproduction1998;13:2962‐5. ">Ashok 1998</a>; <a href="./references#CD002253-bbs2-0215" title="BugalhoA , FaundesA , JamisseL , UsfaM , MariaE , BiqueC . Evaluation of the effectiveness of vaginal misoprostol to induce first trimester abortion. Contraception1996;53:244‐6. ">Bugalho 1996</a>), for the induction of labour (<a href="./references#CD002253-bbs2-0212" title="AlfirevicZ , AflaifelN , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3] ">Alfirevic 2014</a>; <a href="./references#CD002253-bbs2-0221" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>) and for the prevention of postpartum haemorrhage (<a href="./references#CD002253-bbs2-0232" title="TunçalpÖ , HofmeyrGJ , GülmezogluAM . Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD000494.pub4] ">Tunçalp 2012</a>), despite the fact that it has not been registered for such use. The sensitivity of the uterus for misoprostol increases with the duration of pregnancy. Though the optimal dose for the induction of first or second trimester miscarriage is not known, and remains a subject of interest in the included studies. </p> <p>Dinoproston is a natural prostaglandin E2. It advances uterine contraction and also ripens the cervix, though its exact mechanism is not known. Other uterotonic drugs include ergometrine (while it acts at alpha‐adrenergic, dopaminergic and serotonin receptors, it exerts on the uterus a stimulant effect) and oxytocin (a synthetic nano peptide, identical to oxytocin produced by the pituitary gland, causing rhythmic contractions of the uterus). </p> <p>Other uterotonic drugs that could have a role in the induction of miscarriage include ergometrine, oxytocin, </p> <p>The progesterone antagonist, mifepristone, is of value in terminating early unwanted pregnancies and may be useful in non‐viable pregnancies and spontaneous miscarriage (<a href="./references#CD002253-bbs2-0214" title="BaulieuE , UlmannA . Antiprogesterone activity of RU‐486 and its contragestive and other applications. Human Reproduction1986;1:107‐10. [PUBMED: 3031127] ">Baulieu 1986</a>, <a href="./references#CD002253-bbs2-0224" title="KovacsL , SasM , ReschBA , UgocsaiG , SwahnML , Bygdeman , et al. Termination of very early pregnancy by RU 486‐‐an antiprogestational compound. Contraception1984;29(5):399‐410. ">Kovacs 1984</a>), alone or in combination with prostaglandin (<a href="./references#CD002253-bbs2-0216" title="CameronIT , MichieAF , BairdDT . Therapeutic abortion in early pregnancy with antiprogestogen RU486 alone or in combination with prostaglandin analogue (gemeprost). Contraception1986;34(5):459‐68. [PUBMED: 3816230] ">Cameron 1986</a>). Methotrexate has been researched for medical treatment of ectopic pregnancy and might have a place in the treatment of intrauterine non‐viable pregnancies as well. </p> </section> <section id="CD002253-sec-0048"> <h3 class="title" id="CD002253-sec-0048">Why it is important to do this review</h3> <p>The use of medical treatment in termination of non‐viable pregnancies is increasing. Since miscarriage is the most frequent complication of pregnancy it is important to have knowledge about the different types of medical treatment, their (cost) effectiveness and their side effects. </p> <p>The initial protocol for this review aimed to combine trials of medical treatments for both non‐viable pregnancies and for incomplete miscarriage but on further reflection, this was illogical. Non‐viable pregnancies contain viable trophoblast (placental) tissue, which produces hormones, which may in theory make these pregnancies more susceptible to anti‐hormone therapy and more resistant to uterotonic (stimulating uterine contractions) therapy than pregnancies in which (incomplete) miscarriage has already taken place. This review will therefore focus exclusively on non‐viable pregnancies, before miscarriage. Another review assesses trials of medical treatments after miscarriage has occurred (<a href="./references#CD002253-bbs2-0223" title="KimC , BarnardS , NeilsonJP , HickeyM , VazquezJC , DouL . Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD007223.pub4] ">Kim 2017</a>). A further review compares expectant management with surgical treatment for miscarriage (<a href="./references#CD002253-bbs2-0228" title="NandaK , LopezLM , GrimesDA , PeloggiaA , NandaG . Expectant care versus surgical treatment for miscarriage. Cochrane Database of Systematic Reviews2012, Issue 3. [DOI: 10.1002/14651858.CD003518.pub3] ">Nanda 2012</a>). </p> <p>Our review was first published in 2006. It was last edited and published online on January 21, 2009. Since the publication of the review in 2006, multiple new clinical trials concerning medical treatment of early fetal death have been conducted, and results published. The review therefore needed to be updated. </p> </section> </section> </section> <section class="objectives"> <div class="section-header section-collapse-header" id="CD002253-sec-0049" lang="en"> <h2 class="title section-collapse-title"> Objectives <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="objectives" lang="en"> <div class="section-header" id="CD002253-sec-0049"></div> <p>To assess, from clinical trials, the effectiveness and safety of different medical treatments for the termination of non‐viable pregnancies. </p> </section> </section> <section class="methods"> <div class="section-header section-collapse-header" id="CD002253-sec-0050" lang="en"> <h2 class="title section-collapse-title"> Methods <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="methods" lang="en"> <div class="section-header" id="CD002253-sec-0050"></div> <section id="CD002253-sec-0051"> <h3 class="title">Criteria for considering studies for this review</h3> <section id="CD002253-sec-0052"> <h4 class="title">Types of studies</h4> <p>Randomised clinical trials comparing a medical treatment with another treatment (for example, surgical evacuation), or placebo, or no treatment to terminate non‐viable pregnancies. Quasi‐randomised studies were excluded. Cluster‐randomised trials were eligible for inclusion, as were studies reported in abstract form, if sufficient information was available to assess eligibility. </p> </section> <section id="CD002253-sec-0053"> <h4 class="title">Types of participants</h4> <p>Women with non‐viable pregnancies (i.e. where the embryo or fetus had died in utero, and in whom miscarriage would have happened inevitably in due course) if less than 24 weeks estimated gestational age. If applicable, subgroup analyses were performed for women in first and women in the second trimester (up to 24 weeks of gestational age) of pregnancy. Since different studies might use different cut‐off values to consider a pregnancy in its second trimester (varying between 12 and 15 weeks of gestational age), in the subgroup analysis the exact gestational age that was used in the included studies is mentioned. </p> </section> <section id="CD002253-sec-0054"> <h4 class="title">Types of interventions</h4> <p>Trials were considered if they compared medical treatment with other methods (for example, expectant management, placebo or any other intervention including surgical evacuation). Comparisons between different routes of administration of medical treatment (for example, oral versus vaginal), or between different drugs or doses of drug, or duration or timing of treatment, were also included if data existed. </p> </section> <section id="CD002253-sec-0055"> <h4 class="title">Types of outcome measures</h4> <p>Trials were considered if any of the following outcomes were measured.</p> <section id="CD002253-sec-0056"> <h5 class="title">Primary outcomes</h5> <p> <ol id="CD002253-list-0001"> <li> <p>Complete miscarriage (i.e. no pregnancy tissues remaining in uterus ‐ based on clinical findings at surgery or ultrasound examination, or both after a specific period or an uncomplicated follow‐up period, or both without the need for additional surgical intervention). </p> </li> <li> <p>Death or serious complications (e.g. uterine rupture, uterine perforation, hysterectomy, organ failure, intensive care unit admission). </p> </li> </ol> </p> </section> <section id="CD002253-sec-0057"> <h5 class="title">Secondary outcomes</h5> <p> <ol id="CD002253-list-0002"> <li> <p>Blood transfusion.</p> </li> <li> <p>Haemorrhage.</p> </li> <li> <p>Blood loss (measured amount of blood, post‐treatment haemoglobin or post‐treatment haematocrit, or both). </p> </li> <li> <p>Days of bleeding.</p> </li> <li> <p>Pain (relief) (defined as: 1. differences in pain scores between the different treatment methods and/or 2. the increase or decrease in pain score after a certain treatment) and/or 3. incidence of pain as a complaint and/or 4. the use of pain medication after a certain treatment). </p> </li> <li> <p>Pelvic infection (defined by the authors as fever most likely caused by pelvic infection or documented pelvic infection, or both). </p> </li> <li> <p>Cervical damage.</p> </li> <li> <p>Digestive disorders (nausea or vomiting or diarrhoea).</p> </li> <li> <p>Hypertensive disorders.</p> </li> <li> <p>Time to expulsion.</p> </li> <li> <p>Duration of stay in hospital.</p> </li> <li> <p>Psychological effects.</p> </li> <li> <p>Subsequent fertility.</p> </li> <li> <p>Woman's satisfaction/acceptability of method.</p> </li> <li> <p>Costs.</p> </li> </ol> </p> </section> </section> </section> <section id="CD002253-sec-0058"> <h3 class="title">Search methods for identification of studies</h3> <p>The following methods section of this review is based on a standard template used by Cochrane Pregnancy and Childbirth. </p> <section id="CD002253-sec-0059"> <h4 class="title">Electronic searches</h4> <p>We searched Cochrane Pregnancy and Childbirth’s Trials Register by contacting their Information Specialist (24 October 2018). </p> <p>The Register is a database containing over 24,000 reports of controlled trials in the field of pregnancy and childbirth. It represents over 30 years of searching. For full current search methods used to populate Pregnancy and Childbirth’s Trials Register including the detailed search strategies for CENTRAL, MEDLINE, Embase and CINAHL; the list of handsearched journals and conference proceedings, and the list of journals reviewed via the current awareness service, please follow this <a href="https://pregnancy.cochrane.org/sites/pregnancy.cochrane.org/files/public/uploads/Cochrane%20Pregnancy%20and%20Childbirth%20Group%20search%20methods%20for%20Intervention%20reviews_0.pdf" target="_blank">link</a>. </p> <p>Briefly, Cochrane Pregnancy and Childbirth’s Trials Register is maintained by their Information Specialist and contains trials identified from: </p> <p> <ol id="CD002253-list-0003"> <li> <p>monthly searches of the Cochrane Central Register of Controlled Trials (CENTRAL);</p> </li> <li> <p>weekly searches of MEDLINE (Ovid);</p> </li> <li> <p>weekly searches of Embase (Ovid);</p> </li> <li> <p>monthly searches of CINAHL (EBSCO);</p> </li> <li> <p>handsearches of 30 journals and the proceedings of major conferences;</p> </li> <li> <p>weekly current awareness alerts for a further 44 journals plus monthly BioMed Central email alerts. </p> </li> </ol> </p> <p>Search results are screened by two people and the full text of all relevant trial reports identified through the searching activities described above is reviewed. Based on the intervention described, each trial report is assigned a number that corresponds to a specific Pregnancy and Childbirth review topic (or topics), and is then added to the Register. The Information Specialist searches the Register for each review using this topic number rather than keywords. This results in a more specific search set that has been fully accounted for in the relevant review sections (<a href="./references#CD002253-bbs1-0001" title="">Included studies</a>; <a href="./references#CD002253-bbs1-0002" title="">Excluded studies</a>; <a href="./references#CD002253-bbs1-0003" title="">Ongoing studies</a>). </p> <p>In addition, we searched <a href="http://clinicaltrials.gov/" target="_blank">ClinicalTrials.gov</a> and the WHO International Clinical Trials Registry Platform (<a href="http://apps.who.int/trialsearch/" target="_blank">ICTRP</a>) (24 October 2018) for unpublished, planned and ongoing trial reports using the search terms given in <a href="./appendices#CD002253-sec-0183">Appendix 1</a>. </p> </section> <section id="CD002253-sec-0060"> <h4 class="title">Searching other resources</h4> <p>We searched the reference lists of retrieved studies.</p> <p>We did not apply any language or date restrictions.</p> </section> </section> <section id="CD002253-sec-0061"> <h3 class="title" id="CD002253-sec-0061">Data collection and analysis</h3> <p>For methods used in the previous version of this review, <i>see</i><a href="./references#CD002253-bbs2-0235" title="NeilsonJP , HickeyM , VazquezJC . Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002253.pub3] ">Neilson 2006</a>. </p> <p>For this update, the following methods were used for assessing the reports that were identified as a result of the updated search. </p> <section id="CD002253-sec-0062"> <h4 class="title">Selection of studies</h4> <p>Two review authors independently assessed for inclusion all the potential studies we identified as a result of the search strategy. Potential trials were assessed for eligibility according to the criteria described in the ‘Eligibility criteria’ section above. If study eligibility needed to be further clarified we contacted the investigators to request further information. Studies published in abstracts only were assessed in the same way as full‐text papers. If there was sufficient information presented in the abstract to demonstrate that it met the eligibility criteria, it was included in analyses. Otherwise it was excluded with reasons noted in the <a href="./references#CD002253-sec-0194" title="">Characteristics of excluded studies</a> table. </p> <p>We resolved any disagreement through discussion or, if required, we consulted a third review author. </p> </section> <section id="CD002253-sec-0063"> <h4 class="title">Data extraction and management</h4> <p>Data were extracted from each relevant publication using a data collection form.</p> <p>In addition to the main outcome measures listed above, information on the setting of the study (country, type of population, socioeconomic status), the method of randomisation, a detailed description of the regimen used (drug(s), route, dose, frequency), definitions of the outcomes (if provided), and whether or not clinicians and participants were 'blind' to treatment allocated, were collected. Furthermore, any information on completeness of follow‐up was collected as well. Also, we collected the key conclusions of the included studies as reported by their authors. </p> <p>For eligible studies, two review authors extracted the data using the agreed form. We resolved discrepancies through discussion or, if required, we consulted a third review author. </p> <p>Data were imported in Review Manager software (<a href="./references#CD002253-bbs2-0230" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>), and checked for accuracy. </p> <p>When information regarding any of the above was unclear, we attempted to contact authors of the original reports to provide further details. </p> </section> <section id="CD002253-sec-0064"> <h4 class="title">Assessment of risk of bias in included studies</h4> <p>Two review authors independently assessed risk of bias for each study using the criteria outlined in the <i>Cochrane Handbook for Systematic Reviews of Interventions</i> (<a href="./references#CD002253-bbs2-0220" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). Any disagreement was resolved by discussion or by involving a third assessor. </p> <section id="CD002253-sec-0065"> <h5 class="title">(1) Random sequence generation (checking for possible selection bias)</h5> <p>We described for each included study the method used to generate the allocation sequence in sufficient detail to allow an assessment of whether it should produce comparable groups. </p> <p>We assessed the method as:</p> <p> <ul id="CD002253-list-0004"> <li> <p>low risk of bias (any truly random process, e.g. random number table; computer random number generator); </p> </li> <li> <p>high risk of bias (any non‐random process, e.g. odd or even date of birth; hospital or clinic record number), if during data extraction we found that the trial was quasi‐randomised we excluded it from further analysis; </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0066"> <h5 class="title">(2) Allocation concealment (checking for possible selection bias)</h5> <p>We described for each included study the method used to conceal allocation to interventions prior to assignment and assessed whether intervention allocation could have been foreseen in advance of, or during recruitment, or changed after assignment. </p> <p>We assessed the methods as:</p> <p> <ul id="CD002253-list-0005"> <li> <p>low risk of bias (e.g. telephone or central randomisation; consecutively numbered sealed opaque envelopes); </p> </li> <li> <p>high risk of bias (open random allocation; unsealed or non‐opaque envelopes);</p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0067"> <h5 class="title">(3.1) Blinding of participants and personnel (checking for possible performance bias)</h5> <p>We described for each included study the methods used, if any, to blind study participants and personnel from knowledge of which intervention a participant received. We considered that studies were at low risk of bias if they were blinded, or if we judged that the lack of blinding was unlikely to affect results. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed the methods as:</p> <p> <ul id="CD002253-list-0006"> <li> <p>low, high or unclear risk of bias for participants;</p> </li> <li> <p>low, high or unclear risk of bias for personnel.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0068"> <h5 class="title">(3.2) Blinding of outcome assessment (checking for possible detection bias)</h5> <p>We described for each included study the methods used, if any, to blind outcome assessors from knowledge of which intervention a participant received. We assessed blinding separately for different outcomes or classes of outcomes. </p> <p>We assessed methods used to blind outcome assessment as:</p> <p> <ul id="CD002253-list-0007"> <li> <p>low, high or unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0069"> <h5 class="title">(4) Incomplete outcome data (checking for possible attrition bias due to the amount, nature and handling of incomplete outcome data) </h5> <p>We described for each included study, and for each outcome or class of outcomes, the completeness of data including attrition and exclusions from the analysis. We stated whether attrition and exclusions were reported and the numbers included in the analysis at each stage (compared with the total randomised participants), reasons for attrition or exclusion where reported, and whether missing data were balanced across groups or were related to outcomes. Where sufficient information was reported, or could be supplied by the trial authors, we planned to re‐include missing data in the analyses which we undertook. </p> <p>We assessed methods as:</p> <p> <ul id="CD002253-list-0008"> <li> <p>low risk of bias (e.g. no missing outcome data; missing outcome data balanced across groups); </p> </li> <li> <p>high risk of bias (e.g. numbers or reasons for missing data imbalanced across groups; ‘as treated’ analysis done with substantial departure of intervention received from that assigned at randomisation); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0070"> <h5 class="title">(5) Selective reporting (checking for reporting bias)</h5> <p>We described for each included study how we investigated the possibility of selective outcome reporting bias and what we found. </p> <p>We assessed the methods as:</p> <p> <ul id="CD002253-list-0009"> <li> <p>low risk of bias (where it is clear that all of the study’s pre‐specified outcomes and all expected outcomes of interest to the review have been reported); </p> </li> <li> <p>high risk of bias (where not all the study’s pre‐specified outcomes have been reported; one or more reported primary outcomes were not pre‐specified; outcomes of interest are reported incompletely and so cannot be used; study fails to include results of a key outcome that would have been expected to have been reported); </p> </li> <li> <p>unclear risk of bias.</p> </li> </ul> </p> </section> <section id="CD002253-sec-0071"> <h5 class="title">(6) Other bias (checking for bias due to problems not covered by (1) to (5) above)</h5> <p>We described for each included study any important concerns we had about other possible sources of bias. </p> </section> <section id="CD002253-sec-0072"> <h5 class="title">(7) Overall risk of bias</h5> <p>We made explicit judgements about whether studies were at high risk of bias, according to the criteria given in the <i>Handbook</i> (<a href="./references#CD002253-bbs2-0220" title="HigginsJP , GreenS , editors. Cochrane Handbook for Systematic Reviews of Interventions Version 5.1.0 [updated March 2011]. The Cochrane Collaboration, 2011. Available from www.cochrane‐handbook.org. ">Higgins 2011</a>). With reference to (1) to (6) above, we planned to assess the likely magnitude and direction of the bias and whether we considered it is likely to impact on the findings. In future updates, we will explore the impact of the level of bias through undertaking sensitivity analyses ‐ <i>see</i><a href="#CD002253-sec-0086">Sensitivity analysis</a>. </p> </section> <section id="CD002253-sec-0073"> <h5 class="title">Assessment of the quality of the evidence using the GRADE approach</h5> <p>For this update the quality of the evidence was assessed using the GRADE approach as outlined in the <a href="http://gdt.guidelinedevelopment.org/central_prod/_design/client/handbook/handbook.html" target="_blank">GRADE handbook</a> in order to assess the quality of the body of evidence relating to the primary and if applicable secondary outcomes for the main comparisons (with a maximum of seven outcomes). The following outcomes were assessed. </p> <p> <ol id="CD002253-list-0010"> <li> <p>Complete miscarriage</p> </li> <li> <p>Pelvic infection</p> </li> <li> <p>Nausea</p> </li> <li> <p>Diarrhoea</p> </li> <li> <p>Blood loss</p> </li> <li> <p>Pain (relief)</p> </li> <li> <p>Woman's satisfaction/acceptability of method</p> </li> </ol> </p> <p>These outcomes were assessed (if applicable) for all 23 comparisons. The most clinically meaningful comparisons are presented in (<a href="./full#CD002253-tbl-0001">summary of findings Table for the main comparison</a>; <a href="./full#CD002253-tbl-0002">summary of findings Table 2</a>); these were: </p> <p> <ol id="CD002253-list-0011"> <li> <p>vaginal misoprostol versus placebo;</p> </li> <li> <p>vaginal misoprostol versus surgical evacuation.</p> </li> </ol> </p> <p>We used the <a href="http://www.guidelinedevelopment.org/" target="_blank">GRADEpro</a> Guideline Development Tool to import data from Review Manager 5.3 (<a href="./references#CD002253-bbs2-0230" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>) in order to create the ’Summary of findings’ tables. A summary of the intervention effect and a measure of quality for each of the above outcomes was produced using the GRADE approach. The GRADE approach uses five considerations (study limitations, consistency of effect, imprecision, indirectness and publication bias) to assess the quality of the body of evidence for each outcome. The evidence can be downgraded from 'high quality' by one level for serious (or by two levels for very serious) limitations, depending on assessments for risk of bias, indirectness of evidence, serious inconsistency, imprecision of effect estimates or potential publication bias. </p> </section> </section> <section id="CD002253-sec-0074"> <h4 class="title">Measures of treatment effect</h4> <section id="CD002253-sec-0075"> <h5 class="title">Dichotomous data</h5> <p>For dichotomous data, we presented results as summary risk ratio with 95% confidence intervals. </p> </section> <section id="CD002253-sec-0076"> <h5 class="title">Continuous data</h5> <p>For continuous data, we use the mean difference if outcomes are measured in the same way between trials. In future updates, if applicable, we will use the standardised mean difference to combine trials that measure the same outcome, but use different methods. </p> </section> </section> <section id="CD002253-sec-0077"> <h4 class="title">Unit of analysis issues</h4> <section id="CD002253-sec-0078"> <h5 class="title">Cluster‐randomised trials</h5> <p>Our protocol stated that we would include cluster‐randomised trials in the analyses along with individually‐randomised trials. We planned to adjust their standard errors using the methods described in the <i>Handbook</i> (Section 16.3.6) using an estimate of the intracluster correlation co‐efficient (ICC) derived from the trial (if possible), from a similar trial or from a study of a similar population. If we used ICCs from other sources, we planned to report this and to conduct sensitivity analyses to investigate the effect of variation in the ICC. If we had identified both cluster‐randomised trials and individually‐randomised trials, we planned to synthesise the relevant information. We would consider it reasonable to combine the results from both if there is little heterogeneity between the study designs and the interaction between the effect of intervention and the choice of randomisation unit is considered to be unlikely. No cluster‐randomised trials were included in this update. </p> </section> <section id="CD002253-sec-0079"> <h5 class="title">Cross‐over trials</h5> <p>It is unlikely that cross‐over designs would be a valid study design for this particular review, and so were expected to be excluded. In the unlikely event that cross‐over trials would have a valid design and were eligible for inclusion in the review, we would use specific methods for 'Risk of bias' assessment and analysis as described in the <i>Handbook</i> (Section 16.4). </p> </section> <section id="CD002253-sec-0080"> <h5 class="title">Other unit of analysis</h5> <p>It was likely that we would identify trials with more than two treatment groups, for example, trials comparing surgical, medical and expectant management of non‐viable pregnancies. If so, we first determined which intervention groups addressed the review objective. If applicable, pair‐wise comparisons of interventions were included in the appropriate analysis. </p> </section> </section> <section id="CD002253-sec-0081"> <h4 class="title">Dealing with missing data</h4> <p>For included studies, we noted levels of attrition. In future updates, if more eligible studies are included, we will explore the impact of including studies with high levels of missing data in the overall assessment of treatment effect by using sensitivity analysis. </p> <p>For all outcomes, analyses were carried out, as far as possible, on an intention‐to‐treat basis, i.e. we attempted to include all participants randomised to each group in the analyses. The denominator for each outcome in each trial was the number randomised minus any participants whose outcomes were known to be missing. </p> </section> <section id="CD002253-sec-0082"> <h4 class="title">Assessment of heterogeneity</h4> <p>We assessed statistical heterogeneity in each meta‐analysis using the Tau², I² and Chi² statistics. We regarded heterogeneity as substantial if an I² was greater than 30% and either the Tau² was greater than zero, or there was a low P value (less than 0.10) in the Chi² test for heterogeneity. If we identified substantial heterogeneity (above 30%), we tried to explore it by subgroup analysis. </p> </section> <section id="CD002253-sec-0083"> <h4 class="title">Assessment of reporting biases</h4> <p>We planned to investigate reporting biases (such as publication bias) using funnel plots. We would have assessed funnel plot asymmetry visually. If asymmetry was suggested by a visual assessment we planned to perform exploratory analyses to investigate it. </p> </section> <section id="CD002253-sec-0084"> <h4 class="title">Data synthesis</h4> <p>We carried out statistical analysis using the Review Manager software (<a href="./references#CD002253-bbs2-0230" title="The Nordic Cochrane Centre, The Cochrane Collaboration. Review Manager (RevMan). Version 5.3. Copenhagen: The Nordic Cochrane Centre, The Cochrane Collaboration, 2014. ">RevMan 2014</a>). We used fixed‐effect meta‐analysis for combining data where it was reasonable to assume that studies were estimating the same underlying treatment effect: i.e. where trials were examining the same intervention, and the trials’ populations and methods were judged sufficiently similar. </p> <p>If there was clinical heterogeneity sufficient to expect that the underlying treatment effects differed between trials, or if substantial statistical heterogeneity was detected, we used random‐effects meta‐analysis to produce an overall summary, if an average treatment effect across trials was considered clinically meaningful. The random‐effects summary was treated as the average of the range of possible treatment effects and we discussed the clinical implications of treatment effects differing between trials. If the average treatment effect was not clinically meaningful, we did not combine trials. Where we used random‐effects analyses, the results were presented as the average treatment effect with 95% confidence intervals, and the estimates of Tau² and I². </p> </section> <section id="CD002253-sec-0085"> <h4 class="title">Subgroup analysis and investigation of heterogeneity</h4> <p>If heterogeneity was identified we checked if there were clinical subgroups of interest; and if there were, that would be the main reason to perform subgroup analysis. We considered whether an overall summary was meaningful, and if it was, used random‐effects analysis to produce it. </p> <p>Separate comparisons were made of different drug regimens, grouped where appropriate by number of doses given and the route of administration. Furthermore, subgroup analyses were made for comparisons that included studies with variation in dosages of medication, time in between different administrations and/or time until follow‐up examination; and subgroup analyses of first versus second trimester pregnancies were performed. All of these mentioned differences might influence the chance of successful outcome. For example: in later gestational age (second trimester pregnancies), the prostaglandin receptors are more developed and therefore the outcomes of interventions with a same dosage of misoprostol could differ between first and second trimester. Another example: when different routes of administration are assessed, the dosage and whether repeat dosages are applied might influence the outcome, which means these should be considered as different subgroups of interest. </p> <p>The primary and secondary outcomes used in subgroup analysis were the same as the outcomes used in the overall analysis. </p> </section> <section id="CD002253-sec-0086"> <h4 class="title">Sensitivity analysis</h4> <p>We planned to carry out sensitivity analyses to explore the effect of trial quality assessed by concealment of allocation, high attrition rates, or both, with poor quality studies being excluded from the analyses in order to assess whether this made any difference to the overall result. </p> </section> </section> </section> </section> <section class="results"> <div class="section-header section-collapse-header" id="CD002253-sec-0087" lang="en"> <h2 class="title section-collapse-title"> Results <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="results" lang="en"> <div class="section-header" id="CD002253-sec-0087"></div> <section id="CD002253-sec-0088"> <h3 class="title">Description of studies</h3> <section id="CD002253-sec-0089"> <h4 class="title">Results of the search</h4> <p>See: <a href="#CD002253-fig-0001">Figure 1</a>. We retrieved 162 trial reports to assess from the database searching (52 new reports, plus 108 that were already awaiting further classification, and two that were ongoing in the previous version of the review (<a href="./references#CD002253-bbs2-0235" title="NeilsonJP , HickeyM , VazquezJC . Medical treatment for early fetal death (less than 24 weeks). Cochrane Database of Systematic Reviews2006, Issue 3. [DOI: 10.1002/14651858.CD002253.pub3] ">Neilson 2006</a>). In addition, we found three more published reports from following up clinical trial registry records (we subsequently excluded these trials as it was clear from the full report that they were not eligible). Of the 165 reports we assessed, we included 21 new trials (27 reports), excluded 112 (124 reports) and six are ongoing trials. We also added one new trial report to a previously included study, and seven new reports to previously excluded studies. </p> <div class="figure" id="CD002253-fig-0001"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 1</div> </div> <hr class="top"/><img alt="Study flow diagram." data-id="CD002253-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG01.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> </div> <p>The original review included 24 studies. One of these studies was published as an abstract (<a href="./references#CD002253-bbs2-0104" title="HeardMJ , StewartGM , BusterJE , CarsonSA , MillerHJ . Outpatient management of missed abortion with vaginal misoprostol [abstract]. Obstetrics &amp; Gynecology2002;99(4 Suppl):20S. ">Heard 2002</a>). Since there were serious concerns about the methodology and no full‐text article was published, this study was excluded from the updated review. We also reassessed and excluded another previously included study (<a href="./references#CD002253-bbs2-0092" title="FadallaFA , MirghaniOA , AdamI . Oral misoprostol vs vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second‐trimester. International Journal of Gynecology &amp; Obstetrics2004;86:52‐3. ">Fadalla 2004*</a>). </p> <p>The review now has 43 included studies.</p> </section> <section id="CD002253-sec-0090"> <h4 class="title">Included studies</h4> <p>This review has included 43 studies comparing vaginal misoprostol versus expectant management (<a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>), placebo (<a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>), surgical evacuation (<a href="./references#CD002253-bbs2-0010" title="DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Human Reproduction2001;16:365‐9. DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3‐8; Washington DC, USA. 2000. ">Demetroulis 2001</a>; <a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a>; <a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a>; <a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>; <a href="./references#CD002253-bbs2-0028" title="MuffleyPE , StitelyML , GhermanRB . Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology2002;187:321‐6. ">Muffley 2002</a>; <a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>), oral or sublingual misoprostol (<a href="./references#CD002253-bbs2-0007" title="ChittacharoenA , HerabutyaY , PunyavachiraP . A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics &amp; Gynecology2003;101:70‐3. ">Chittacharoen 2003*</a>; <a href="./references#CD002253-bbs2-0008" title="CreininMD , MoyerR , GuidoR . Misoprostol for medical evacuation of early pregnancy failure. Obstetrics &amp; Gynecology1997;89:768‐72. ">Creinin 1997</a>; <a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0025" title="MarwahS , GuptaS , BatraNP , BhasinV , SarnaV , KaurN . A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (misoprostol) in management of first trimester missed abortion. Journal of Clinical and Diagnostic Research2016;10(5):QC14‐8. ">Marwah 2016</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0033" title="Rita , GuptaS , KumarS . A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science2006;8(1):35‐8. ">Rita 2006</a>; <a href="./references#CD002253-bbs2-0036" title="ShahN , AzamSI , KhanNH . Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA ‐ Journal of the Pakistan Medical Association2010;60(2):113‐6. ">Shah 2010*</a>; <a href="./references#CD002253-bbs2-0038" title="SonsanohA , ChullapramT . Comparison of sublingual and vaginal misoprostol for termination of early pregnancy failure: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology2014;22(3):128‐36. ">Sonsanoh 2014</a>; <a href="./references#CD002253-bbs2-0039" title="TangOS , LauWN , NgEHY , LeeSW , HoPC . A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction2003;18:176‐81. ">Tang 2003</a>; <a href="./references#CD002253-bbs2-0041" title="TanhaFD , FeiziM , ShariatM . Sublingual versus vaginal misoprostol for the management of missed abortion. Journal of Obstetrics and Gynaecology Research2010;36(3):525‐32. ">Tanha 2010a</a>), other types of vaginal or intracervical prostaglandin preparation (<a href="./references#CD002253-bbs2-0002" title="Al IniziSA , EzimokhaiM . Vaginal misoprostol versus dinoprostone for the management of missed abortion. International Journal of Gynecology &amp; Obstetrics2003;83:73‐4. ">Al Inizi 2003</a>; <a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>; <a href="./references#CD002253-bbs2-0019" title="KaraM , OzdenS , ErogluM , CetinA , AriogluP . Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynecology and Obstetrics1999;1:13‐6. ">Kara 1999*</a>); oxytocin (<a href="./references#CD002253-bbs2-0001" title="AbediaslZ , SheikhM , PooransariP , FarahaniZ , KalaniF . Vaginal misoprostol versus intravenous oxytocin for the management of second‐trimester pregnancies with intrauterine fetal death: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research2016;42(3):246‐51. ">Abediasl 2016*</a>); extra‐amniotic preparations (<a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>); different doses (<a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0027" title="MizrachiY , DekaloA , GluckO , MirembergH , DafnaL , FeldsteinO , et al. Single versus repeat doses of misoprostol for treatment of early pregnancy loss‐a randomized clinical trial. Human Reproduction2017;32(6):1202‐7. ">Mizrachi 2017</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0032" title="PetersenSG , PerkinsA , GibbonsK , BertoloneJ , Devenish‐MearesP , CaveD , et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2013;53(1):64‐73. ">Petersen 2013</a>) and preparations (<a href="./references#CD002253-bbs2-0015" title="BarnhartKT , BaderT , HuangX , FrederickMM , TimbersKA , ZhangJJ . Hormone pattern after misoprostol administration for a nonviable first‐trimester gestation. Fertility and Sterility2004;81:1099‐105. CreininMD , HarwoodB , GuidoRS , FoxMC , ZhangJ , NICHD Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2004;86:22‐6. DavisAR , RobilottoCM , WesthoffCL , FormanS , ZhangJ , NICHD Management of Early Pregnancy Failure Trial. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Human Reproduction2004;19:1655‐8. GillesJ , CreininMM , BarnhartKT , WesthoffC , FrederickMM , ZangJ , et al. Wet versus dry misoprostol application for treatment of early pregnancy failure. Fertility and Sterility2002;78:S64‐S65. GillesJM , CreininMD , BarnhartK , WesthoffC , FrederickMM , ZhangJ . A randomized trial of saline solution‐moistened misoprostol versus dry misoprostol for the first‐trimester pregnancy failure. American Journal of Obstetrics and Gynecology2004;190:389‐94. ">Gilles 2004</a>) of vaginal misoprostol; the addition to vaginal misoprostol of methotrexate (<a href="./references#CD002253-bbs2-0003" title="AutryA , JacobsonG , SandhuR , IsbillK . Medical management of non‐viable early first trimester pregnancy. International Journal of Gynecology &amp; Obstetrics1999;67(1):9‐13. ">Autry 1999</a>) or laminaria tents (<a href="./references#CD002253-bbs2-0018" title="JainJK , MishellDR . A comparison of misoprostol with and without laminaria tents for induction of second‐trimester abortion. American Journal of Obstetrics and Gynecology1996;175:173‐7. ">Jain 1996*</a>). Furthermore, there were studies comparing sublingual misoprostol versus oral misoprostol (<a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0022" title="KushwahB , SinghA . Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2009;106(1):43‐5. KushwahDS , KushwahB , SalmanMT , VermaVK . Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise. Indian Journal of Pharmacology2011;43(3):306‐10. [DOI: 10.4103/0253‐7613.81513; CRSREF: 3293000] ">Kushwah 2009</a>); different doses (<a href="./references#CD002253-bbs2-0040" title="TangOS , OngCY , TseKY , NgEH , LeeSW , HoPC . A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction2006;21(1):189‐92. ">Tang 2006</a>) and preparations (<a href="./references#CD002253-bbs2-0034" title="SaichuaC , PhupongV . A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics2009;280(3):431‐5. ">Saichua 2009</a>) of sublingual misoprostol; and one study on buccal misoprostol in different doses (<a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*)</a>. Studies using other types of medication other than (only) misoprostol involved mifepristone versus placebo (<a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>); mifepristone plus oral misoprostol versus expectant management (<a href="./references#CD002253-bbs2-0030" title="NielsenS , HahlinM , Platz‐ChristensenJ . Expectant management or pharmacological treatment for first trimester spontaneous abortion: a randomised trial. Acta Obstetricia et Gynecologica Scandinavica1997;76(167:2):77. NielsenS , HahlinM , Platz‐ChristensenJ . Randomised trial comparing expectant with medical management for first trimester miscarriages. British Journal of Obstetrics and Gynaecology1999;106:804‐7. ">Nielsen 1999</a>); mifepristone plus oral misoprostol versus misoprostol alone (<a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a><a href="./references#CD002253-bbs2-0035" title="SchreiberCA , SonalkarS , BarnhartKT , RatcliffeSJ , CreininMD , AtrioJ . Mifepristone pretreatment for the medical management of early pregnancy loss. New England Journal of Medicine2018;378(23):2161‐70. ">Schreiber 2018</a>; <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>); and vaginal gemeprost versus surgical evacuation (<a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>). </p> <p>The <a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a> trial used a comparison of vaginal misoprostol versus placebo to explore comparisons with expectant management (up to seven days) and, therefore, differed in concept from the <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a> and <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a> studies in which early surgical intervention occurred after, respectively, 24 and 48 hours. </p> <p>Eight of the 43 included studies addressed medical treatment of non‐viable pregnancies in the second trimester. The definition of second trimester however varied from gestational age (GA) &gt; 12 weeks to GA &gt; 15 weeks (<a href="./references#CD002253-bbs2-0001" title="AbediaslZ , SheikhM , PooransariP , FarahaniZ , KalaniF . Vaginal misoprostol versus intravenous oxytocin for the management of second‐trimester pregnancies with intrauterine fetal death: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research2016;42(3):246‐51. ">Abediasl 2016*</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0007" title="ChittacharoenA , HerabutyaY , PunyavachiraP . A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics &amp; Gynecology2003;101:70‐3. ">Chittacharoen 2003*</a>; <a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>; <a href="./references#CD002253-bbs2-0018" title="JainJK , MishellDR . A comparison of misoprostol with and without laminaria tents for induction of second‐trimester abortion. American Journal of Obstetrics and Gynecology1996;175:173‐7. ">Jain 1996*</a>; <a href="./references#CD002253-bbs2-0019" title="KaraM , OzdenS , ErogluM , CetinA , AriogluP . Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynecology and Obstetrics1999;1:13‐6. ">Kara 1999*</a>; <a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>). One study (<a href="./references#CD002253-bbs2-0036" title="ShahN , AzamSI , KhanNH . Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA ‐ Journal of the Pakistan Medical Association2010;60(2):113‐6. ">Shah 2010*</a>) included women with non‐viable pregnancies up to a GA of 20 weeks, but made subgroup analyses for first and second trimester pregnancies. These studies are labelled with an asterisk for ease of interpretation. </p> <p>There are additional trials that included data on women with both non‐viable pregnancies and incomplete miscarriages; or that included women with a GA of more than 24 weeks. We contacted several authors to ask for separated data. Four authors responded but were not able to send us the separated data (<a href="./references#CD002253-bbs2-0070" title="BrounsJF , vanWelyM , BurgerMP , vanWijngaardenWJ . Comparison of two dose regimens of misoprostol for second‐trimester pregnancy termination. Contraception2010;82(3):266‐75. ">Brouns 2010</a>; <a href="./references#CD002253-bbs2-0091" title="EslamianL , GosiliR , JamalA , AlyassinA . A prospective randomized controlled trial of two regimens of vaginal misoprostol in second trimester termination of pregnancy. Acta Medica Iranica2007;45(6):497‐500. ">Eslamian 2007</a>; <a href="./references#CD002253-bbs2-0108" title="HidarS , BouddebousM , ChaiebA , JerbiM , BibiM , KhairiH . Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13‐29 weeks. Archives of Gynecology and Obstetrics2005;273(3):157‐60. ">Hidar 2005</a>; <a href="./references#CD002253-bbs2-0229" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: an international journal of obstetrics &amp; gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] ">Petrou 2006</a> (additional report to <a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>); <a href="./references#CD002253-bbs2-0162" title="PromwangkwaK , PuntitpongB , ChirdchimW , SananpanichkulP . Efficacy of sublingual misoprostol with or without loading vaginal misoprostol in second trimester termination of pregnancy: a randomized controlled trial. Journal of the Medical Association of Thailand2017;100(10):1050‐5. ">Promwangkwa 2017</a>). One author responded and sent separated data (<a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>), this study was included in the review. The authors that did not respond are listed under 'Excluded studies'. </p> <section id="CD002253-sec-0091"> <h5 class="title">Dates of study</h5> <p>Included studies date from 1993 until 2018.</p> </section> <section id="CD002253-sec-0092"> <h5 class="title">Funding</h5> <p>Among the included studies no information on funding was available in 29 trials. In 12 trials the funding was independent and mainly provided by the university hospital. One trial mentioned not to have received funding at all, and one trial mentioned to having received a donation from a pharmaceutical company for the execution of the trial. </p> </section> <section id="CD002253-sec-0093"> <h5 class="title">Declaration of interest</h5> <p>Declaration of interest was not mentioned in 28 trials. One trial, of which the authors received a donation from a pharmaceutical company, reported this donation in their declaration of interest. The remaining 14 trials reported not to have any interests to declare. </p> </section> </section> <section id="CD002253-sec-0094"> <h4 class="title">Excluded studies</h4> <p>The trials that were excluded in the initial review were checked to ensure that no trial has been excluded for non‐reporting of outcomes and that reasons are still valid according to current Cochrane standards. There are 162 excluded studies and these are listed in the reference section under <a href="./references#CD002253-bbs1-0002" title="">Excluded studies</a>. The table <a href="./references#CD002253-sec-0194" title="">Characteristics of excluded studies</a> states the reasons for exclusion from this review. These reasons mainly include: study not randomised; study including women with ongoing or incomplete miscarriage only; studies assessing medical treatment for fetal demise &gt; 24 weeks of gestational age (GA), and studies including women having termination of pregnancy. We have also excluded studies where we tried to contact the authors for data that separates treatment of non‐viable pregnancies with other types of patients (with either incomplete miscarriage, &gt; 24 weeks, or planned termination of pregnancy), however either the authors did not respond or they were not able to provide suitable data (<a href="./references#CD002253-bbs2-0063" title="BehrashiM , MahdianM . Vaginal versus oral misoprostol for second‐trimester pregnancy termination: a randomized trial. Pakistan Journal of Biological Sciences2008;11(21):2505‐8. ">Behrashi 2008</a>; <a href="./references#CD002253-bbs2-0068" title="BiswasSC , DeyR , JanaR , ChattopadhyayN . Comparative study of intravaginal misoprostol and extra amniotic ethacridine lactate instillation for mid trimester pregnancy termination. Journal of Obstetrics and Gynaecology of India2007;57(3):211‐3. ">Biswas 2007</a>; <a href="./references#CD002253-bbs2-0070" title="BrounsJF , vanWelyM , BurgerMP , vanWijngaardenWJ . Comparison of two dose regimens of misoprostol for second‐trimester pregnancy termination. Contraception2010;82(3):266‐75. ">Brouns 2010</a>; <a href="./references#CD002253-bbs2-0072" title="CaliskanE , DilbazS , DogerE , OzerenS , DilbazB . Randomized comparison of 3 misoprostol protocols for abortion induction at 13‐20 weeks of gestation. Journal of Reproductive Medicine2005;50(3):173‐80. ">Caliskan 2005</a>; <a href="./references#CD002253-bbs2-0083" title="DickinsonJE , GodfreyM , EvansSF . Efficacy of intravaginal misoprostol in second‐trimester pregnancy termination: a randomized controlled trial. Journal of Maternal‐Fetal Medicine1998;7:115‐9. ">Dickinson 1998</a>; <a href="./references#CD002253-bbs2-0084" title="DickinsonJE , EvansSF . The optimization of intravaginal misoprostol dosing schedules in second‐trimester pregnancy termination. American Journal of Obstetrics and Gynecology2002;186:470‐4. ">Dickinson 2002</a>; <a href="./references#CD002253-bbs2-0088" title="ElhassanEM , AbubakerMS , AdamI . Sublingual compared with oral and vaginal misoprostol for termination of pregnancy with second‐trimester fetal demise. International Journal of Gynecology &amp; Obstetrics2008;100(1):82‐3. ">Elhassan 2008</a>; <a href="./references#CD002253-bbs2-0089" title="ElSokkaryHH . Comparison between sublingual and vaginal administration of misoprostol in management of missed abortion. Journal of Obstetrics and Gynaecology of India2016;66(S1):S24‐S29. ">El Sokkary 2016</a>; <a href="./references#CD002253-bbs2-0090" title="EppelW , FacchinettiF , SchleussnerE , PiccininiF , PizziC , GruberDM , et al. Second trimester abortion using isosorbide mononitrate in addition to gemeprost compared with gemeprost alone: a double blind randomized, placebo‐controlled multicenter trial. American Journal of Obstetrics and Gynecology2005;192:856‐61. ">Eppel 2005</a>; <a href="./references#CD002253-bbs2-0091" title="EslamianL , GosiliR , JamalA , AlyassinA . A prospective randomized controlled trial of two regimens of vaginal misoprostol in second trimester termination of pregnancy. Acta Medica Iranica2007;45(6):497‐500. ">Eslamian 2007</a>; <a href="./references#CD002253-bbs2-0092" title="FadallaFA , MirghaniOA , AdamI . Oral misoprostol vs vaginal misoprostol for termination of pregnancy with intrauterine fetal demise in the second‐trimester. International Journal of Gynecology &amp; Obstetrics2004;86:52‐3. ">Fadalla 2004*</a><a href="./references#CD002253-bbs2-0093" title="FeldmanDM , BorgidaAF , RodisJF , LeoMV , CampbellWA . A randomized comparison of two regimens of misoprostol for second‐trimester pregnancy termination. American Journal of Obstetrics and Gynecology2003;189:710‐3. ">Feldman 2003</a>; <a href="./references#CD002253-bbs2-0096" title="GhorabMN , ElHelwBA . Second‐trimester termination of pregnancy by extra‐amniotic prostaglandin F2alpha or endocervical misoprostol. Acta Obstetricia et Gynecologica Scandinavica1998;77:429‐32. ">Ghorab 1998</a>; <a href="./references#CD002253-bbs2-0097" title="GonzalezJA , CarlanSJ , AlversonMW . Outpatient second trimester pregnancy termination. Contraception2001;63:89‐93. ">Gonzalez 2001</a>; <a href="./references#CD002253-bbs2-0098" title="GrimesDA , SmithMS , WithamAD . Mifepristone and misoprostol versus dilatation and evacuation for midtrimester abortion: a pilot randomised controlled trial. BJOG: an international journal of obstetrics and gynaecology2004;111:148‐53. ">Grimes 2004</a>; <a href="./references#CD002253-bbs2-0105" title="HerabutyaY , O‐PrasertsawatP . A comparison of intravaginal misoprostol with intracervical prostaglandin E2 gel for the management of dead fetus in utero. Thai Journal of Obstetrics and Gynaecology1997;9(2):95‐8. ">Herabutya 1997a</a>; <a href="./references#CD002253-bbs2-0107" title="HidarS , FekihM , ChaiebA , BibiM , MellouliR , KhairiH . Oxytocin and misoprostol administered intravaginally for termination of pregnancy at 13‐29 weeks of amenorrhea. A prospective randomized trial [Apport de l'association d'ocytocine au misoprostol administre en intravaginal au cours des interruptions de grossesses entre 13 et 29 semaines d'amenorrhee. Essai clinique prospectif randomise]. Journal de Gynecologie, Obstetrique et Biologie de la Reproduction2001;30:439‐43. ">Hidar 2001</a>; <a href="./references#CD002253-bbs2-0108" title="HidarS , BouddebousM , ChaiebA , JerbiM , BibiM , KhairiH . Randomized controlled trial of vaginal misoprostol versus vaginal misoprostol and isosorbide dinitrate for termination of pregnancy at 13‐29 weeks. Archives of Gynecology and Obstetrics2005;273(3):157‐60. ">Hidar 2005</a>; <a href="./references#CD002253-bbs2-0111" title="HoggB , OwenJ . Laminaria versus extraamniotic saline infusion (EASI) for cervical ripening and mid‐trimester labor induction. American Journal of Obstetrics and Gynecology2000;182(1 Pt 2):S135. ">Hogg 2000</a>; <a href="./references#CD002253-bbs2-0113" title="HughesJ , RyanM , HinshawK , HenshawR , RispinR , TempletonA . The costs of treating miscarriage: a comparison of medical and surgical management. British Journal of Obstetrics and Gynaecology1996;103(12):1217‐21. ">Hughes 1996</a>; <a href="./references#CD002253-bbs2-0114" title="ImranF , AnserA , DanishN , FatimaN . Misoprostol for the purpose of mid‐trimester termination of pregnancy: a comparative study with prostaglandin F2 alpha. Journal of Ayub Medical College, Abbottabad: JAMC2010;22(4):87‐91. ">Imran 2010</a>; <a href="./references#CD002253-bbs2-0118" title="JainJK , MishellDR . A comparison of intravaginal misoprostol with prostaglandin E2 for termination of second‐trimester pregnancy. New England Journal of Medicine1994;331:290‐3. ">Jain 1994</a>; <a href="./references#CD002253-bbs2-0119" title="JainJK , KuoJ , MishellDR . A comparison of two dosing regimens of intravaginal misoprostol for second‐trimester pregnancy termination. Obstetrics &amp; Gynecology1999;93:571‐5. ">Jain 1999</a>; <a href="./references#CD002253-bbs2-0126" title="KurshidR , AhmedA , MirS , Ul ShamasI . To assess the efficacy of two regimens of misoprostol for second trimester pregnancy termination‐a randomized comparison. Internet Journal of Gynecology and Obstetrics2010; Vol. 14, issue 1. ">Kurshid 2010</a>; <a href="./references#CD002253-bbs2-0127" title="KyawO , YiKH , ThidaM . A comparison of medical evacuation using single dose vaginal misoprostol (800mug) versus surgical evacuation in management of early pregnancy loss in North Okkalapa General and Teaching Hospital, Yangon. Journal of Obstetrics and Gynaecology Research2015;41:3, Abstract no: YGA O 06. ">Kyaw 2015</a>; <a href="./references#CD002253-bbs2-0135" title="MakhloufAM , Al‐HussainiTK , HabibDM , MakaremMH . Second‐trimester pregnancy termination: comparison of three different methods. Journal of Obstetrics and Gynaecology2003;23:407‐11. ">Makhlouf 2003</a>; <a href="./references#CD002253-bbs2-0139" title="Mostafa‐GharebaghiP , MansourfarM , Sadeghi‐BazarganiH . Low dose vaginal misoprostol versus prostaglandin E2 suppository for early uterine evacuation: a randomized clinical trial. Pakistan Journal of Biological Sciences2010;13(19):946‐50. ">Mostafa‐Gharebaghi 2010</a>; <a href="./references#CD002253-bbs2-0142" title="NakintuN . A comparative study of vaginal misoprostol and intravenous oxytocin for induction of labour in women with intrauterine fetal death in Mulago Hospital, Uganda. African Health Sciences2001;1:55‐9. ">Nakintu 2001</a>; <a href="./references#CD002253-bbs2-0148" title="NgaiSW , ChanYM , TangOS , HoPC . Vaginal misoprostol as medical treatment for first trimester spontaneous miscarriage. Human Reproduction2001;16(7):1493‐6. ">Ngai 2001</a>; <a href="./references#CD002253-bbs2-0150" title="NiinimakiM , JouppilaP , MartikainenH , Talvensaari‐MattilaA . A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Fertility and Sterility2006;86(2):367‐72. NiinimakiM , KarinenP , HartikainenAL , PoutaA . Treating miscarriages: a randomised study of cost‐effectiveness in medical or surgical choice. BJOG: an international journal of obstetrics and gynaecology2009;116(7):984‐90. [DOI: 10.1111/j.1471‐0528.2009.02161.x] ">Niinimaki 2006</a>; <a href="./references#CD002253-bbs2-0153" title="NuutilaM , ToivonenJ , YlikorkalaO , HalmesmakiE . A comparison between two doses of intravaginal misoprostol and gemeprost for induction of second‐trimester abortion. Obstetrics &amp; Gynecology1997;90:896‐900. ">Nuutila 1997</a>; <a href="./references#CD002253-bbs2-0154" title="OwenJ , HauthJC . Vaginal misoprostol vs concentrated oxytocin plus low‐dose prostaglandin E2 for second trimester pregnancy termination. Journal of Maternal‐Fetal Medicine1999;8:48‐50. ">Owen 1999</a>; <a href="./references#CD002253-bbs2-0162" title="PromwangkwaK , PuntitpongB , ChirdchimW , SananpanichkulP . Efficacy of sublingual misoprostol with or without loading vaginal misoprostol in second trimester termination of pregnancy: a randomized controlled trial. Journal of the Medical Association of Thailand2017;100(10):1050‐5. ">Promwangkwa 2017</a><a href="./references#CD002253-bbs2-0165" title="RamseyPS , SavageK , LincolnT , OwenJ . Vaginal misoprostol versus concentrated oxytocin and vaginal PGE2 for second‐trimester labor induction. Obstetrics &amp; Gynecology2004;104:138‐45. ">Ramsey 2004</a>; <a href="./references#CD002253-bbs2-0192" title="TanhaFD . Comparison of the efficacy of two routes of misoprostol administration (sublingual and vaginal) for termination of second trimester pregnancy. en.irct.ir/trial/23272010. [[CRSREF: 3293102] TanhaFD , GolgachiT , NiroomandN , GhajarzadehM , NasrR . Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Archives of Gynecology and Obstetrics2013;287(1):65‐9. ">Tanha 2013</a>; <a href="./references#CD002253-bbs2-0194" title="ThavarasahAS , AlmohdzarSA . Prostaglandin (F2alpha) in missed abortion. Intravenous extra‐amniotic and intramuscular administration ‐ a randomized study. Biological Research in Pregnancy1986;7:106‐10. ">Thavarasah 1986</a>; <a href="./references#CD002253-bbs2-0195" title="ThidaM , ShweMM , HtunKT , MaungNM , KhineEP , WinKS , et al. A randomised clinical trial comparing different routes of administration of repeated doses of 400ug misoprostol for management of missed miscarriages and anembryonic gestations in North Okkalapa General Hospital, Yangon, Myanmar. BJOG: an international journal of obstetrics and gynaecology2015;122(Suppl S1):26‐7. ">Thida 2015</a>; <a href="./references#CD002253-bbs2-0197" title="ToptasT , MendilciogluI , SimsekM , TaskinO . Comparison of intravaginal misoprostol alone to combination of intravaginal misoprostol and extraamniotic Foley catheter for the second trimester of pregnancies. American Journal of Obstetrics and Gynecology2011;204(1 Suppl):S126. ">Toptas 2011</a>; <a href="./references#CD002253-bbs2-0198" title="RosenbergP . Expectant versus immediate medical management for the evacuation of the non evolutive pregnancies before 13 GW. clinicaltrials.gov/ct2/show/NCT00190294 (first received 19 September 2005). TorreA , HuchonC , BussieresL , MachevinE , CamusE , FauconnierA . Immediate versus delayed medical treatment for first‐trimester miscarriage: a randomized trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):215.e1‐6. ">Torre 2012</a>; <a href="./references#CD002253-bbs2-0199" title="VanMenselK , ClaerhoutF , DeboisP , KeirseMJ , HanssensM . A randomized controlled trial of misoprostol and sulprostone to end pregnancy after fetal death [Article ID 496320]. Obstetrics and Gynecology International2009. ">Van Mensel 2009</a>; <a href="./references#CD002253-bbs2-0204" title="ZhangC , ChengW . A contrastive analysis of the efficacy of misoprostol and li fan nuo in intermediate term of pregnancy. Journal of Wuhan University of Science and Technology (Natural Science Edition)2000;23(4):409‐11. ">Zhang 2000</a>; <a href="./references#CD002253-bbs2-0205" title="ChenBA , ReevesMF , CreininMD , GillesJM , BarnhartK , WesthoffC , et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. American Journal of Obstetrics &amp; Gynecology2008;198(6):626.e1‐626.e5. [DOI: doi.org/10.1016/j.ajog.2007.11.045] CreininMD , HuangX , WesthoffC , BarnhartK , GillesJM , ZhangJ , et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstetrics &amp; Gynecology2006;107(4):901‐7. DavisAR , HendlishSK , WesthoffC , FrederickMM , ZhangJ , GillesJM , et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. American Journal of Obstetrics and Gynecology2007;196(1):31. [10.1016/j.ajog.2006.07.053] HarwoodB , NanselT , National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Quality of life and acceptability of medical versus surgical management of early pregnancy failure. BJOG: an international journal of obstetrics and gynaecology2008;115(4):501‐8. [DOI: 10.1111/j.1471‐0528.2007.01632.x] RauschM , LorchS , ChungK , FrederickM , ZhangJ , BarnhartK . A cost‐effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertility and Sterility2012;97(2):355‐60.e1. [DOI: 10.1016/j.fertnstert.2011.11.044] ZhangJ , GillesJM , BarnhartK , CreininMD , WesthoffC , FrederickMM , et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. New England Journal of Medicine2005;353:761‐9. ZhangJ , GillesK , BarnhartK , CreininM , WesthoffC , FrederickM . Medical management with misoprostol for early pregnancy failure: a multicenter, randomized equivalence trial. Fertility and Sterility2004;82 Suppl 2:S53‐S54. ">Zhang 2005</a>). Eight references turned out to be trial protocols or conference abstracts regarding studies that were also retrieved in our search and were added as additional reports to the reference of the published study results (<a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0131" title="LughmaniST . A comparison of intravaginal misoprostol with prostaglandin E2 for termination of 1st trimester pregnancy. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):179. LughmaniST . A comparison of intravaginal misoprostol with prostaglandin E2 for termination of 1st trimester pregnancy. Double blind randomized trial [abstract]. 31st British International Congress of Obstetrics and Gynaecology. London, UK, 2007, July 4‐6; Vol. 209. [CRSREF: 3293006] ">Lughmani 2008</a>; <a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>; <a href="./references#CD002253-bbs2-0144" title="NassarAH . A randomized trial of two regimens of misoprostol for second trimester intrauterine fetal death. clinicaltrials.gov/ct2/show/NCT001418952006. ">Nassar 2006</a>; <a href="./references#CD002253-bbs2-0152" title="NuthalapatyF , RamseyP , BiggioJ , OwenJ . Comparative efficacy of high dose vaginal misoprostol versus concentrated oxytocin + low dose vaginal misoprostol for mid‐trimester labor induction. American Journal of Obstetrics and Gynecology2004;191(6 Suppl 1):S73. NuthalapatyFS , RamseyPS , BiggioJR , OwenJ . High‐dose vaginal misoprostol versus concentrated oxytocin plus low‐dose vaginal misoprostol for midtrimester labor induction: a randomized trial. American Journal of Obstetrics and Gynecology2005;193(3 Pt 2):1065‐70. ">Nuthalapaty 2005</a>; <a href="./references#CD002253-bbs2-0187" title="MachtingerR , StockheimD , GoldenbergM , SorianoD , AtlasM , SeidmanDS . A randomized prospective study of misoprostol alone or combined with mifepristone for treatment of first trimester spontaneous abortion. Fertility and Sterility2002;78(3 Suppl 1):S64. StockheimD , MachtingerR , WiserA , DulitzkyM , SorianoD , GoldenbergM , et al. A randomized prospective study of misoprostol or mifepristone followed by misoprostol when needed for the treatment of women with early pregnancy failure. Fertility and Sterility2006;86(4):956‐60. ">Stockheim 2006</a>; <a href="./references#CD002253-bbs2-0192" title="TanhaFD . Comparison of the efficacy of two routes of misoprostol administration (sublingual and vaginal) for termination of second trimester pregnancy. en.irct.ir/trial/23272010. [[CRSREF: 3293102] TanhaFD , GolgachiT , NiroomandN , GhajarzadehM , NasrR . Sublingual versus vaginal misoprostol for second trimester termination: a randomized clinical trial. Archives of Gynecology and Obstetrics2013;287(1):65‐9. ">Tanha 2013</a>; <a href="./references#CD002253-bbs2-0198" title="RosenbergP . Expectant versus immediate medical management for the evacuation of the non evolutive pregnancies before 13 GW. clinicaltrials.gov/ct2/show/NCT00190294 (first received 19 September 2005). TorreA , HuchonC , BussieresL , MachevinE , CamusE , FauconnierA . Immediate versus delayed medical treatment for first‐trimester miscarriage: a randomized trial. American Journal of Obstetrics &amp; Gynecology2012;206(3):215.e1‐6. ">Torre 2012</a>). Sixteen studies were excluded because only a conference abstract was available and full data publication could not be retrieved (<a href="./references#CD002253-bbs2-0045" title="Abdel FattahIH . PGE1 analogue for the induction of midtrimester abortion in cases of intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement1997;76(167:2):26. ">Abdel Fattah 1997</a>; <a href="./references#CD002253-bbs2-0052" title="AndermanS , JaschevatzkyOE , BallasS . Comparison between a double balloon device and the foley catheter in extraamniotic prostaglandin F2a infusion for termination of midtrimester missed abortion. XVI FIGO World Congress of Obstetrics &amp; Gynecology; 2000 Sept 3‐8; Washington DC, USA. 2000:162. ">Anderman 2000</a>; <a href="./references#CD002253-bbs2-0053" title="AndersonJ , GoukE , YoungL , TurnbullL , SayeedG , ElattarA , et al. A randomised controlled trial of oral versus vaginal misoprostol for medical management of early fetal demise. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S533. ">Anderson 2009</a>; <a href="./references#CD002253-bbs2-0054" title="AraG , NargisS , KhatunR , SahaA . Vaginal misoprostol as a medical management in early pregnancy loss. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S533‐S534. ">Ara 2009</a>; <a href="./references#CD002253-bbs2-0057" title="AyeTT , AungKL , MyintSS . A comparative study on effect of sublingual versus vaginal misoprostol in management of first trimester miscarriage in Magway Teaching Hospital. Journal of Obstetrics and Gynaecology Research2017;43:185‐6, Abstract no: 9020. ">Aye 2017</a>; <a href="./references#CD002253-bbs2-0075" title="ChowdhuryS , UddinAW . Misoprostol in the management of second trimester missed abortion: a randomized controlled trial. International Journal of Gynaecology and Obstetrics2012;119(Suppl 3):S310. ">Chowdhury 2012</a>; <a href="./references#CD002253-bbs2-0104" title="HeardMJ , StewartGM , BusterJE , CarsonSA , MillerHJ . Outpatient management of missed abortion with vaginal misoprostol [abstract]. Obstetrics &amp; Gynecology2002;99(4 Suppl):20S. ">Heard 2002</a>; <a href="./references#CD002253-bbs2-0112" title="HombalegowdaRB , SamapthkumarS , VanaH , JogiP , RamaiahR . A randomized controlled trial comparing different doses of intravaginal misoprostol for early pregnancy failure. Contraception2015;92(4):364‐5. ">Hombalegowda 2015</a>; <a href="./references#CD002253-bbs2-0128" title="LinnTW , NyuntKK , KuSK . Effectiveness of low doses vaginal misoprostol in intrauterine fetal death. Journal of Obstetrics and Gynaecology Research2015;41(Suppl S1):60, Abstract no: FC 10.12. ">Linn 2015</a>; <a href="./references#CD002253-bbs2-0132" title="MachtingerR , StockheimD , ShulmanA , DulitzkiM , SchiffE , SeidmanDS . A randomized prospective study comparing the effectiveness of four protocols for treatment of first trimester spontaneous abortion. Fertility and Sterility2004;82 Suppl 2:S80. ">Machtinger 2004</a>; <a href="./references#CD002253-bbs2-0143" title="NasreenZ . What for early pregnancy failure manual vacuum aspiration (MVA) with small dose misoprostol or misoprostol alone?. International Journal of Gynecology &amp; Obstetrics2009;107(Suppl 2):S539‐S540. ">Nasreen 2009</a>; <a href="./references#CD002253-bbs2-0170" title="RoyG , FerreiraE , HudonL , MarquetteG . The efficacy of oral versus vaginal misoprostol for second‐trimester termination of pregnancy: a double blind, randomized placebo‐controlled trial. American Journal of Obstetrics and Gynecology2003;189(6):S70. ">Roy 2003</a>; <a href="./references#CD002253-bbs2-0176" title="ShaikhZA . Comparison between misoprostol alone and misoprostol with manual vacuum aspiration for the treatment of missed and incomplete miscarriage. BJOG: an international journal of obstetrics and gynaecology2008;115(s1):83. ">Shaikh 2008</a>; <a href="./references#CD002253-bbs2-0178" title="ShobeiraJM , AtashkhoiiS . Second trimester pregnancy termination by intravaginal and parenteral form of prostaglandin E2 [abstract]. 31st British International Congress of Obstetrics and Gynaecology; 2007 July 4‐6; London, UK. 2007:210. ">Shobeira 2007</a>; <a href="./references#CD002253-bbs2-0189" title="SuchonwanitP . Comparative study between vaginal misoprostol 200 mg and 400 mg in first trimester intrauterine fetal death and anembryonic gestation. Thai Journal of Obstetrics and Gynaecology1999;11(4):263. ">Suchonwanit 1999</a>; <a href="./references#CD002253-bbs2-0190" title="SuritaFG , CecattiJG , Pintoe Silva JL . Misoprostol versus laminaria for cervical ripening in intrauterine fetal death. Acta Obstetricia et Gynecologica Scandinavica Supplement1997;76(167:2):32. ">Surita 1997</a>). One study was published twice (<a href="./references#CD002253-bbs2-0022" title="KushwahB , SinghA . Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2009;106(1):43‐5. KushwahDS , KushwahB , SalmanMT , VermaVK . Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise. Indian Journal of Pharmacology2011;43(3):306‐10. [DOI: 10.4103/0253‐7613.81513; CRSREF: 3293000] ">Kushwah 2009</a>), these two references were grouped together as one study. </p> <p>Several studies turned out to be secondary analyses (cost‐analyses, follow‐up on fertility outcome of subsequent pregnancies, etcetera) of previous randomised controlled trials and were added as additional reports to the main references (five additional reports to <a href="./references#CD002253-bbs2-0205" title="ChenBA , ReevesMF , CreininMD , GillesJM , BarnhartK , WesthoffC , et al. Misoprostol for treatment of early pregnancy failure in women with previous uterine surgery. American Journal of Obstetrics &amp; Gynecology2008;198(6):626.e1‐626.e5. [DOI: doi.org/10.1016/j.ajog.2007.11.045] CreininMD , HuangX , WesthoffC , BarnhartK , GillesJM , ZhangJ , et al. Factors related to successful misoprostol treatment for early pregnancy failure. Obstetrics &amp; Gynecology2006;107(4):901‐7. DavisAR , HendlishSK , WesthoffC , FrederickMM , ZhangJ , GillesJM , et al. Bleeding patterns after misoprostol vs surgical treatment of early pregnancy failure: results from a randomized trial. American Journal of Obstetrics and Gynecology2007;196(1):31. [10.1016/j.ajog.2006.07.053] HarwoodB , NanselT , National Institute of Child Health and Human Development Management of Early Pregnancy Failure Trial. Quality of life and acceptability of medical versus surgical management of early pregnancy failure. BJOG: an international journal of obstetrics and gynaecology2008;115(4):501‐8. [DOI: 10.1111/j.1471‐0528.2007.01632.x] RauschM , LorchS , ChungK , FrederickM , ZhangJ , BarnhartK . A cost‐effectiveness analysis of surgical versus medical management of early pregnancy loss. Fertility and Sterility2012;97(2):355‐60.e1. [DOI: 10.1016/j.fertnstert.2011.11.044] ZhangJ , GillesJM , BarnhartK , CreininMD , WesthoffC , FrederickMM , et al. A comparison of medical management with misoprostol and surgical management for early pregnancy failure. New England Journal of Medicine2005;353:761‐9. ZhangJ , GillesK , BarnhartK , CreininM , WesthoffC , FrederickM . Medical management with misoprostol for early pregnancy failure: a multicenter, randomized equivalence trial. Fertility and Sterility2004;82 Suppl 2:S53‐S54. ">Zhang 2005</a>, two to <a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>, two to <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>, and one extra reference to respectively <a href="./references#CD002253-bbs2-0087" title="Elami‐SuzinM , FreemanMD , PoratN , RojanskyN , LauferN , Ben‐MeirA . Mifepristone followed by misoprostol or oxytocin for second‐trimester abortion: a randomized controlled trial. Obstetrics and Gynecology2013;122(4):815‐20. FreemanMD , PoratN , RojanskyN , Elami‐SuzinM , WinogradO , Ben‐MeirA . Physical symptoms and emotional responses among women undergoing induced abortion protocols during the second trimester. International Journal of Gynaecology and Obstetrics2016;135(2):154‐7. [DOI: 10.1016/j.ijgo.2016.05.008] ">Elami‐Suzin 2013</a>, <a href="./references#CD002253-bbs2-0150" title="NiinimakiM , JouppilaP , MartikainenH , Talvensaari‐MattilaA . A randomized study comparing efficacy and patient satisfaction in medical or surgical treatment of miscarriage. Fertility and Sterility2006;86(2):367‐72. NiinimakiM , KarinenP , HartikainenAL , PoutaA . Treating miscarriages: a randomised study of cost‐effectiveness in medical or surgical choice. BJOG: an international journal of obstetrics and gynaecology2009;116(7):984‐90. [DOI: 10.1111/j.1471‐0528.2009.02161.x] ">Niinimaki 2006</a> and <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>). These reports however did not provide suitable additional data for meta‐analysis. </p> </section> </section> <section id="CD002253-sec-0095"> <h3 class="title">Risk of bias in included studies</h3> <p>Please see <a href="#CD002253-fig-0002">Figure 2</a>; <a href="#CD002253-fig-0003">Figure 3</a> for a summary of 'Risk of bias' assessments. </p> <div class="figure" id="CD002253-fig-0002"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 2</div> </div> <hr class="top"/><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002253-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG02.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> </div> <div class="figure" id="CD002253-fig-0003"> <div class="figure-caption-wrapper-top"> <nav class="inline-nav-list has-dividers"> <ul> <li><a class="open-in-figure-viewer" href="#0">Open in figure viewer</a></li> </ul> </nav> <div class="figure-label">Figure 3</div> </div> <hr class="top"/><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002253-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG03.png"/><hr class="bottom"/> <div class="figure-caption-wrapper-bottom"> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> </div> <section id="CD002253-sec-0096"> <h4 class="title">Allocation</h4> <p>In 30 studies the risk of bias concerning random sequence generation was assessed as being at low risk of bias (<a href="./references#CD002253-bbs2-0001" title="AbediaslZ , SheikhM , PooransariP , FarahaniZ , KalaniF . Vaginal misoprostol versus intravenous oxytocin for the management of second‐trimester pregnancies with intrauterine fetal death: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research2016;42(3):246‐51. ">Abediasl 2016*</a>; <a href="./references#CD002253-bbs2-0003" title="AutryA , JacobsonG , SandhuR , IsbillK . Medical management of non‐viable early first trimester pregnancy. International Journal of Gynecology &amp; Obstetrics1999;67(1):9‐13. ">Autry 1999</a>; <a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0007" title="ChittacharoenA , HerabutyaY , PunyavachiraP . A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics &amp; Gynecology2003;101:70‐3. ">Chittacharoen 2003*</a>; <a href="./references#CD002253-bbs2-0008" title="CreininMD , MoyerR , GuidoR . Misoprostol for medical evacuation of early pregnancy failure. Obstetrics &amp; Gynecology1997;89:768‐72. ">Creinin 1997</a>; <a href="./references#CD002253-bbs2-0010" title="DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Human Reproduction2001;16:365‐9. DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3‐8; Washington DC, USA. 2000. ">Demetroulis 2001</a>; <a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a>; <a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a>; <a href="./references#CD002253-bbs2-0015" title="BarnhartKT , BaderT , HuangX , FrederickMM , TimbersKA , ZhangJJ . Hormone pattern after misoprostol administration for a nonviable first‐trimester gestation. Fertility and Sterility2004;81:1099‐105. CreininMD , HarwoodB , GuidoRS , FoxMC , ZhangJ , NICHD Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2004;86:22‐6. DavisAR , RobilottoCM , WesthoffCL , FormanS , ZhangJ , NICHD Management of Early Pregnancy Failure Trial. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Human Reproduction2004;19:1655‐8. GillesJ , CreininMM , BarnhartKT , WesthoffC , FrederickMM , ZangJ , et al. Wet versus dry misoprostol application for treatment of early pregnancy failure. Fertility and Sterility2002;78:S64‐S65. GillesJM , CreininMD , BarnhartK , WesthoffC , FrederickMM , ZhangJ . A randomized trial of saline solution‐moistened misoprostol versus dry misoprostol for the first‐trimester pregnancy failure. American Journal of Obstetrics and Gynecology2004;190:389‐94. ">Gilles 2004</a>; <a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>; <a href="./references#CD002253-bbs2-0018" title="JainJK , MishellDR . A comparison of misoprostol with and without laminaria tents for induction of second‐trimester abortion. American Journal of Obstetrics and Gynecology1996;175:173‐7. ">Jain 1996*</a>; <a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0022" title="KushwahB , SinghA . Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2009;106(1):43‐5. KushwahDS , KushwahB , SalmanMT , VermaVK . Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise. Indian Journal of Pharmacology2011;43(3):306‐10. [DOI: 10.4103/0253‐7613.81513; CRSREF: 3293000] ">Kushwah 2009</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0025" title="MarwahS , GuptaS , BatraNP , BhasinV , SarnaV , KaurN . A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (misoprostol) in management of first trimester missed abortion. Journal of Clinical and Diagnostic Research2016;10(5):QC14‐8. ">Marwah 2016</a>; <a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>; <a href="./references#CD002253-bbs2-0027" title="MizrachiY , DekaloA , GluckO , MirembergH , DafnaL , FeldsteinO , et al. Single versus repeat doses of misoprostol for treatment of early pregnancy loss‐a randomized clinical trial. Human Reproduction2017;32(6):1202‐7. ">Mizrachi 2017</a>; <a href="./references#CD002253-bbs2-0028" title="MuffleyPE , StitelyML , GhermanRB . Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology2002;187:321‐6. ">Muffley 2002</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0032" title="PetersenSG , PerkinsA , GibbonsK , BertoloneJ , Devenish‐MearesP , CaveD , et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2013;53(1):64‐73. ">Petersen 2013</a>; <a href="./references#CD002253-bbs2-0034" title="SaichuaC , PhupongV . A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics2009;280(3):431‐5. ">Saichua 2009</a>; <a href="./references#CD002253-bbs2-0035" title="SchreiberCA , SonalkarS , BarnhartKT , RatcliffeSJ , CreininMD , AtrioJ . Mifepristone pretreatment for the medical management of early pregnancy loss. New England Journal of Medicine2018;378(23):2161‐70. ">Schreiber 2018</a>; <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>; <a href="./references#CD002253-bbs2-0039" title="TangOS , LauWN , NgEHY , LeeSW , HoPC . A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction2003;18:176‐81. ">Tang 2003</a>; <a href="./references#CD002253-bbs2-0040" title="TangOS , OngCY , TseKY , NgEH , LeeSW , HoPC . A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction2006;21(1):189‐92. ">Tang 2006</a>; <a href="./references#CD002253-bbs2-0041" title="TanhaFD , FeiziM , ShariatM . Sublingual versus vaginal misoprostol for the management of missed abortion. Journal of Obstetrics and Gynaecology Research2010;36(3):525‐32. ">Tanha 2010a</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>). These studies mainly used (computer‐generated) random number tables. In one study (<a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>) randomisation was carried out by "blindly picking a sealed number from a box and then odd numbers were assigned to group A (misoprostol) and even numbers to group B (gemeprost)", and so although the picking of the number from a box describes a random component to the method of sequence generation, we are unclear about the use of an odd and even number to assign thereafter. We therefore considered this as potentially high risk of bias. In the remaining 12 studies random sequence generation was not (adequately) described (<a href="./references#CD002253-bbs2-0002" title="Al IniziSA , EzimokhaiM . Vaginal misoprostol versus dinoprostone for the management of missed abortion. International Journal of Gynecology &amp; Obstetrics2003;83:73‐4. ">Al Inizi 2003</a>; <a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>; <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0019" title="KaraM , OzdenS , ErogluM , CetinA , AriogluP . Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynecology and Obstetrics1999;1:13‐6. ">Kara 1999*</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>; <a href="./references#CD002253-bbs2-0030" title="NielsenS , HahlinM , Platz‐ChristensenJ . Expectant management or pharmacological treatment for first trimester spontaneous abortion: a randomised trial. Acta Obstetricia et Gynecologica Scandinavica1997;76(167:2):77. NielsenS , HahlinM , Platz‐ChristensenJ . Randomised trial comparing expectant with medical management for first trimester miscarriages. British Journal of Obstetrics and Gynaecology1999;106:804‐7. ">Nielsen 1999</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0033" title="Rita , GuptaS , KumarS . A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science2006;8(1):35‐8. ">Rita 2006</a>; <a href="./references#CD002253-bbs2-0036" title="ShahN , AzamSI , KhanNH . Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA ‐ Journal of the Pakistan Medical Association2010;60(2):113‐6. ">Shah 2010*</a>; <a href="./references#CD002253-bbs2-0038" title="SonsanohA , ChullapramT . Comparison of sublingual and vaginal misoprostol for termination of early pregnancy failure: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology2014;22(3):128‐36. ">Sonsanoh 2014</a>; <a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>). Three studies mentioned the use of block randomisation without further description. The risk of bias was for random sequence generation was therefore considered unclear. </p> <p>Twenty‐five studies used robust methods of allocation concealment. Most studies used sequentially numbered sealed opaque envelopes, or numbered and sealed packets containing study medication. Furthermore, randomisation using a computer program to guarantee allocation concealment was used (<a href="./references#CD002253-bbs2-0001" title="AbediaslZ , SheikhM , PooransariP , FarahaniZ , KalaniF . Vaginal misoprostol versus intravenous oxytocin for the management of second‐trimester pregnancies with intrauterine fetal death: a randomized clinical trial. Journal of Obstetrics and Gynaecology Research2016;42(3):246‐51. ">Abediasl 2016*</a>; <a href="./references#CD002253-bbs2-0003" title="AutryA , JacobsonG , SandhuR , IsbillK . Medical management of non‐viable early first trimester pregnancy. International Journal of Gynecology &amp; Obstetrics1999;67(1):9‐13. ">Autry 1999</a>; <a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0007" title="ChittacharoenA , HerabutyaY , PunyavachiraP . A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics &amp; Gynecology2003;101:70‐3. ">Chittacharoen 2003*</a>;<a href="./references#CD002253-bbs2-0008" title="CreininMD , MoyerR , GuidoR . Misoprostol for medical evacuation of early pregnancy failure. Obstetrics &amp; Gynecology1997;89:768‐72. ">Creinin 1997</a>; <a href="./references#CD002253-bbs2-0010" title="DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. Human Reproduction2001;16:365‐9. DemetroulisC , SaridoganE , KundeD , NaftalinAA . A prospective randomized control trial comparing medical and surgical treatment for early pregnancy failure. XVI FIGO World Congress of Obstetrics and Gynecology; 2000 Sept 3‐8; Washington DC, USA. 2000. ">Demetroulis 2001</a>; <a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a>; <a href="./references#CD002253-bbs2-0015" title="BarnhartKT , BaderT , HuangX , FrederickMM , TimbersKA , ZhangJJ . Hormone pattern after misoprostol administration for a nonviable first‐trimester gestation. Fertility and Sterility2004;81:1099‐105. CreininMD , HarwoodB , GuidoRS , FoxMC , ZhangJ , NICHD Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2004;86:22‐6. DavisAR , RobilottoCM , WesthoffCL , FormanS , ZhangJ , NICHD Management of Early Pregnancy Failure Trial. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Human Reproduction2004;19:1655‐8. GillesJ , CreininMM , BarnhartKT , WesthoffC , FrederickMM , ZangJ , et al. Wet versus dry misoprostol application for treatment of early pregnancy failure. Fertility and Sterility2002;78:S64‐S65. GillesJM , CreininMD , BarnhartK , WesthoffC , FrederickMM , ZhangJ . A randomized trial of saline solution‐moistened misoprostol versus dry misoprostol for the first‐trimester pregnancy failure. American Journal of Obstetrics and Gynecology2004;190:389‐94. ">Gilles 2004</a>; <a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>; <a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0025" title="MarwahS , GuptaS , BatraNP , BhasinV , SarnaV , KaurN . A comparative study to evaluate the efficacy of vaginal vs oral prostaglandin E1 analogue (misoprostol) in management of first trimester missed abortion. Journal of Clinical and Diagnostic Research2016;10(5):QC14‐8. ">Marwah 2016</a>; <a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>; <a href="./references#CD002253-bbs2-0027" title="MizrachiY , DekaloA , GluckO , MirembergH , DafnaL , FeldsteinO , et al. Single versus repeat doses of misoprostol for treatment of early pregnancy loss‐a randomized clinical trial. Human Reproduction2017;32(6):1202‐7. ">Mizrachi 2017</a>; <a href="./references#CD002253-bbs2-0028" title="MuffleyPE , StitelyML , GhermanRB . Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology2002;187:321‐6. ">Muffley 2002</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0032" title="PetersenSG , PerkinsA , GibbonsK , BertoloneJ , Devenish‐MearesP , CaveD , et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2013;53(1):64‐73. ">Petersen 2013</a>; <a href="./references#CD002253-bbs2-0034" title="SaichuaC , PhupongV . A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics2009;280(3):431‐5. ">Saichua 2009</a>; <a href="./references#CD002253-bbs2-0035" title="SchreiberCA , SonalkarS , BarnhartKT , RatcliffeSJ , CreininMD , AtrioJ . Mifepristone pretreatment for the medical management of early pregnancy loss. New England Journal of Medicine2018;378(23):2161‐70. ">Schreiber 2018</a>; <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>; <a href="./references#CD002253-bbs2-0038" title="SonsanohA , ChullapramT . Comparison of sublingual and vaginal misoprostol for termination of early pregnancy failure: a randomized controlled trial. Thai Journal of Obstetrics and Gynaecology2014;22(3):128‐36. ">Sonsanoh 2014</a>; <a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>). For these studies the risk of bias was considered low risk for allocation concealment. Sixteen reports failed to describe the process of allocation concealment (<a href="./references#CD002253-bbs2-0002" title="Al IniziSA , EzimokhaiM . Vaginal misoprostol versus dinoprostone for the management of missed abortion. International Journal of Gynecology &amp; Obstetrics2003;83:73‐4. ">Al Inizi 2003</a>; <a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>; <a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a>; <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0018" title="JainJK , MishellDR . A comparison of misoprostol with and without laminaria tents for induction of second‐trimester abortion. American Journal of Obstetrics and Gynecology1996;175:173‐7. ">Jain 1996*</a>; <a href="./references#CD002253-bbs2-0019" title="KaraM , OzdenS , ErogluM , CetinA , AriogluP . Comparison of misoprostol and dinoproston administration for the induction of labour in second trimester pregnancies in cases of intrauterine fetal loss. Italian Journal of Gynecology and Obstetrics1999;1:13‐6. ">Kara 1999*</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>; <a href="./references#CD002253-bbs2-0022" title="KushwahB , SinghA . Sublingual versus oral misoprostol for uterine evacuation following early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2009;106(1):43‐5. KushwahDS , KushwahB , SalmanMT , VermaVK . Acceptability and safety profile of oral and sublingual misoprostol for uterine evacuation following early fetal demise. Indian Journal of Pharmacology2011;43(3):306‐10. [DOI: 10.4103/0253‐7613.81513; CRSREF: 3293000] ">Kushwah 2009</a>; <a href="./references#CD002253-bbs2-0030" title="NielsenS , HahlinM , Platz‐ChristensenJ . Expectant management or pharmacological treatment for first trimester spontaneous abortion: a randomised trial. Acta Obstetricia et Gynecologica Scandinavica1997;76(167:2):77. NielsenS , HahlinM , Platz‐ChristensenJ . Randomised trial comparing expectant with medical management for first trimester miscarriages. British Journal of Obstetrics and Gynaecology1999;106:804‐7. ">Nielsen 1999</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0033" title="Rita , GuptaS , KumarS . A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science2006;8(1):35‐8. ">Rita 2006</a>; <a href="./references#CD002253-bbs2-0039" title="TangOS , LauWN , NgEHY , LeeSW , HoPC . A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction2003;18:176‐81. ">Tang 2003</a>; <a href="./references#CD002253-bbs2-0040" title="TangOS , OngCY , TseKY , NgEH , LeeSW , HoPC . A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction2006;21(1):189‐92. ">Tang 2006</a>; <a href="./references#CD002253-bbs2-0041" title="TanhaFD , FeiziM , ShariatM . Sublingual versus vaginal misoprostol for the management of missed abortion. Journal of Obstetrics and Gynaecology Research2010;36(3):525‐32. ">Tanha 2010a</a>). In these studies risk of bias for allocation concealment was unclear. This was also the case for two more studies (<a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>; <a href="./references#CD002253-bbs2-0036" title="ShahN , AzamSI , KhanNH . Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA ‐ Journal of the Pakistan Medical Association2010;60(2):113‐6. ">Shah 2010*</a>). In these studies numbers were picked from a box, and depending on the randomness of the sequence, blinding of allocation cannot be guaranteed. </p> </section> <section id="CD002253-sec-0097"> <h4 class="title">Blinding</h4> <p>Seven studies describe both doctors and women were blinded for the treatment allocation and used matching placebo medication to establish this (<a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*;</a><a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>). The risk of bias was therefore considered low. Two other studies mention the use of placebo medication (<a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>). It is therefore likely that women were blinded for the intervention. However the authors fail to describe if placebo tablets look similar to medication and therefore it is unsure whether doctors were also blinded for the intervention. Performance bias was unclear for these two studies. In the remaining 33 studies blinding was either not possible (due to the nature of the intervention) or not performed. In these studies performance bias was assessed high. </p> <p>For the six double‐blind placebo‐controlled trials (<a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>) it was very likely that outcome assessors were blinded for the intervention and detection bias was therefore considered low. This was also the case for two more studies (<a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a> and <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>) which described outcome assessors were blinded for the intervention. Two more studies used placebo medication, (<a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>) and it is therefore likelier that outcome assessors were blinded for the intervention. This is however not clearly described. Risk of bias was assessed as unclear for these two studies. One study describes nurses being in charge of the administration of medication (sublingual or oral misoprostol) (<a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>) and since doctors were the outcome assessors it could have been that they were blinded for the intervention. This is however not described. Risk of detection bias was assessed unclear in this case. In the remaining 32 studies blinding of the outcome was either not possible (due to the nature of the intervention) or not described. We considered it to be very unlikely that in these cases outcome assessors were blinded for the intervention. In these remaining 32 studies risk of detection bias was considered high. </p> </section> <section id="CD002253-sec-0098"> <h4 class="title">Incomplete outcome data</h4> <p>Data were incomplete in at least three studies (<a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>). In these studies women were allocated to a specific treatment, and then wrongfully excluded from analysis. Risk of bias was considered high for these studies. In four more studies risk of attrition bias was unclear (<a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0033" title="Rita , GuptaS , KumarS . A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science2006;8(1):35‐8. ">Rita 2006</a>). For these studies lost to follow up was &lt; 10%, secondary outcomes were not available for all included women, or failed to report on loss to follow‐up. In the remaining 36 studies risk of attrition bias was considered low, because primary outcomes were available for nearly all included women. </p> </section> <section id="CD002253-sec-0099"> <h4 class="title">Selective reporting</h4> <p>Five studies (<a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0034" title="SaichuaC , PhupongV . A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics2009;280(3):431‐5. ">Saichua 2009</a>; <a href="./references#CD002253-bbs2-0035" title="SchreiberCA , SonalkarS , BarnhartKT , RatcliffeSJ , CreininMD , AtrioJ . Mifepristone pretreatment for the medical management of early pregnancy loss. New England Journal of Medicine2018;378(23):2161‐70. ">Schreiber 2018</a>) had inconsistencies in outcome reporting and showed evidence of omission of outcomes in results. Furthermore, there was one study mentioning that several secondary outcomes were not reported in this paper. It was unclear whether these outcomes were reported elsewhere. These studies were considered to have a high risk on reporting bias. For 18 studies (<a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0008" title="CreininMD , MoyerR , GuidoR . Misoprostol for medical evacuation of early pregnancy failure. Obstetrics &amp; Gynecology1997;89:768‐72. ">Creinin 1997</a>; <a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>; <a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a>; <a href="./references#CD002253-bbs2-0015" title="BarnhartKT , BaderT , HuangX , FrederickMM , TimbersKA , ZhangJJ . Hormone pattern after misoprostol administration for a nonviable first‐trimester gestation. Fertility and Sterility2004;81:1099‐105. CreininMD , HarwoodB , GuidoRS , FoxMC , ZhangJ , NICHD Early Pregnancy Failure Trial. Endometrial thickness after misoprostol use for early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2004;86:22‐6. DavisAR , RobilottoCM , WesthoffCL , FormanS , ZhangJ , NICHD Management of Early Pregnancy Failure Trial. Bleeding patterns after vaginal misoprostol for treatment of early pregnancy failure. Human Reproduction2004;19:1655‐8. GillesJ , CreininMM , BarnhartKT , WesthoffC , FrederickMM , ZangJ , et al. Wet versus dry misoprostol application for treatment of early pregnancy failure. Fertility and Sterility2002;78:S64‐S65. GillesJM , CreininMD , BarnhartK , WesthoffC , FrederickMM , ZhangJ . A randomized trial of saline solution‐moistened misoprostol versus dry misoprostol for the first‐trimester pregnancy failure. American Journal of Obstetrics and Gynecology2004;190:389‐94. ">Gilles 2004</a>; <a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>; <a href="./references#CD002253-bbs2-0020" title="KovavisarachE , SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum: a randomised controlled trial. Australian and New Zealand Journal of Obstetrics and Gynaecology2002;42:161‐3. SathapanachaiU . Intravaginal 400 micrograms misoprostol for pregnancy termination in cases of blighted ovum. Thai Journal of Obstetrics and Gynaecology2000;12(4):363. ">Kovavisarach 2002</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0028" title="MuffleyPE , StitelyML , GhermanRB . Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology2002;187:321‐6. ">Muffley 2002</a>; <a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0032" title="PetersenSG , PerkinsA , GibbonsK , BertoloneJ , Devenish‐MearesP , CaveD , et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2013;53(1):64‐73. ">Petersen 2013</a>; <a href="./references#CD002253-bbs2-0033" title="Rita , GuptaS , KumarS . A randomised comparison of oral and vaginal misoprostol for medical management of first trimester missed abortion. JK Science2006;8(1):35‐8. ">Rita 2006</a>; <a href="./references#CD002253-bbs2-0036" title="ShahN , AzamSI , KhanNH . Sublingual versus vaginal misoprostol in the management of missed miscarriage. JPMA ‐ Journal of the Pakistan Medical Association2010;60(2):113‐6. ">Shah 2010*</a>; <a href="./references#CD002253-bbs2-0039" title="TangOS , LauWN , NgEHY , LeeSW , HoPC . A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction2003;18:176‐81. ">Tang 2003</a>; <a href="./references#CD002253-bbs2-0040" title="TangOS , OngCY , TseKY , NgEH , LeeSW , HoPC . A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction2006;21(1):189‐92. ">Tang 2006</a>; <a href="./references#CD002253-bbs2-0041" title="TanhaFD , FeiziM , ShariatM . Sublingual versus vaginal misoprostol for the management of missed abortion. Journal of Obstetrics and Gynaecology Research2010;36(3):525‐32. ">Tanha 2010a</a>) reporting bias was unclear due to the problem that all studies reported on outcomes that were not prespecified in the method section. It was therefore impossible to assess whether all outcomes were reported upon. One study (<a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>) failed to present a clear description of primary and secondary outcomes in the methods section which makes it difficult to give a judgment on selective reporting and the risk was therefore also labelled as unclear. Risk of reporting bias was considered low in 19 studies that reported on all outcomes that were mentioned in their method section. </p> </section> <section id="CD002253-sec-0100"> <h4 class="title">Other potential sources of bias</h4> <p>For none of the included studies other potential sources of bias were detected.</p> </section> </section> <section id="CD002253-sec-0101"> <h3 class="title" id="CD002253-sec-0101">Effects of interventions</h3> <p>See: <a href="./full#CD002253-tbl-0001"><b>Summary of findings for the main comparison</b> Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</a>; <a href="./full#CD002253-tbl-0002"><b>Summary of findings 2</b> Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</a> </p> <p>Forty‐three studies, with a total of 4966 women, were included. Twenty‐two of the studies addressed termination of non‐viable pregnancies before 14 weeks. There were few reports of serious adverse effects in the reported trials, but one woman required a bowel resection after uterine perforation at evacuation of the uterus (<a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>). </p> <section id="CD002253-sec-0102"> <h4 class="title">Subgroup analyses</h4> <p>For a number of comparisons with subgroups of clinical interest, extra subgroup analyses were carried out. These included the following. </p> <p>For comparison 1: vaginal misoprostol versus placebo; primary outcome complete miscarriage:</p> <p> <ol id="CD002253-list-0012"> <li> <p>complete miscarriage less than one day;</p> </li> <li> <p>complete miscarriage less than two days;</p> </li> <li> <p>complete miscarriage less than seven days.</p> </li> </ol> </p> <p>For comparison 6: vaginal misoprostol wet versus dry preparations: primary outcome complete miscarriage: </p> <p> <ol id="CD002253-list-0013"> <li> <p>complete miscarriage less than three days;</p> </li> <li> <p>complete miscarriage less than eight days;</p> </li> <li> <p>complete miscarriage less than 15 days;</p> </li> <li> <p>complete miscarriage less than 30 days.</p> </li> </ol> </p> <p>For comparison 8: vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone: primary outcome complete miscarriage: </p> <p> <ol id="CD002253-list-0014"> <li> <p>complete miscarriage less than one day;</p> </li> <li> <p>complete miscarriage less than two days.</p> </li> </ol> </p> <p>For comparison 18: buccal misoprostol lower versus higher regimen: primary outcome complete miscarriage 13 to 23 weeks: </p> <p> <ol id="CD002253-list-0015"> <li> <p>complete miscarriage less than one day;</p> </li> <li> <p>complete miscarriage less than two days.</p> </li> </ol> </p> <p>For comparison 19: mifepristone versus placebo: primary outcome complete miscarriage:</p> <p> <ol id="CD002253-list-0016"> <li> <p>complete miscarriage less than two days;</p> </li> <li> <p>complete miscarriage less than three days;</p> </li> <li> <p>complete miscarriage less than four days;</p> </li> <li> <p>complete miscarriage less than five days.</p> </li> </ol> </p> <p>All results per comparison are mentioned in the following paragraphs.</p> </section> <section id="CD002253-sec-0103"> <h4 class="title">1. Vaginal misoprostol versus placebo</h4> <section id="CD002253-sec-0104"> <h5 class="title">Primary outcomes</h5> <p>Treatment with vaginal misoprostol hastens miscarriage (passage of products of conception, whether complete or incomplete) when compared with placebo: miscarriage less than 24 hours (2 trials, 138 women, risk ratio (RR) 4.73, 95% confidence interval (CI) 2.70 to 8.28) miscarriage less than 48 hours (2 (other) trials, 84 women, RR 5.74, 95% CI 2.70 to 12.19); complete miscarriage without need for surgical intervention at seven days (1 trial, 83 women, RR 2.99, 95% CI 1.80 to 4.99). For these five studies combined (total of 305 women) RR of successful evacuation with misoprostol compared to placebo was 4.23, 95% CI 3.01 to 5.94; low‐quality evidence; <a href="./references#CD002253-fig-0004" title="">Analysis 1.1</a>. In the GRADE assessment, the risk of bias was considered as serious because several studies lacked (information) on blinding. Furthermore, there was serious indirectness since there were differences in timing of outcome measurement: after 24 hours (two studies), after 48 hours (two studies) or after seven days (one study) which might have influenced the incidence of successful outcome, though effect of the outcome was considered large. The quality of evidence was therefore assessed as low (<a href="./full#CD002253-tbl-0001">summary of findings Table for the main comparison</a>). In one study, one women in the placebo group had a uterine perforation after surgical evacuation was performed (1 trial, 84 women, RR 0.33, 95% CI 0.01 to 7.96) (<a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>) (<a href="./references#CD002253-fig-0005" title="">Analysis 1.2</a>). </p> </section> <section id="CD002253-sec-0105"> <h5 class="title">Secondary outcomes</h5> <p>There was no difference in the need for blood transfusion (1 study, 84 women, RR 0.20, 95% CI 0.01 to 4.04), no difference in haemoglobin level after treatment (1 study, 50 women, RR 1.25, 95% CI 0.38 to 4.12; very‐low quality evidence) or duration of bleeding (in days) (1 study, 32 women, RR 1.00, 95% CI 0.41 to 2.45; <a href="./references#CD002253-fig-0006" title="">Analysis 1.3</a>; <a href="./references#CD002253-fig-0007" title="">Analysis 1.4</a>; <a href="./references#CD002253-fig-0008" title="">Analysis 1.5</a>). There was no increase in adverse effects: nausea (2 trials, 88 women, RR 1.38, 95% CI 0.43 to 4.40; low‐quality evidence), diarrhoea (2 trials, 88 women, RR 2.21, 95% CI 0.35 to 14.06; low‐quality evidence; <a href="./references#CD002253-fig-0009" title="">Analysis 1.6</a>; <a href="./references#CD002253-fig-0010" title="">Analysis 1.7</a>). In one small study (<a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>), two out of 42 women used opiates for pain relief when treated with misoprostol, compared to 0 out of 42 women in the placebo group (1 trial, 84 women, RR 5.00, 95% CI 0.25 to 101.11; very‐low quality evidence; <a href="./references#CD002253-fig-0011" title="">Analysis 1.8</a>). According to one study a similar number of women (58%) who would choose the same treatment strategy in the future (<a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>); although more women who had complete miscarriage after misoprostol (76%) would choose this treatment than those who required subsequent curettage (38%) (1 trial, 32 women, RR 1.17, 95% CI 0.83 to 1.64; low‐quality evidence; <a href="./references#CD002253-fig-0012" title="">Analysis 1.9</a>). For all these secondary outcomes there were some limitations in study design, with unclear allocation concealment for some studies, there was evidence of 'imprecision' with small numbers of studies and wide CIs contributing to effect estimates and also some evidence of indirectness for one study (see <a href="./full#CD002253-tbl-0001">summary of findings Table for the main comparison</a>). </p> <p>The following secondary outcomes were not reported in the trials for this comparison: haemorrhage; pelvic infection; cervical damage; hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; and costs. </p> </section> </section> <section id="CD002253-sec-0106"> <h4 class="title">2. Vaginal misoprostol versus expectant management</h4> <section id="CD002253-sec-0107"> <h5 class="title">Primary outcomes</h5> <p>One study was included (614 women); in which a complete miscarriage (described as no need for additional intervention) occurred more often after misoprostol treatment compared to expectant management (RR 1.25, 95% CI 1.09 to 1.45; <a href="./references#CD002253-fig-0013" title="">Analysis 2.1</a>). The quality of this evidence in GRADE assessment was downgraded because of serious risk of bias (only one study included, no blinding performed) and serious imprecision; and was therefore assessed as low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0108"> <h5 class="title">Secondary outcomes</h5> <p>Although the total number of events was low, in the misoprostol group more infections occurred within eight weeks after study entry compared to the expectant management group (1 study, 618 women, RR 8.05, 95% CI 1.87 to 34.72; <a href="./references#CD002253-fig-0014" title="">Analysis 2.2</a>); in the included trial (<a href="./references#CD002253-bbs2-0042" title="PetrouS , TrinderJ , BrocklehurstP , SmithL . Economic evaluation of alternative management methods of first‐trimester miscarriage based on results from the MIST trial. BJOG: An International Journal of Obstetrics &amp; Gynaecology2006;113(8):879‐89. [DOI: 10.1111/j.1471‐0528.2006.00998.x; CRSREF: 3293040] SmithL . Extension to: randomised controlled trial of expectant, medical and surgical management of early miscarriage. Research Findings Register (www.refer.nhs.uk) (accessed 7 March 2006)2006. TrinderJ , BrocklehurstP , PorterR , ReadM , VyasS , SmithL . Management of miscarriage: expectant, medical, or surgical? Results of randomised controlled trial (miscarriage treatment (MIST) trial). BMJ2006;332(7552):1235‐40. ">Trinder 2006</a>) infections were defined as two or more of purulent vaginal discharges, pyrexia more than 38.0°C, tenderness over the uterus on abdominal examination, and a white cell count above 15x10^9/L. Risk of bias was considered serious since no blinding was performed, and there was serious imprecision with very wide CIs because of few events in the treatment arms. The GRADE certainty of evidence is therefore considered low. </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; haemorrhage; blood loss; days of bleeding; pain (relief); cervical damage; digestive disorders (nausea or vomiting or diarrhoea); hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; woman's satisfaction/acceptability of method; and costs. </p> </section> </section> <section id="CD002253-sec-0109"> <h4 class="title">3. Vaginal misoprostol versus surgical evacuation of uterus</h4> <section id="CD002253-sec-0110"> <h5 class="title">Primary outcomes</h5> <p>Complete miscarriage was lower after initial misoprostol treatment compared to primary surgical treatment (6 studies, 943 women, average RR 0.40, 95% CI 0.32 to 0.50; low‐quality evidence; Heterogeneity: Tau<sup>2</sup>0.03 I<sup>2</sup> = 46%; <a href="./references#CD002253-fig-0015" title="">Analysis 3.1</a>). The GRADE certainty of evidence was assessed as low; there was a serious risk of bias with no blinding performed in all studies but one and concerns due to inconsistency, but the effect was large and there were no other serious risks (<a href="./full#CD002253-tbl-0002">summary of findings Table 2</a>). Though in the women who were treated successfully with misoprostol, surgery could be avoided. One study reported on uterine perforation (<a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>), and occurred in one woman (1 trial, 154 women, RR 0.32, 95% CI 0.01 to 7.65; <a href="./references#CD002253-fig-0016" title="">Analysis 3.2</a>). </p> </section> <section id="CD002253-sec-0111"> <h5 class="title">Secondary outcomes</h5> <p>One study (<a href="./references#CD002253-bbs2-0028" title="MuffleyPE , StitelyML , GhermanRB . Early intrauterine pregnancy failure: a randomized trial of medical versus surgical treatment. American Journal of Obstetrics and Gynecology2002;187:321‐6. ">Muffley 2002</a>) assessed blood loss in women treated with vaginal misoprostol compared to surgical evacuation, and showed no difference in haematocrit level post treatment % (1 study, 50 women mean difference (MD) ‐1.40, 95% CI ‐3.51 to 0.71; low‐quality evidence; <a href="./references#CD002253-fig-0017" title="">Analysis 3.3</a>). The use of pain relief was similar among women treated with vaginal misoprostol and surgical evacuation (1 study, 154 women, RR 1.42, 95% CI 0.82 to 4.46; low‐quality evidence; <a href="./references#CD002253-fig-0018" title="">Analysis 3.4</a>). The rate of infections less than eight weeks after study entry was similar (1 trial, 618 women, RR 0.73, 95% CI 0.39 to 1.37; low‐quality evidence; <a href="./references#CD002253-fig-0019" title="">Analysis 3.5</a>). Misoprostol treatment was associated with more nausea (1 trial, 154 women, RR 21.85, 95% CI 1.31 to 364.37; low‐quality evidence) and diarrhoea (1 trial, 154 women, RR 40.85, 95% CI 2.52 to 662.57; low‐quality evidence; <a href="./references#CD002253-fig-0020" title="">Analysis 3.6</a>; <a href="./references#CD002253-fig-0021" title="">Analysis 3.7</a>). Woman's satisfaction was not better when treated with curettage compared to misoprostol (1 study, 45 women, RR 0.67, 95% CI 0.40 to 1.11; low‐quality evidence; <a href="./references#CD002253-fig-0022" title="">Analysis 3.8</a>). The quality of evidence was low because of serious risk of bias concerns, some inconsistency with varied sampling and different medication regimens and much of the data for outcomes were from single studies with wide CIs (see <a href="./full#CD002253-tbl-0002">summary of findings Table 2</a>). In one trial (<a href="./references#CD002253-bbs2-0016" title="GraziosiGC , BruinseHW , ReuwerPJ , TeteringenO , MolBW . Fertility outcome after a randomized trial comparing curettage with misoprostol for treatment of early pregnancy failure. Human Reproduction2005;20:1749‐50. GraziosiGC , BruinseHW , ReuwerPJ , vanKesselPH , WesterweelPE , MolBW . Misoprostol versus curettage in women with early pregnancy failure: impact on women's health‐related quality of life. A randomized controlled trial. Human Reproduction2005;20:2340‐7. GraziosiGC , MolBW , ReuwerPJ , DrogtropA , BruinseHW . Misoprostol versus curettage in women with early pregnancy failure after initial expectant management: a randomized trial. Human Reproduction2004;19:1894‐9. GraziosiGC , van derSteegJW , ReuwerPH , DrogtropAP , BruinseHW , MolBW . Economic evaluation of misoprostol in the treatment of early pregnancy failure compared to curettage after an expectant management. Human Reproduction2005;20:1067‐71. ">Graziosi 2004</a>), one women in the surgical evacuation group developed Asherman syndrome. </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; haemorrhage; cervical damage; hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; and costs. </p> </section> </section> <section id="CD002253-sec-0112"> <h4 class="title">4. Vaginal misoprostol versus vaginal dinoprostone</h4> <section id="CD002253-sec-0113"> <h5 class="title">Primary outcomes</h5> <p>Vaginal misoprostol is more effective to achieve a complete miscarriage than vaginal dinoprostone for pregnancies &lt; 14 weeks as well as &gt; 14 weeks (2 trials, 125 women, RR 1.83, 95% CI 1.37 to 2.46; <a href="./references#CD002253-fig-0023" title="">Analysis 4.1</a>). However there was a very serious risk of bias with no information on randomisation method in the included studies, no information on allocation concealment, and no blinding. The quality of the evidence was therefore considered very low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0114"> <h5 class="title">Secondary outcomes</h5> <p>In the misoprostol group, two women needed blood transfusion (1 trial, 60 women, RR 6.07, 95% CI 0.30 to 121.33; <a href="./references#CD002253-fig-0024" title="">Analysis 4.2</a>). The incidence of nausea was similar in the one small trial that was included in this comparison (65 women, RR 1.03, 95% CI 0.28 to 3.78; <a href="./references#CD002253-fig-0025" title="">Analysis 4.3</a>). The mean duration of hospital stay in days was lower in the misoprostol group (1 trial, 60 women, MD ‐2.38, 95% CI ‐3.36 to ‐1.40; <a href="./references#CD002253-fig-0026" title="">Analysis 4.4</a>). The GRADE quality of evidence for these outcomes was very low because of very serious risk of bias (no clear randomisation method, no blinding) and serious imprecision (study not powered for this outcome, wide CI). </p> <p>The following secondary outcomes were not reported in the trials for this comparison: haemorrhage; blood loss; days of bleeding; pain (relief); pelvic infection; cervical damage; digestive disorders (vomiting or diarrhoea); hypertensive disorders; time to expulsion; psychological effects; subsequent fertility; woman's satisfaction/acceptability of method; and costs. </p> </section> </section> <section id="CD002253-sec-0115"> <h4 class="title">5. Vaginal misoprostol lower versus higher‐dose regimens</h4> <section id="CD002253-sec-0116"> <h5 class="title">Primary outcomes</h5> <p>Vaginal misoprostol has been administered in doses of 400 mcg, 600 mcg, and 800 mcg in trials: higher‐dose regimens were no more effective in producing miscarriage &lt; 13 weeks, (2 studies, 397 women, average RR 0.82, 95% CI 0.58 to 1.14; Heterogeneity Tau<sup>2</sup> = 0.05; I<sup>2</sup> = 73%) or 13 to 23 weeks (1 study, 100 women, RR 1.05, 95% CI 0.87 to 1.26; <a href="./references#CD002253-fig-0027" title="">Analysis 5.1</a>; <a href="./references#CD002253-fig-0028" title="">Analysis 5.2</a>). There was risk of bias because lack of proper blinding in two of the included studies (<a href="./references#CD002253-bbs2-0031" title="NiromaneshS , Hashemi‐FeasharakiM , Mosavi‐JarrahiA . Second trimester abortion using intravaginal misoprostol. International Journal of Gynecology &amp; Obstetrics2005;89:276‐7. ">Niromanesh 2005*</a>; <a href="./references#CD002253-bbs2-0032" title="PetersenSG , PerkinsA , GibbonsK , BertoloneJ , Devenish‐MearesP , CaveD , et al. Can we use a lower intravaginal dose of misoprostol in the medical management of miscarriage? A randomised controlled study. Australian &amp; New Zealand Journal of Obstetrics &amp; Gynaecology2013;53(1):64‐73. ">Petersen 2013</a>), and there was serious inconsistency between the studies with differences in the gestational age (GA) of included patients (&lt; or &gt; 14 weeks), differences in misoprostol regimen, and differences in time to outcome measurements (24 hours, 48 hours or seven days). There seemed to be a dose‐response gradient, the quality of the evidence was assessed as moderate. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0117"> <h5 class="title">Secondary outcomes</h5> <p>There were no differences in nausea (2 trials, 214 women, RR 0.67, 95% CI 0.31 to 1.41) and diarrhoea (2 trials, 214 women, RR 0.54, 95% CI 1015 to 1.91) between higher‐ or lower‐dose regimens (<a href="./references#CD002253-fig-0029" title="">Analysis 5.3</a>; <a href="./references#CD002253-fig-0030" title="">Analysis 5.4</a>). However, because the risk of bias and the inconsistencies described above at the primary outcomes; the quality of the evidence were assessed as low. </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; haemorrhage; blood loss; days of bleeding; pain (relief); pelvic infection; cervical damage; digestive disorders (nausea or vomiting or diarrhoea); hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; and costs. </p> </section> </section> <section id="CD002253-sec-0118"> <h4 class="title">6. Vaginal misoprostol wet versus dry vaginal preparations</h4> <section id="CD002253-sec-0119"> <h5 class="title">Primary outcomes</h5> <p>Based on one trial there seems no clear advantage to administering a 'wet' preparation of vaginal misoprostol compared to a 'dry' preparation; miscarriage less than three days (1 trial, 80 women, RR 1.14, 95% CI 0.85 to 1.54; <a href="./references#CD002253-fig-0031" title="">Analysis 6.1</a>). When the outcome complete miscarriage was assessed on day eight, 15 or 30 there was still no clear advantage of a 'wet' preparation compared to a 'dry' preparation. Since there was serious risk of bias with only one study included, no blinding performed, and a small sample size, the quality was assessed as being low‐quality. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0120"> <h5 class="title">Secondary outcomes</h5> <p>There were no differences in diarrhoea (1 trial, 77 women, RR 1.75, 95% CI 0.89 to 3.42) and vomiting (1 trial, 77 women, RR 0.93, 95% CI 0.33 to 2.62), (<a href="./references#CD002253-fig-0032" title="">Analysis 6.2</a>; <a href="./references#CD002253-fig-0033" title="">Analysis 6.3</a>). Woman's satisfaction, as measured by whether they would wish/probably wish same treatment in the future, suggests no difference between wet and dry vaginal preparations (1 trial, 73 women, RR 1.18, 95% CI 0.93 to 1.49; <a href="./references#CD002253-fig-0034" title="">Analysis 6.4</a>). Again, the quality of the evidence was considered very low. </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; haemorrhage; blood loss; days of bleeding; pain (relief); pelvic infection; cervical damage; hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; and costs. </p> </section> </section> <section id="CD002253-sec-0121"> <h4 class="title">7. Vaginal misoprostol + methotrexate versus vaginal misoprostol</h4> <section id="CD002253-sec-0122"> <h5 class="title">Primary outcomes</h5> <p>Adding methotrexate treatment to vaginal misoprostol has not been demonstrated to be advantageous in the single small trial to address this: complete miscarriage after treatment (21 women, RR 1.13, 95% CI 0.85 to 1.50; <a href="./references#CD002253-fig-0035" title="">Analysis 7.1</a>). The quality of this evidence is very low because of very serious risk of bias (only one small study included, no blinding). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0123"> <h5 class="title">Secondary outcomes</h5> <p>In the small trial with 21 women that was included in this comparison there were no differences in incidence of haemorrhage (RR 2.31, 95% CI 0.10 to 50.85; <a href="./references#CD002253-fig-0036" title="">Analysis 7.2</a>) and in pain relief (RR 0.75, 95% CI 0.25 to 2.22; <a href="./references#CD002253-fig-0037" title="">Analysis 7.3</a>); but due to the small number of participants and a serious risk of bias (no blinding) the quality of this evidence is very low. </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; blood loss; days of bleeding; pelvic infection; cervical damage; hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; woman's satisfaction/acceptability of method; and costs. </p> </section> </section> <section id="CD002253-sec-0124"> <h4 class="title">8. Vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone</h4> <p>Laminaria tents were not proven useful adjuncts to vaginal misoprostol during the second trimester: complete miscarriage less than 24 hours (1 trial, 38 women, RR 0.90, 95% CI 0.65 to 1.25), or 48 hours (<a href="./references#CD002253-fig-0038" title="">Analysis 8.1</a>). GRADE score on quality of the evidence was downgraded two levels because of serious risk of bias (only one small study included, no blinding) and imprecision; and was considered very low. </p> <p>Death or serious complications were not reported in the trial. No secondary outcomes were reported. </p> </section> <section id="CD002253-sec-0125"> <h4 class="title">9. Vaginal misoprostol versus sublingual misoprostol</h4> <section id="CD002253-sec-0126"> <h5 class="title">Primary outcome</h5> <p>No differences in effects were established when comparing vaginal versus sublingual preparations of misoprostol in inducing complete miscarriage &lt; 13 weeks, although the evidence was limited by small sample sizes and heterogeneity of the included trials (five trials, 513 women, random‐effects model average RR 0.84, 95% CI 0.61 to 1.16; heterogeneity Tau² = 0.10; I² = 82%; <a href="./references#CD002253-fig-0039" title="">Analysis 9.1</a>). One trial comparing vaginal misoprostol and sublingual misoprostol for miscarriage 13 to 23 weeks also showed no difference, and also included very limited numbers (9 women, RR 0.50, 95% CI 0.13 to 2.00). The quality of evidence was downgraded because of serious risk of bias (no blinding performed in the including studies) and therefore assessed as low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0127"> <h5 class="title">Secondary outcomes</h5> <p>Although there seemed to be no differences between vaginal and sublingual misoprostol regarding nausea (4 trials, 302 women, RR 0.42, 95% CI 0.12 to 1.44; <a href="./references#CD002253-fig-0043" title="">Analysis 9.5</a>); vomiting (2 trials, 300 women, RR 0.76, 95% CI 0.46 to 1.26; <a href="./references#CD002253-fig-0044" title="">Analysis 9.6</a>); and excessive blood loss (2 trials, 340 women, RR 0.54, 95% CI 0.15 to 1.89; <a href="./references#CD002253-fig-0041" title="">Analysis 9.3</a>) these results are based on relatively small trials with large heterogeneity. Vaginal misoprostol caused less pain than sublingual misoprostol (3 trials, 392 women, RR 0.58, 95% CI 0.46 to 0.74; <a href="./references#CD002253-fig-0042" title="">Analysis 9.4</a>); and less diarrhoea (4 trials, 472 women, RR 0.71, 95% CI 0.54 to 0.92; <a href="./references#CD002253-fig-0045" title="">Analysis 9.7</a>); because of serious risk of bias described in the primary outcome above the GRADE assessment showed a very low quality of evidence. Quality of evidence was very low because of serious risk of bias, serious imprecision and serious inconsistency with differences in GA and misoprostol regimen of the included studies). </p> <p>The following secondary outcomes were not reported in the trials for this comparison: blood transfusion; haemorrhage; days of bleeding; pelvic infection; cervical damage; hypertensive disorders; time to expulsion; duration of stay in hospital; psychological effects; subsequent fertility; woman's satisfaction/acceptability of method; and costs. </p> </section> </section> <section id="CD002253-sec-0128"> <h4 class="title">10. Vaginal misoprostol versus intravenous oxytocin</h4> <section id="CD002253-sec-0129"> <h5 class="title">Primary outcomes</h5> <p>Misoprostol and oxytocin had similar efficacy in inducing complete evacuation of the uterus in second trimester fetal death (1 trial, 85 women, RR 1.10, 95% CI 0.96 to 1.25; <a href="./references#CD002253-fig-0046" title="">Analysis 10.1</a>). The quality of evidence was assessed as low because of very serious risk of bias (only one small study included, no blinding). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0130"> <h5 class="title">Secondary outcomes</h5> <p>The incidence of excessive blood loss was not different between the groups, however the total number of events was very low (1 trial, 85 women, RR 0.56, 95% CI 0.05 to 5.97), the quality of evidence is low because of the same reasons as described in the primary outcome) (<a href="./references#CD002253-fig-0047" title="">Analysis 10.2</a>). </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0131"> <h4 class="title">11. Vaginal misoprostol versus vaginal gemeprost</h4> <section id="CD002253-sec-0132"> <h5 class="title">Primary outcomes</h5> <p>There was no difference between vaginal misoprostol and gemeprost in the induction of miscarriage less than 24 hours for fetal death after 13 weeks (1 trial, 50 women, RR 1.24, 95% CI 0.90 to 1.70; <a href="./references#CD002253-fig-0048" title="">Analysis 11.1</a>). GRADE assessment produced a low quality of evidence because of a very serious risk of bias (no blinding, doubtful randomisation report, and some signs of selective reporting). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0133"> <h5 class="title">Secondary outcomes</h5> <p>One study reported on the use of opiates for pain relief (<a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>). In this study, none of the women either treated with misoprostol or gemeprost used opiates for pain relief. The incidences of vomiting and diarrhoea did not differ between the misoprostol and the gemeprost group (1 trial, 50 patients, respectively RR 3.00, 95% CI 0.13 to 70.30; RR 0.14, 95% CI 0.01 to 2.63); however the studies were relatively small (<a href="./references#CD002253-fig-0050" title="">Analysis 11.3</a>; <a href="./references#CD002253-fig-0051" title="">Analysis 11.4</a>). The quality of evidence for the outcomes which were assessed were low because of the very serious risk of bias as described previously. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0134"> <h4 class="title">12. Sublingual + vaginal misoprostol versus only vaginal misoprostol</h4> <section id="CD002253-sec-0135"> <h5 class="title">Primary outcomes</h5> <p>Sublingual and oral misoprostol did not differ in inducing a complete miscarriage (2 studies, 238 women, RR 1.07, 95% CI 0.88 to 1.30; <a href="./references#CD002253-fig-0052" title="">Analysis 12.1</a>). There was a serious risk of bias in the two included studies (no blinding, no clear allocation concealment) and there were serious inconsistencies (differences between the included studies regarding misoprostol regimen), which was partly compensated by a dose‐response gradient. The GRADE quality of evidence was therefore assessed as moderate. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0136"> <h5 class="title">Secondary outcomes</h5> <p>There were no differences in abdominal pain, diarrhoea and patients satisfaction (<a href="./references#CD002253-fig-0053" title="">Analysis 12.2</a>; <a href="./references#CD002253-fig-0055" title="">Analysis 12.4</a>; <a href="./references#CD002253-fig-0056" title="">Analysis 12.5</a>). Gastro‐intestinal side effects (nausea, vomiting) occurred less in the sublingual misoprostol group (2 studies, 238 women, RR 0.59, 95% CI 0.41 to 0.85; <a href="./references#CD002253-fig-0054" title="">Analysis 12.3</a>). For fever, nausea, diarrhoea and abdominal pain the quality of evidence is low because of serious risk of bias and serious inconsistencies. For patients satisfaction with treatment the quality was downgraded to very low because only one small study was included at high risk of bias for blinding. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0137"> <h4 class="title">13. Sublingual powdery versus sublingual compact misoprostol</h4> <section id="CD002253-sec-0138"> <h5 class="title">Primary outcomes</h5> <p>According to the small trial included in this comparison there is no clear advantage of administering a powdery preparation of sublingual misoprostol compared to a compact preparation: complete miscarriage (1 trial, 54 women, RR 0.96, 95% CI 0.66 to 1.41; <a href="./references#CD002253-fig-0057" title="">Analysis 13.1</a>). Since there is only one study included in which no blinding was performed and that showed signs of selective reporting, there was a very serious risk of bias and the quality of evidence is very low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0139"> <h5 class="title">Secondary outcomes</h5> <p>The incidence of nausea/vomiting and diarrhoea was similar between the groups (<a href="./references#CD002253-fig-0058" title="">Analysis 13.2</a>; <a href="./references#CD002253-fig-0059" title="">Analysis 13.3</a>). Again, the quality of evidence is very low because of the very serious risk of bias as described in the primary outcome. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0140"> <h4 class="title">14. Sublingual misoprostol with versus without extended course</h4> <section id="CD002253-sec-0141"> <h5 class="title">Primary outcomes</h5> <p>An extended course of daily 400 mcg misoprostol for a week after initial misoprostol treatment does not lead to more cases with complete miscarriage (1 trial, 180 women, RR 1.01, 95% CI 0.93 to 1.10; <a href="./references#CD002253-fig-0060" title="">Analysis 14.1</a>). The quality of evidence was downgraded because of a very serious risk of bias (only one small study included, no blinding performed, signs of selective reporting) which was partly compensated by a dose‐response gradient, and was assessed as low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0142"> <h5 class="title">Secondary outcomes</h5> <p>The extended course of misoprostol produces more diarrhoea (1 trial, 180 women, RR 2.00, 95% CI 1.25 to 3.19; <a href="./references#CD002253-fig-0064" title="">Analysis 14.5</a>). The incidence of other side effects like nausea, vomiting and pain was not different (<a href="./references#CD002253-fig-0061" title="">Analysis 14.2</a>; <a href="./references#CD002253-fig-0062" title="">Analysis 14.3</a>; <a href="./references#CD002253-fig-0063" title="">Analysis 14.4</a>; again quality of evidence was assessed as low since these comparisons included the same trial as was described in the primary outcome). </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0143"> <h4 class="title">15. Sublingual misoprostol versus oral misoprostol</h4> <section id="CD002253-sec-0144"> <h5 class="title">Primary outcomes</h5> <p>Adding sublingual misoprostol to vaginal misoprostol does not lead to more complete miscarriages (1 trial, 80 women, RR 1.00, 95% CI 0.85 to 1.18; <a href="./references#CD002253-fig-0065" title="">Analysis 15.1</a>). In this comparison only one study was included (<a href="./references#CD002253-bbs2-0039" title="TangOS , LauWN , NgEHY , LeeSW , HoPC . A prospective randomized study to compare the use of repeated doses of vaginal with sublingual misoprostol in the management of first trimester silent miscarriage. Human Reproduction2003;18:176‐81. ">Tang 2003</a>), with a small number of participants, no blinding and no allocation concealment, which means a very serious risk of bias. The GRADE quality of evidence therefore is very low. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0145"> <h5 class="title">Secondary outcomes</h5> <p>While efficacy seemed not to differ, adding sublingual misoprostol to a vaginal misoprostol treatment produces more diarrhoea (1 trial, 80 women, RR 2.55, 95% CI 1.48 to 4.38, quality of evidence very low because of the reasons described above). The incidence of other side effects like nausea, vomiting and pain was no different between the groups (respectively RR 1.20, 95% CI 0.80 to 1.79; RR 0.78, 95% CI 0.32 to 1.88; RR 0.75, 95% CI 0.29 to 1.97; <a href="./references#CD002253-fig-0067" title="">Analysis 15.3</a>; <a href="./references#CD002253-fig-0068" title="">Analysis 15.4</a>; <a href="./references#CD002253-fig-0070" title="">Analysis 15.6</a>). A large proportion of women was satisfied with either sublingual and vaginal misoprostol or vaginal misoprostol alone. There was no difference in women's satisfaction (1 study, 77 women, RR 0.99, 95% CI 0.79 to 1.25; <a href="./references#CD002253-fig-0071" title="">Analysis 15.7</a>). Again, the quality of evidence for these outcomes is very low. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0146"> <h4 class="title">16. Oral misoprostol versus vaginal misoprostol</h4> <section id="CD002253-sec-0147"> <h5 class="title">Primary outcomes</h5> <p>Overall, oral misoprostol seemed to be less effective than vaginal misoprostol in producing complete miscarriage &lt; 13 weeks but this was not clearly shown in the effect estimates (4 studies, 418 women, average RR 0.68, 95% CI 0.45 to 1.03; Heterogeneity Tau<sup>2</sup> = 0.13, I<sup>2</sup> = 90%). A difference was seen only with the 400 mcg oral versus 800 mcg vaginal dose in first trimester miscarriages (1 trial, 20 women, RR 0.29, 95% CI 0.10 to 0.79) and with the 400 mcg oral versus 600 mcg vaginal dose in first trimester miscarriage (1 trial, 100 women, RR 0.45, 95% CI 0.30 to 0.67; <a href="./references#CD002253-fig-0072" title="">Analysis 16.1</a>). In one trial (<a href="./references#CD002253-bbs2-0007" title="ChittacharoenA , HerabutyaY , PunyavachiraP . A randomized trial of oral and vaginal misoprostol to manage delivery in cases of fetal death. Obstetrics &amp; Gynecology2003;101:70‐3. ">Chittacharoen 2003*</a>) all participating women using oral and vaginal misoprostol had a complete miscarriage, thus both regimens were equally effective. GRADE assessment showed serious risk of bias and serious inconsistencies because of differences between the studies regarding GA, misoprostol regimen and timing of outcome measurement; and blinding was performed in non of the included studies. Since a dose‐response gradient could be suspected the quality of evidence was assessed as moderate. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0148"> <h5 class="title">Secondary outcomes</h5> <p>There seemed to be no differences in the incidence of vomiting (2 trials, 290 women, random‐effects model average RR 0.73, 95% CI 0.11 to 4.89; Heterogeneity: Tau² = 1.52; I² = 80%), nausea (3 trials, 220 women, RR 1.18, 95% CI 0.93 to 1.48) and diarrhoea (4 trials, 410 women, RR 1.06, 95% CI 0.72 to 1.58; <a href="./references#CD002253-fig-0077" title="">Analysis 16.6</a>; <a href="./references#CD002253-fig-0078" title="">Analysis 16.7</a>; <a href="./references#CD002253-fig-0079" title="">Analysis 16.8</a>). However, oral misoprostol seemed to cause slightly more often pain than vaginal misoprostol (2 trials, 200 women, RR 1.60, 95% CI 1.01 to 2.55; <a href="./references#CD002253-fig-0076" title="">Analysis 16.5</a>). There were high (and similar) levels of satisfaction with treatment (1 trial, 198 women, RR 0.96, 95% CI 0.86 to 1.06, but the quality of evidence for this outcome is very low since only one trial was included). </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0149"> <h4 class="title">17. Oral misoprostol + mifepristone versus expectant management</h4> <section id="CD002253-sec-0150"> <h5 class="title">Primary outcomes</h5> <p>In the single study included in this comparison, there was no difference in medical treatment compared to expectant management for complete miscarriage after five days (1 study, 122 women, RR 1.08, 95% CI 0.90 to 1.30; <a href="./references#CD002253-fig-0081" title="">Analysis 17.1</a>). The quality of evidence is low because of very serious risk of bias (only one study included, no blinding performed). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0151"> <h5 class="title">Secondary outcomes</h5> <p>A difference in severe blood loss could not be established between the groups (1 study, 122 women, RR 0.34, 95% CI 0.01 to 8.29) but this was based on one study with large CIs (<a href="./references#CD002253-fig-0082" title="">Analysis 17.2</a>). Furthermore, the incidence of pelvic inflammatory disease (RR 0.52, 95% CI 0.05 to 5.55; <a href="./references#CD002253-fig-0085" title="">Analysis 17.5</a>) did not differ but the total number of events for this outcome was low. Woman's satisfaction was not different for both treatment modalities (1 study, 122 women, MD 3.40, 95% CI ‐5.54 to 12.34; <a href="./references#CD002253-fig-0086" title="">Analysis 17.6</a>). The quality of evidence was calculated as very low in the GRADE assessment because of a very serious risk of bias and serious imprecision (only one study included, wide CIs). </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0152"> <h4 class="title">18. Buccal misoprostol lower versus higher‐dose regimen</h4> <section id="CD002253-sec-0153"> <h5 class="title">Primary outcomes</h5> <p>The efficacy of a higher‐dose regimen of buccal misoprostol is better than a lower dose: complete miscarriage within two days (1 study, 135 women, RR 0.76, 95% CI 0.60 to 0.96); complete evacuation less than one day (1 study, 135 women, RR 0.64, 95% CI 0.46 to 0.89; <a href="./references#CD002253-fig-0087" title="">Analysis 18.1</a>). The quality of evidence was calculated as low in the GRADE assessment because of a very serious risk of bias (only one small study included, signs of selective reporting). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0154"> <h5 class="title">Secondary outcomes</h5> <p>A higher‐dose regimen caused more vomiting (1 study, 135 women, RR 0.30, 95% CI 0.12 to 0.76) and diarrhoea (RR 0.40, 95% CI 0.19 to 0.82; <a href="./references#CD002253-fig-0089" title="">Analysis 18.3</a>; <a href="./references#CD002253-fig-0090" title="">Analysis 18.4</a>). The incidence of nausea was similar between the groups (RR 0.61, 95% CI 0.28 to 1.34), as well as the incidence of pain (RR 0.96, 95% CI 0.87 to 1.06; <a href="./references#CD002253-fig-0088" title="">Analysis 18.2</a>; <a href="./references#CD002253-fig-0091" title="">Analysis 18.5</a>). The quality of evidence for the secondary outcomes was low because of the reasons described above. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0155"> <h4 class="title">19. Mifepristone versus placebo</h4> <section id="CD002253-sec-0156"> <h5 class="title">Primary outcomes</h5> <p>The single study included in this comparison found mifepristone to be more effective than placebo: miscarriage complete by day five after treatment (46 women, RR 9.50, 95% CI 2.49 to 36.19; <a href="./references#CD002253-fig-0093" title="">Analysis 19.1</a>). However the quality of this evidence is very low: there is a very serious risk of bias with signs of incomplete data and no proper intention‐to‐treat analysis in the included study; and serious imprecision with wide confidence intervals. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0157"> <h5 class="title">Secondary outcomes</h5> <p>The incidence of vaginal bleeding before day five was higher in the misoprostol group (1 trial, 44 women, RR 3.92, 95% CI 1.89 to 8.10; <a href="./references#CD002253-fig-0094" title="">Analysis 19.2</a>). There were no major differences in the incidence of pain (1 trial, 44 women, RR 2.19, 95% CI 0.93 to 5.17; <a href="./references#CD002253-fig-0095" title="">Analysis 19.3</a>) but again the quality of evidence is very low according to the GRADE assessment, for the same reasons as described in the primary outcome. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0158"> <h4 class="title">20. Mifepristone + misoprostol versus misoprostol alone</h4> <section id="CD002253-sec-0159"> <h5 class="title">Primary outcomes</h5> <p>Three studies were included in this comparison and showed no additional value of mifepristone for the complete miscarriage rate (3 studies 447 participants, RR 1.18, 95% CI 0.95 to 1.47; <a href="./references#CD002253-fig-0096" title="">Analysis 20.1</a>). This quality of these studies was assessed moderate, two studies were not blinded, though in one of these the outcome assessor was blinded for the intervention. </p> </section> <section id="CD002253-sec-0160"> <h5 class="title">Secondary outcomes</h5> <p>One trial reported on the need for blood transfusion, pelvic infection, nausea and diarrhoea. Incidence of transfusion was low was similar in both groups (300 women, RR 3.04, 95% CI 0.32 to 28.90; <a href="./references#CD002253-fig-0097" title="">Analysis 20.2</a>). Similarly, incidence of pelvic infection was low and equal in both groups (300 women, RR 1.01, 95% CI 0.14 to 7.10; <a href="./references#CD002253-fig-0098" title="">Analysis 20.3</a>). Nausea and diarrhoea were more common side effects, but incidence did not differ between both groups (nausea: 300 women, RR 1.01, 95% CI 0.76 to 1.36; <a href="./references#CD002253-fig-0099" title="">Analysis 20.4</a> and diarrhoea: 300 women, RR 0.94, 95% CI 0.66 to 1.35). </p> <p>Two trials reported on woman's satisfaction. Women were more satisfied when treated with mifepristone + misoprostol compared to misoprostol alone (two trials, 135 women, RR 1.36, 95% CI 1.06 to 1.75; <a href="./references#CD002253-fig-0101" title="">Analysis 20.6</a>). </p> </section> </section> <section id="CD002253-sec-0161"> <h4 class="title">21. Vaginal gemeprost versus surgical evacuation of uterus</h4> <section id="CD002253-sec-0162"> <h5 class="title">Primary outcomes</h5> <p>In the one study included in this comparison (<a href="./references#CD002253-bbs2-0011" title="EgarterC , LederhilgerJ , KurzC , KarasH , ReisenbergerK . Gemeprost for first trimester missed abortion. Archives of Gynecology and Obstetrics1995;256:29‐32. ">Egarter 1995</a>), surgical evacuation was more effective than gemeprost treatment (87 women, RR 0.80, 95% CI 0.67 to 0.96; <a href="./references#CD002253-fig-0102" title="">Analysis 21.1</a>). In the surgical group, two of 44 women underwent additional treatment, one because of persistent vaginal bleeding and one because of ambiguous histology results based on what later turned out to be a tubal pregnancy. Two patients in the surgical evacuation group had a perforation of the uterus (RR (Non‐event) 1.05, 95% CI 0.97 to 1.13) (4.5%, <a href="./references#CD002253-fig-0103" title="">Analysis 21.2</a>). In the GRADE assessment, the score was downgraded because of a very serious risk of bias: no clear description of primary and secondary outcomes in the methods of the included study. There is also serious imprecision: only one small study included; especially for the secondary outcomes there are wide CI. The quality of evidence is therefore calculated as very low. </p> </section> <section id="CD002253-sec-0163"> <h5 class="title">Secondary outcomes</h5> <p>The incidence of nausea was similar in both groups (RR 1.79, 95% CI 0.56 to 5.68; <a href="./references#CD002253-fig-0104" title="">Analysis 21.3</a>), with very low quality of evidence because of the reasons described above. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0164"> <h4 class="title">22. Intravaginal extraamniotic misoprostol versus vaginal misoprostol</h4> <section id="CD002253-sec-0165"> <h5 class="title">Primary outcomes</h5> <p>In the one study included in this comparison (<a href="./references#CD002253-bbs2-0026" title="MitwallyAB . Intra uterine extra amniotic (200 µg) versus vaginal (200 µg) misoprostol for second trimester pregnancy termination: randomized controlled trial. clinicaltrials.gov/ct2/show/NCT02669420 (first received 1 February 2016). MitwalyAB , AbbasAM , AbdellahMS . Intra uterine extra‐amniotic versus vaginal misoprostol for termination of second trimester miscarriage: a randomized controlled trial. International Journal of Reproductive Biomedicine2016;14(10):643‐8. ">Mitwaly 2016*</a>), women receive either misoprostol dissolved in saline through a Foley catheter (extraamniotic route) or vaginal misoprostol. There seemed to be no differences in inducing complete miscarriage (180 women, RR 1.10, 95% CI 1.00 to 1.22; <a href="./references#CD002253-fig-0105" title="">Analysis 22.1</a>). The quality of evidence was low because of a very serious risk of bias with only one study included; there was no blinding performed and there was very serious imprecision since the study was not powered for the secondary outcomes. </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0166"> <h5 class="title">Secondary outcomes</h5> <p>The time to expulsion (in hours) was shorter for the extra‐amniotic preparation (MD ‐4.81, 95% CI ‐5.66 to ‐3.96; <a href="./references#CD002253-fig-0110" title="">Analysis 22.6</a>). Although incidences of diarrhoea and vomiting were similar (<a href="./references#CD002253-fig-0107" title="">Analysis 22.3</a>; <a href="./references#CD002253-fig-0108" title="">Analysis 22.4</a>); there were more complaints of nausea in the group receiving vaginal misoprostol (1 trial, 180 women, RR 1.57, 95% CI 1.33 to 1.85; <a href="./references#CD002253-fig-0106" title="">Analysis 22.2</a>). The quality of evidence for the secondary outcomes is assessed as very low because of the very serious risk of bias described in the primary outcome; and imprecision with wide CIs, especially for diarrhoea. </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0167"> <h4 class="title">23. Vaginal misoprostol with or without extended course</h4> <section id="CD002253-sec-0168"> <h5 class="title">Primary outcomes</h5> <p>In one study included in this comparison (<a href="./references#CD002253-bbs2-0027" title="MizrachiY , DekaloA , GluckO , MirembergH , DafnaL , FeldsteinO , et al. Single versus repeat doses of misoprostol for treatment of early pregnancy loss‐a randomized clinical trial. Human Reproduction2017;32(6):1202‐7. ">Mizrachi 2017</a>), women were treated with 800 mcg of vaginal misoprostol either once, or twice with an interval of four days. In the other study included (<a href="./references#CD002253-bbs2-0040" title="TangOS , OngCY , TseKY , NgEH , LeeSW , HoPC . A randomized trial to compare the use of sublingual misoprostol with or without an additional 1 week course for the management of first trimester silent miscarriage. Human Reproduction2006;21(1):189‐92. ">Tang 2006</a>), women were treated with 600mcg of sublingual misoprostol every three hours on the first day. Half of the women were treated with an extended course of misoprostol: 400mcg of sublingual misoprostol from day two until day eight. There were no differences in inducing complete miscarriage (351 women, RR 1.00, 95% CI 0.92 to 1.09; <a href="./references#CD002253-fig-0111" title="">Analysis 23.1</a>). The quality of evidence is low because of a very serious risk of bias (two studies included, no blinding of outcome assessors performed). </p> <p>Death or serious complications were not reported in the trial.</p> </section> <section id="CD002253-sec-0169"> <h5 class="title">Secondary outcomes</h5> <p>There were no differences found in the incidence of nausea, vomiting and diarrhoea (<a href="./references#CD002253-fig-0112" title="">Analysis 23.2</a>; <a href="./references#CD002253-fig-0113" title="">Analysis 23.3</a>; <a href="./references#CD002253-fig-0114" title="">Analysis 23.4</a>). Fewer women required analgesia for pain in the single dose group (171 women, RR 0.84, 95% CI 0.71 to 1.00; <a href="./references#CD002253-fig-0115" title="">Analysis 23.5</a>). Patients satisfaction was similar for both treatment arms, the majority of women would probably choose this treatment again (171 women, RR 1.01, 95% CI 0.84 to 1.22; <a href="./references#CD002253-fig-0116" title="">Analysis 23.6</a>). </p> <p>No other secondary outcomes were reported.</p> </section> </section> <section id="CD002253-sec-0170"> <h4 class="title">Sensitivity analyses</h4> <p>We had planned to perform sensitivity analyses, but since too few studies were included in any analysis to carry out meaningful sensitivity analysis, this was not performed. </p> </section> </section> </section> </section> <section class="discussion"> <div class="section-header section-collapse-header" id="CD002253-sec-0171" lang="en"> <h2 class="title section-collapse-title"> Discussion <i aria-hidden="true" class="fa fa-caret-up section-collapse-icon"></i> </h2> </div> <section class="discussion" lang="en"> <div class="section-header" id="CD002253-sec-0171"></div> <section id="CD002253-sec-0172"> <h3 class="title" id="CD002253-sec-0172">Summary of main results</h3> <p>The majority of included trials (41/43) assessed the use of misoprostol (mainly by vaginal administration). Vaginal misoprostol is an effective treatment option for early fetal death, compared to expectant management or placebo, in effecting a complete miscarriage. Compared to surgical evacuation there are more gastro‐intestinal side effects, such as nausea and diarrhoea. However surgical evacuation may have particular risks that can be avoided by primary medical treatment (for example, perforation of the uterus, lesions of the cervix). Higher‐dose regimens of vaginal misoprostol seemed not to be more effective than lower‐dose regimens with a similar incidence of adverse effects. Furthermore, a repeat dose of vaginal misoprostol after a certain time period seems not to further increase the number of complete miscarriages. For vaginal misoprostol treatment, adding methotrexate or laminaria tents has no advantage. Based on one trial, a wet preparation does not seem to be more effective than dry preparations of misoprostol. </p> <p>Misoprostol can be administered through different routes. The vaginal route is well studied. Other routes that were assessed in trials were sublingual, oral or buccal administrations. None of the other administration routes were superior to vaginal misoprostol. </p> <p>The efficacy of vaginally or sublingually administered misoprostol is similar, but sublingual administration seems to cause more pain. Adding sublingual misoprostol to a vaginal course does not improve outcomes while it may have more side effects, especially diarrhoea. Using a powdery sublingual preparation has no advantage compared to compact tablets. Sublingual misoprostol is as effective as oral misoprostol but gives less gastro‐intestinal side effects. </p> <p>Oral misoprostol seems to be less effective than vaginal misoprostol. For buccal administrations, a higher dose improves complete miscarriage, but may lead to more side effects. </p> <p>Vaginal misoprostol has equivalent efficacy compared to prostaglandin analogues (dinoprostone, gemeprost) and (in second trimester fetal death) to intravenous oxytocin. </p> <p>Other medications that were assessed in this review were mifepristone (versus placebo) and vaginal gemeprost (versus surgical evacuation). Mifepristone was more effective than placebo in inducing complete miscarriage. Treatment with vaginal gemeprost was less effective than curettage for complete miscarriage, with a similar incidence of side effects (nausea). </p> </section> <section id="CD002253-sec-0173"> <h3 class="title" id="CD002253-sec-0173">Overall completeness and applicability of evidence</h3> <p>This review comprises 23 comparisons of medication (compared to other medication or to other types of treatment) that can be used for treatment of early fetal death. Several types of preparations, routes of administration and dosages were assessed, especially for misoprostol treatment. This large heterogeneity in medication regimens makes it difficult to present robust statements on the efficacy of misoprostol in general; especially since for several comparisons the level of evidence was low or even very low. For misoprostol treatment alone, 30 different regimens were used in the included trials. Most investigated were 800 mcg of misoprostol vaginally in one dosage (eight trials), 800 mcg of vaginal misoprostol repeated once after 24 hours (six trials) or four days (one trial) and 600 mcg of oral or sublingual misoprostol repeated every three hours with a maximum of four dosages (four trials). Especially for the higher dose of vaginal misoprostol (800 mcg) and the higher dose of sublingual misoprostol (600 mcg) it is safe to say that these are effective treatment options for early fetal death. The other routes of administration and dosages require more investigation to compose more robust results. </p> </section> <section id="CD002253-sec-0174"> <h3 class="title" id="CD002253-sec-0174">Quality of the evidence</h3> <p>There were large differences in quality of evidence among the different comparisons. In 16 comparisons only one trial was included, which meant a downgrade of at least one level in the GRADE assessment for certainty of evidence. In general, the quality of evidence for comparisons that included more trials was higher than comparisons in which only one trial was included. </p> <p>'Summary of findings' tables are presented for the two comparisons that we considered clinically most meaningful: vaginal misoprostol versus placebo (<a href="./full#CD002253-tbl-0001">summary of findings Table for the main comparison</a>) and vaginal misoprostol versus surgical evacuation (<a href="./full#CD002253-tbl-0002">summary of findings Table 2</a>). The first of these comparisons presents the results of (vaginal) medical treatment itself, while the latter presents the results for medical treatment compared to the most applied other treatment option: surgical evacuation of the uterus. Since we found no major differences in effectiveness between different routes of administration; these findings might be generalised to other routes of administration as well. </p> <p>The GRADE score for vaginal misoprostol compared to placebo, was assessed as low quality for complete miscarriage, nausea and diarrhoea and for treatment satisfaction. For treatment blood loss and pain, the quality of the evidence was assessed as very low. Since no included studies for this comparison reported on pelvic infection, GRADE scores could not be established for this outcome. The main reasons for downgrading the quality of evidence were due to risk of bias concerns with unclear allocation concealment and blinding and also due to concerns regarding imprecision and indirectness of the evidence. </p> <p>The quality of the evidence for the comparison vaginal misoprostol versus curettage, was assessed as low quality for all outcomes: complete miscarriage; pelvic infection; nausea; diarrhoea; blood loss; pain; and woman's satisfaction. Quality of evidence was downgraded because for these outcomes due to imprecision, with only one trial providing data for these outcomes. Furthermore, blinding was not possible due to the nature of the intervention, and reports were inconsistent. </p> <p>The risk of bias varied among the included trials (<a href="#CD002253-fig-0002">Figure 2</a>). For 12 trials randomisation procedure had an unclear risk of bias due to inadequate description of the random sequence allocation and in 16 trials allocation concealment was unclear. Improper allocation concealment might have influenced the results in these trials, especially in trials where patients and personnel were not blinded for the type of intervention. One trial (<a href="./references#CD002253-bbs2-0012" title="EngNS , GuanAC . Comparative study of intravaginal misoprostol with gemeprost as an abortifacient in second trimester missed abortion. Australian and New Zealand Journal of Obstetrics and Gynaecology1997;37:331‐4. ">Eng 1997*</a>) was considered to have a high risk of bias. In this trial even and odd numbers were used for sequence allocation, and this is of course not random (<a href="#CD002253-fig-0003">Figure 3</a>). In several trials blinding would have been very difficult or even impossible due to the nature of the interventions; for example, in trials that compared medical treatment to surgical evacuation. For trials that compared vaginal versus sublingual or oral medication one could argue that the use of placebo would have been possible: one group should receive vaginal medication and oral or sublingual placebo, the other group oral/sublingual medication and vaginal placebo. This is laborious and in some cases more inconvenient for the patients, but it would have been a manner to guarantee proper blinding. Furthermore, even if blinding of patients was impossible, still the outcome assessor could have been blinded. In only eight of the 43 trials blinding of patients, personnel and/or outcome assessors was mentioned (<a href="./references#CD002253-bbs2-0005" title="BagrateeJS , KhullarV , ReganL , MoodleyJ , KagoroH . A randomized controlled trial comparing medical and expectant management of first trimester miscarriage. Human Reproduction2004;19:266‐71. ">Bagratee 2004</a>; <a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>; <a href="./references#CD002253-bbs2-0014" title="GangulyRP , MukhopadhyayS , BurmanSK , PatraKK , JhaT , MukherjiJ . A randomized trial of misoprostol compared with manual vacuum aspiration for early pregnancy failure. Nepal Journal of Obstetrics and Gynaecology2010;5(2):8‐13. ">Ganguly 2010</a>; <a href="./references#CD002253-bbs2-0021" title="KovavisarachE , JamnansiriC . Intravaginal misoprostol 600mcg and 800mcg for the treatment of early pregnancy failure. International Journal of Gynecology &amp; Obstetrics2005;90:208‐12. ">Kovavisarach 2005</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>; <a href="./references#CD002253-bbs2-0024" title="ListerMS , ShafferLE , BellJG , LutterKQ , MoormaKH . Randomized, double‐blind, placebo‐controlled trial of vaginal misoprostol for management of early pregnancy failures. American Journal of Obstetrics and Gynecology2005;193:1338‐43. ">Lister 2005</a>; <a href="./references#CD002253-bbs2-0037" title="SinhaP , SunejaA , GuleriaK , AggarwalR , VaidNB . Comparison of mifepristone followed by misoprostol with misoprostol alone for treatment of early pregnancy failure: a randomized double‐blind placebo‐controlled trial. Journal of Obstetrics and Gynecology of India2018;68(1):39‐44. ">Sinha 2018</a>; <a href="./references#CD002253-bbs2-0043" title="WoodSL , BrainPH . Medical management of missed abortion: a randomized clinical trial. Obstetrics &amp; Gynecology2002;99:563‐6. ">Wood 2002</a>). In most trials outcome was assessed by performing (transvaginal) ultrasound. However, ultrasound after miscarriage might have inter‐ and even intra‐observer variability; without blinding of the outcome assessor this imposes a risk of bias. Other concerns in risk of bias were the reporting of incomplete outcome data in three trials (<a href="./references#CD002253-bbs2-0009" title="DehbashiZ , MoosazadehM , AfshariM . Comparison between sublingual and vaginal route of misoprostol in management of first trimester miscarriage missing. Materia Socio‐Medica2016;28(4):271‐3. ">Dehbashi 2016</a>; <a href="./references#CD002253-bbs2-0013" title="FangAH , ChenQF , ZhengW , LiYH , ChenRY . Termination of missed abortion in a combined procedure: a randomized controlled trial. Journal of Reproduction and Contraception2009;20(1):45‐9. ">Fang 2009</a>; <a href="./references#CD002253-bbs2-0023" title="LelaidierC , Baton‐Saint‐MleuxC , FernandezH , BourgetP , FrydmanR . Mifepristone (RU 486) induces embryo expulsion in first trimester non‐developing pregnancies: a prospective randomized trial. Human Reproduction1993;8:492‐5. ">Lelaidier 1993</a>) and signs of selective reporting in five trials (<a href="./references#CD002253-bbs2-0004" title="AyudhayaOP , HerabutyaY , ChanrachakulB , AyuthayaNI , O‐PrasertsawatP . A comparison of the efficacy of sublingual and oral misoprostol 400 microgram in the management of early pregnancy failure: a randomized controlled trial. Journal of the Medical Association of Thailand2006;89(Suppl 4):S5‐S10. ">Ayudhaya 2006</a>; <a href="./references#CD002253-bbs2-0017" title="HerabutyaY , O‐PrasertsawatP . Misoprostol in the management of missed abortion. International Journal of Gynecology &amp; Obstetrics1997;56:263‐6. ">Herabutya 1997</a>; <a href="./references#CD002253-bbs2-0029" title="NgocNT , BlumJ , WestheimerE , QuanTTV , WinikoffB . Medical treatment of missed abortion using misoprostol. International Journal of Gynecology &amp; Obstetrics2004;87:138‐42. ">Ngoc 2004</a>; <a href="./references#CD002253-bbs2-0034" title="SaichuaC , PhupongV . A randomized controlled trial comparing powdery sublingual misoprostol and sublingual misoprostol tablet for management of embryonic death or anembryonic pregnancy. Archives of Gynecology and Obstetrics2009;280(3):431‐5. ">Saichua 2009</a>; <a href="./references#CD002253-bbs2-0035" title="SchreiberCA , SonalkarS , BarnhartKT , RatcliffeSJ , CreininMD , AtrioJ . Mifepristone pretreatment for the medical management of early pregnancy loss. New England Journal of Medicine2018;378(23):2161‐70. ">Schreiber 2018</a>). In 18 other trials it was unclear whether there was selective reporting; in most of these trials the methods section stated that 'adverse effects' or 'side effects' were measured without further specification, while the results section showed detailed outcomes on specific side effects, but it was unclear if that were all the effects that were measured. </p> <p>Since the quality of evidence is low or very low for several comparisons, mainly because they included only one or two (small) trials; further research is necessary to assess the effectiveness, safety and side effects of medical treatment in different medication regimes. </p> </section> <section id="CD002253-sec-0175"> <h3 class="title" id="CD002253-sec-0175">Potential biases in the review process</h3> <p>We have conducted a thorough investigation but still there could be biases in the review process. </p> <p>Screening for eligible articles from the updated search and data extraction was performed by at least two review authors using the prespecified set of inclusion and exclusion criteria. There were some discrepancies, but we resolved these through mutual discussion. The inclusion or exclusion of conference abstracts was discussed in detail. We decided to exclude conference abstracts that were not clearly randomised trials or did not present applicable results. Furthermore, we searched for full‐text articles that might have been published on these trials, and in some cases we contacted the authors to ask for full results of their studies. Unfortunately, none of them replied thus, in the end we excluded all conference abstracts. </p> <p>There were several trials that could have been useful for the review, but that included patients with a gestational age more than 24 weeks as well, or patients with induced abortion/termination of pregnancy (for example, because of congenital malformations). We contacted the authors of these trials to ask for subgroup analyses or individual data. If the authors did not respond immediately, we sent them a reminder. If still they did not respond we excluded their trial. Some articles did not provide contact details for the authors; in which case we searched for other articles from these authors to find contact details, or we tried to find them on social media (Research Gate). For most of these authors we found contact details, but none of them responded to our questions. We believe that this approach was the best in order to obtain as much information as possible; however it did not provide us with extra data except for one trial (<a href="./references#CD002253-bbs2-0006" title="BrackenH , NgocNT , BanksE , BlumenthalP , DermanR , PatelA , et al. Misoprostol for treatment of intrauterine fetal death at 14‐28 weeks of pregnancy. American Journal of Obstetrics and Gynecology2013;208 (1Suppl):S62‐3. [DOI: 10.1016/j.contraception.2013.11.014; CRSREF: 3292934] BrackenH , NgocNT , BanksE , BlumenthalPD , DermanRJ , PatelA , et al. Buccal misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy: a double‐blind randomized controlled trial. Contraception2014;89(3):187‐92. WinikoffB . Misoprostol for treatment of fetal death at 14‐28 weeks of pregnancy, inclusive, not accompanied by complete expulsion of the contents of the uterus. clinicaltrials.gov/ct2/show/record/NCT00671060 (first received 29 April, 2008). ">Bracken 2014*</a>). Not having included results from these trials (especially in comparisons where currently only one trial is included) could have biased our results in two different ways; either over‐ or underestimating the potential effects. </p> <p>Assessment of the level of evidence was also performed by two authors, any discrepancies were resolved through discussion. We think our assessment was as thorough and complete as possible. </p> </section> <section id="CD002253-sec-0176"> <h3 class="title" id="CD002253-sec-0176">Agreements and disagreements with other studies or reviews</h3> <p>The reproductive use of misoprostol is considered in other Cochrane Reviews, for indications that include treatment of incomplete miscarriage (<a href="./references#CD002253-bbs2-0223" title="KimC , BarnardS , NeilsonJP , HickeyM , VazquezJC , DouL . Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD007223.pub4] ">Kim 2017</a>), termination of unwanted pregnancies (<a href="./references#CD002253-bbs2-0225" title="KulierR , KappN , GulmezogluAM , HofmeyrGJ , ChengLN , CampanaA . Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD002855.pub4] ">Kulier 2011</a>; <a href="./references#CD002253-bbs2-0231" title="SayL , KulierR , GulmezogluAM , CampanaA . Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2] ">Say 2002</a>), induction of labour (<a href="./references#CD002253-bbs2-0212" title="AlfirevicZ , AflaifelN , WeeksA . Oral misoprostol for induction of labour. Cochrane Database of Systematic Reviews2014, Issue 6. [DOI: 10.1002/14651858.CD001338.pub3] ">Alfirevic 2014</a>; <a href="./references#CD002253-bbs2-0221" title="HofmeyrGJ , GülmezogluAM , PileggiC . Vaginal misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2010, Issue 10. [DOI: 10.1002/14651858.CD000941.pub2] ">Hofmeyr 2010</a>; <a href="./references#CD002253-bbs2-0227" title="MuzonziniG , HofmeyrGJ . Buccal or sublingual misoprostol for cervical ripening and induction of labour. Cochrane Database of Systematic Reviews2004, Issue 4. [DOI: 10.1002/14651858.CD004221.pub2] ">Muzonzini 2004</a>), and prevention and treatment of postpartum haemorrhage (<a href="./references#CD002253-bbs2-0226" title="MousaHA , BlumJ , Abou El SenounG , ShakurH , AlfirevicZ . Treatment for primary postpartum haemorrhage. Cochrane Database of Systematic Reviews2014, Issue 2. [DOI: 10.1002/14651858.CD003249.pub3] ">Mousa 2014</a>; <a href="./references#CD002253-bbs2-0232" title="TunçalpÖ , HofmeyrGJ , GülmezogluAM . Prostaglandins for preventing postpartum haemorrhage. Cochrane Database of Systematic Reviews2012, Issue 8. [DOI: 10.1002/14651858.CD000494.pub4] ">Tunçalp 2012</a>). </p> <p>For treatment of incomplete miscarriage (<a href="./references#CD002253-bbs2-0223" title="KimC , BarnardS , NeilsonJP , HickeyM , VazquezJC , DouL . Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD007223.pub4] ">Kim 2017</a>), there appeared to be a slightly lower incidence of complete miscarriage with misoprostol in comparison to surgical evacuation (average risk ratio (RR) 0.96, 95% confidence interval (CI) 0.94 to 0.98; 15 studies, 3862 women, random‐effects; very low‐quality evidence) but with success rate high for both methods. Overall, there were fewer surgical evacuations with misoprostol (average RR 0.05, 95% CI 0.02 to 0.11; 13 studies, 3070 women, random‐effects; very low‐quality evidence) but more unplanned procedures (average RR 5.03, 95% CI 2.71 to 9.35; 11 studies, 2690 women, random‐effects; low‐quality evidence). </p> <p>In termination of unwanted pregnancies the rate of abortions not completed with the intended method was higher in the prostaglandin group (RR 2.7, 95% CI 1.1 to 6.8) compared to surgery (<a href="./references#CD002253-bbs2-0231" title="SayL , KulierR , GulmezogluAM , CampanaA . Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2] ">Say 2002</a>). This is in line with our finding that misoprostol is less effective than surgery. In incomplete miscarriage the cervical ostium is already open, therefore misoprostol for incomplete miscarriage might be more effective than misoprostol for fetal death. Nonetheless, for all indications misoprostol still reduces the overall number of patients that receive surgical evacuation. Since surgical evacuation has some specific risks (in our review for example, there were patients with uterus perforation or Asherman syndrome), misoprostol would be a good alternative as primary treatment. </p> <p>The incidence of pelvic infection in our review was comparable to treatment of incomplete miscarriage and termination of unwanted pregnancy. Duration of bleeding was longer for medical treatment compared to surgery in termination of pregnancy (<a href="./references#CD002253-bbs2-0231" title="SayL , KulierR , GulmezogluAM , CampanaA . Medical versus surgical methods for first trimester termination of pregnancy. Cochrane Database of Systematic Reviews2002, Issue 4. [DOI: 10.1002/14651858.CD003037.pub2] ">Say 2002</a>). In our review duration of bleeding for this comparison was not assessed, but post treatment haematocrit was comparable between the groups (<a href="./references#CD002253-fig-0017" title="">Analysis 3.3</a>). </p> <p>Compared to expectant management, in incomplete miscarriage there was no difference identified in the need for surgical evacuation if patients were treated with misoprostol compared to expectant management (average RR 0.62, 95% CI 0.17 to 2.26; 2 studies, 308 women, random‐effects; low‐quality evidence). Furthermore, there was no difference in complete miscarriage (average RR 1.23, 95% CI 0.72 to 2.10; 2 studies, 150 women, random‐effects; very low‐quality evidence) (<a href="./references#CD002253-bbs2-0223" title="KimC , BarnardS , NeilsonJP , HickeyM , VazquezJC , DouL . Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD007223.pub4] ">Kim 2017</a>). On the contrary, in our review misoprostol decreases the need for surgical evacuation in patients with early fetal death. In incomplete miscarriage the mechanism of miscarriage is already in motion, for example, the cervical ostium is dilated and there might be contractions of the uterus. Therefore, expectant management in incomplete miscarriage might be more effective than expectant management in early fetal death, when the ostium is closed and there are no contractions. There was no difference identified in pelvic infection between misoprostol and expectant management in incomplete miscarriage (average RR 2.42, 95% CI 0.59 to 9.98; 3 studies, 333 women; <a href="./references#CD002253-bbs2-0223" title="KimC , BarnardS , NeilsonJP , HickeyM , VazquezJC , DouL . Medical treatments for incomplete miscarriage. Cochrane Database of Systematic Reviews2017, Issue 1. [DOI: 10.1002/14651858.CD007223.pub4] ">Kim 2017</a>); while in our review incidence of pelvic infection was higher in the misoprostol group. </p> <p>For termination of unwanted pregnancy, misoprostol administered orally is less effective (more failures) than the vaginal route (RR 3.00, 95% CI 1.44 to 6.24; <a href="./references#CD002253-bbs2-0225" title="KulierR , KappN , GulmezogluAM , HofmeyrGJ , ChengLN , CampanaA . Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD002855.pub4] ">Kulier 2011</a>), and may be associated with more frequent side effects such as nausea and diarrhoea. This is in line with our findings. Sublingual routes in induced abortion were similarly effective compared to the vaginal route (<a href="./references#CD002253-bbs2-0225" title="KulierR , KappN , GulmezogluAM , HofmeyrGJ , ChengLN , CampanaA . Medical methods for first trimester abortion. Cochrane Database of Systematic Reviews2011, Issue 11. [DOI: 10.1002/14651858.CD002855.pub4] ">Kulier 2011</a>), but had higher rates of side effects; while in our review side effects were similar apart from abdominal pain. Both in our review as in the review by Kulier and colleagues, there was large variety in medication regimens; this might have influenced the incidence of side effects: higher dosages that are repeated more often might lead to a higher incidence and more severe side effects. </p> </section> </section> </section> <div class="figures-list"> <div class="figure" id="CD002253-fig-0001"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-AFig-FIG01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-AFig-FIG01.png" target="_blank"><b></b></a></p> </div><img alt="Study flow diagram." data-id="CD002253-fig-0001" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 1</div> <div class="figure-caption"> <p>Study flow diagram.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-fig-0001">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0002"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-AFig-FIG02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-AFig-FIG02.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies." data-id="CD002253-fig-0002" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 2</div> <div class="figure-caption"> <p>'Risk of bias' graph: review authors' judgements about each risk of bias item presented as percentages across all included studies. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-fig-0002">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0003"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-AFig-FIG03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-AFig-FIG03.png" target="_blank"><b></b></a></p> </div><img alt="'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study." data-id="CD002253-fig-0003" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Figure 3</div> <div class="figure-caption"> <p>'Risk of bias' summary: review authors' judgements about each risk of bias item for each included study. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-fig-0003">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-AFig-FIG03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0004"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0004" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.1</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 1 Complete miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0004">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0005"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 2 Death or serious complications: uterine perforation." data-id="CD002253-fig-0005" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.2</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 2 Death or serious complications: uterine perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0005">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0006"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 3 Blood transfusion." data-id="CD002253-fig-0006" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.3</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 3 Blood transfusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0006">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0007"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 4 Blood loss: haemoglobin difference &gt; 10 g/L." data-id="CD002253-fig-0007" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.4</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 4 Blood loss: haemoglobin difference &gt; 10 g/L. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0007">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0008"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 5 Days of bleeding: vaginal bleeding 2 weeks after treatment." data-id="CD002253-fig-0008" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.5</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 5 Days of bleeding: vaginal bleeding 2 weeks after treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0008">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0009"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 6 Nausea." data-id="CD002253-fig-0009" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.6</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 6 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0009">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0010"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 7 Diarrhoea." data-id="CD002253-fig-0010" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.7</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 7 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0010">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0011"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 8 Pain (opiate use)." data-id="CD002253-fig-0011" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.8</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 8 Pain (opiate use).</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0011">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0012"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-001-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-001-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 1 Vaginal misoprostol versus placebo, Outcome 9 Woman's satisfaction with treatment." data-id="CD002253-fig-0012" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 1.9</div> <div class="figure-caption"> <p>Comparison 1 Vaginal misoprostol versus placebo, Outcome 9 Woman's satisfaction with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0012">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-001-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0013"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-002-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-002-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vaginal misoprostol versus expectant management, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0013" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-002-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.1</div> <div class="figure-caption"> <p>Comparison 2 Vaginal misoprostol versus expectant management, Outcome 1 Complete miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0013">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-002-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0014"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-002-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-002-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 2 Vaginal misoprostol versus expectant management, Outcome 2 Pelvic infection." data-id="CD002253-fig-0014" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-002-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 2.2</div> <div class="figure-caption"> <p>Comparison 2 Vaginal misoprostol versus expectant management, Outcome 2 Pelvic infection.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0014">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-002-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0015"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0015" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.1</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0015">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0016"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 2 Uterine perforation." data-id="CD002253-fig-0016" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.2</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 2 Uterine perforation. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0016">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0017"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 3 Blood loss: post‐treatment haematocrit (%)." data-id="CD002253-fig-0017" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.3</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 3 Blood loss: post‐treatment haematocrit (%). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0017">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0018"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 4 Pain relief." data-id="CD002253-fig-0018" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.4</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 4 Pain relief. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0018">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0019"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 5 Pelvic infection." data-id="CD002253-fig-0019" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.5</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 5 Pelvic infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0019">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0020"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 6 Nausea." data-id="CD002253-fig-0020" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.6</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 6 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0020">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0021"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 7 Diarrhoea." data-id="CD002253-fig-0021" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.7</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 7 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0021">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0022"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-003-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-003-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 8 Woman's satisfaction." data-id="CD002253-fig-0022" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 3.8</div> <div class="figure-caption"> <p>Comparison 3 Vaginal misoprostol versus surgical evacuation of uterus, Outcome 8 Woman's satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0022">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-003-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0023"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-004-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-004-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0023" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.1</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 1 Complete miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0023">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0024"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-004-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-004-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 2 Blood transfusion." data-id="CD002253-fig-0024" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.2</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 2 Blood transfusion.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0024">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0025"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-004-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-004-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 3 Nausea." data-id="CD002253-fig-0025" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.3</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 3 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0025">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0026"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-004-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-004-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 4 Duration of hospital stay (days)." data-id="CD002253-fig-0026" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 4.4</div> <div class="figure-caption"> <p>Comparison 4 Vaginal misoprostol versus vaginal dinoprostone, Outcome 4 Duration of hospital stay (days). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0026">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-004-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0027"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-005-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-005-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 1 Complete miscarriage &lt; 13 weeks." data-id="CD002253-fig-0027" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.1</div> <div class="figure-caption"> <p>Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 1 Complete miscarriage &lt; 13 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0027">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0028"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-005-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-005-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 2 Complete miscarriage 13‐23 weeks." data-id="CD002253-fig-0028" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.2</div> <div class="figure-caption"> <p>Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 2 Complete miscarriage 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0028">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0029"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-005-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-005-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 3 Nausea." data-id="CD002253-fig-0029" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.3</div> <div class="figure-caption"> <p>Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 3 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0029">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0030"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-005-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-005-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 4 Diarrhoea." data-id="CD002253-fig-0030" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 5.4</div> <div class="figure-caption"> <p>Comparison 5 Vaginal misoprostol lower versus higher‐dose regimens, Outcome 4 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0030">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-005-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0031"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-006-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-006-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0031" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.1</div> <div class="figure-caption"> <p>Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0031">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0032"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-006-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-006-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 2 Diarrhoea." data-id="CD002253-fig-0032" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.2</div> <div class="figure-caption"> <p>Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 2 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0032">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0033"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-006-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-006-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 3 Vomiting." data-id="CD002253-fig-0033" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.3</div> <div class="figure-caption"> <p>Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 3 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0033">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0034"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-006-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-006-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 4 Acceptability of method: would wish/probably wish same treatment in future nonviable pregnancy." data-id="CD002253-fig-0034" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 6.4</div> <div class="figure-caption"> <p>Comparison 6 Vaginal misoprostol wet versus dry vaginal preparations, Outcome 4 Acceptability of method: would wish/probably wish same treatment in future nonviable pregnancy. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0034">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-006-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0035"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-007-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-007-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0035" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.1</div> <div class="figure-caption"> <p>Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0035">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0036"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-007-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-007-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 2 Haemorrhage." data-id="CD002253-fig-0036" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.2</div> <div class="figure-caption"> <p>Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 2 Haemorrhage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0036">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0037"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-007-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-007-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 3 Pain relief." data-id="CD002253-fig-0037" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 7.3</div> <div class="figure-caption"> <p>Comparison 7 Vaginal misoprostol + methotrexate versus vaginal misoprostol alone, Outcome 3 Pain relief. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0037">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-007-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0038"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-008-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-008-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 8 Vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0038" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-008-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 8.1</div> <div class="figure-caption"> <p>Comparison 8 Vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0038">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-008-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0039"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 1 Complete miscarriage &lt; 13 weeks." data-id="CD002253-fig-0039" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.1</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 1 Complete miscarriage &lt; 13 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0039">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0040"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 2 Complete miscarriage 13‐23 weeks." data-id="CD002253-fig-0040" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.2</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 2 Complete miscarriage 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0040">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0041"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 3 Blood loss: excessive (&gt; menstruation)." data-id="CD002253-fig-0041" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.3</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 3 Blood loss: excessive (&gt; menstruation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0041">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0042"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 4 Pain." data-id="CD002253-fig-0042" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.4</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 4 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0042">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0043"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 5 Nausea." data-id="CD002253-fig-0043" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.5</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 5 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0043">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0044"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 6 Vomiting." data-id="CD002253-fig-0044" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.6</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 6 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0044">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0045"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-009-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-009-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 7 Diarrhoea." data-id="CD002253-fig-0045" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 9.7</div> <div class="figure-caption"> <p>Comparison 9 Vaginal misoprostol versus sublingual misoprostol, Outcome 7 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0045">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-009-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0046"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-010-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-010-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Vaginal misoprostol versus intravenous oxytocin, Outcome 1 Complete miscarriage 13‐23 weeks." data-id="CD002253-fig-0046" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-010-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.1</div> <div class="figure-caption"> <p>Comparison 10 Vaginal misoprostol versus intravenous oxytocin, Outcome 1 Complete miscarriage 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0046">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-010-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0047"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-010-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-010-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 10 Vaginal misoprostol versus intravenous oxytocin, Outcome 2 Blood loss: excessive." data-id="CD002253-fig-0047" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-010-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 10.2</div> <div class="figure-caption"> <p>Comparison 10 Vaginal misoprostol versus intravenous oxytocin, Outcome 2 Blood loss: excessive. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0047">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-010-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0048"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-011-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-011-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 1 Complete miscarriage 13‐23 weeks." data-id="CD002253-fig-0048" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.1</div> <div class="figure-caption"> <p>Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 1 Complete miscarriage 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0048">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0049"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-011-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-011-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 2 Opiates for pain relief." data-id="CD002253-fig-0049" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.2</div> <div class="figure-caption"> <p>Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 2 Opiates for pain relief. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0049">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0050"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-011-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-011-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 3 Vomiting." data-id="CD002253-fig-0050" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.3</div> <div class="figure-caption"> <p>Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 3 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0050">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0051"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-011-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-011-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 4 Diarrhoea." data-id="CD002253-fig-0051" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 11.4</div> <div class="figure-caption"> <p>Comparison 11 Vaginal misoprostol versus vaginal gemeprost, Outcome 4 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0051">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-011-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0052"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-012-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-012-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0052" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.1</div> <div class="figure-caption"> <p>Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 1 Complete miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0052">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0053"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-012-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-012-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 2 Pain." data-id="CD002253-fig-0053" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.2</div> <div class="figure-caption"> <p>Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 2 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0053">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0054"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-012-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-012-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 3 Nausea and/or vomiting." data-id="CD002253-fig-0054" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.3</div> <div class="figure-caption"> <p>Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 3 Nausea and/or vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0054">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0055"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-012-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-012-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 4 Diarrhoea." data-id="CD002253-fig-0055" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.4</div> <div class="figure-caption"> <p>Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 4 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0055">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0056"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-012-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-012-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 5 Woman's satisfaction with treatment." data-id="CD002253-fig-0056" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 12.5</div> <div class="figure-caption"> <p>Comparison 12 Sublingual misoprostol versus oral misoprostol, Outcome 5 Woman's satisfaction with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0056">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-012-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0057"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-013-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-013-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0057" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.1</div> <div class="figure-caption"> <p>Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0057">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0058"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-013-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-013-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 2 Nausea/vomiting." data-id="CD002253-fig-0058" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.2</div> <div class="figure-caption"> <p>Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 2 Nausea/vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0058">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0059"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-013-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-013-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 3 Diarrhoea." data-id="CD002253-fig-0059" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 13.3</div> <div class="figure-caption"> <p>Comparison 13 Sublingual powdery versus sublingual compact misoprostol, Outcome 3 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0059">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-013-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0060"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-014-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-014-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0060" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.1</div> <div class="figure-caption"> <p>Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0060">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0061"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-014-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-014-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 2 Nausea." data-id="CD002253-fig-0061" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.2</div> <div class="figure-caption"> <p>Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 2 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0061">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0062"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-014-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-014-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 3 Pain." data-id="CD002253-fig-0062" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.3</div> <div class="figure-caption"> <p>Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 3 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0062">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0063"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-014-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-014-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 4 Vomiting." data-id="CD002253-fig-0063" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.4</div> <div class="figure-caption"> <p>Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 4 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0063">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0064"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-014-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-014-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 5 Diarrhoea." data-id="CD002253-fig-0064" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 14.5</div> <div class="figure-caption"> <p>Comparison 14 Sublingual misoprostol with versus without extended course, Outcome 5 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0064">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-014-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0065"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0065" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.1</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0065">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0066"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 2 Blood loss: haemoglobin level." data-id="CD002253-fig-0066" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.2</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 2 Blood loss: haemoglobin level. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0066">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0067"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 3 Nausea." data-id="CD002253-fig-0067" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.3</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 3 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0067">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0068"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 4 Vomiting." data-id="CD002253-fig-0068" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.4</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 4 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0068">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0069"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 5 Diarrhoea." data-id="CD002253-fig-0069" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.5</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 5 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0069">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0070"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 6 Pain." data-id="CD002253-fig-0070" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.6</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 6 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0070">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0071"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-015-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-015-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 7 Woman's satisfaction with treatment." data-id="CD002253-fig-0071" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 15.7</div> <div class="figure-caption"> <p>Comparison 15 Sublingual + vaginal misoprostol versus only vaginal misoprostol, Outcome 7 Woman's satisfaction with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0071">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-015-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0072"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 1 Complete miscarriage &lt; 13 weeks." data-id="CD002253-fig-0072" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.1</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 1 Complete miscarriage &lt; 13 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0072">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0073"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 2 Complete miscarriage &gt; 13‐23 weeks." data-id="CD002253-fig-0073" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.2</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 2 Complete miscarriage &gt; 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0073">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0074"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 3 Blood loss: excessive." data-id="CD002253-fig-0074" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.3</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 3 Blood loss: excessive.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0074">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0075"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 4 Pain (visual analogue scale)." data-id="CD002253-fig-0075" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.4</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 4 Pain (visual analogue scale). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0075">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0076"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 5 Pain." data-id="CD002253-fig-0076" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.5</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 5 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0076">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0077"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 6 Vomiting." data-id="CD002253-fig-0077" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.6</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 6 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0077">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0078"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-07" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-07.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 7 Nausea." data-id="CD002253-fig-0078" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-07.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.7</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 7 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0078">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-07.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0079"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-08" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-08.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 8 Diarrhoea." data-id="CD002253-fig-0079" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-08.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.8</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 8 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0079">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-08.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0080"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-016-09" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-016-09.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 9 Woman's satisfaction with treatment." data-id="CD002253-fig-0080" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-09.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 16.9</div> <div class="figure-caption"> <p>Comparison 16 Oral misoprostol versus vaginal misoprostol, Outcome 9 Woman's satisfaction with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0080">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-016-09.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0081"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0081" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.1</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0081">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0082"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 2 Blood loss (severe)." data-id="CD002253-fig-0082" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.2</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 2 Blood loss (severe). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0082">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0083"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 3 Days of bleeding." data-id="CD002253-fig-0083" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.3</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 3 Days of bleeding. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0083">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0084"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 4 Pain." data-id="CD002253-fig-0084" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.4</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 4 Pain. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0084">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0085"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 5 Pelvic infection." data-id="CD002253-fig-0085" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.5</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 5 Pelvic infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0085">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0086"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-017-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-017-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 6 Woman's satisfaction with treatment (visual analogue scale day 14)." data-id="CD002253-fig-0086" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 17.6</div> <div class="figure-caption"> <p>Comparison 17 Oral misoprostol + mifepristone versus expectant management, Outcome 6 Woman's satisfaction with treatment (visual analogue scale day 14). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0086">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-017-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0087"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 1 Complete miscarriage 13‐23 weeks." data-id="CD002253-fig-0087" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.1</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 1 Complete miscarriage 13‐23 weeks. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0087">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0088"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 2 Nausea." data-id="CD002253-fig-0088" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.2</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 2 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0088">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0089"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 3 Vomiting." data-id="CD002253-fig-0089" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.3</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 3 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0089">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0090"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 4 Diarrhoea." data-id="CD002253-fig-0090" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.4</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 4 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0090">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0091"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 5 Pain." data-id="CD002253-fig-0091" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.5</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 5 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0091">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0092"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-018-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-018-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 6 Woman's satisfaction with treatment (satisfied or very satisfied)." data-id="CD002253-fig-0092" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 18.6</div> <div class="figure-caption"> <p>Comparison 18 Buccal misoprostol lower versus higher‐dose regimen, Outcome 6 Woman's satisfaction with treatment (satisfied or very satisfied). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0092">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-018-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0093"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-019-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-019-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Mifepristone versus placebo, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0093" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.1</div> <div class="figure-caption"> <p>Comparison 19 Mifepristone versus placebo, Outcome 1 Complete miscarriage.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0093">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0094"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-019-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-019-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Mifepristone versus placebo, Outcome 2 Days of bleeding." data-id="CD002253-fig-0094" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.2</div> <div class="figure-caption"> <p>Comparison 19 Mifepristone versus placebo, Outcome 2 Days of bleeding.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0094">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0095"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-019-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-019-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 19 Mifepristone versus placebo, Outcome 3 Pain." data-id="CD002253-fig-0095" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 19.3</div> <div class="figure-caption"> <p>Comparison 19 Mifepristone versus placebo, Outcome 3 Pain.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0095">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-019-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0096"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0096" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.1</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0096">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0097"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 2 Blood transfusion." data-id="CD002253-fig-0097" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.2</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 2 Blood transfusion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0097">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0098"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 3 Pelvic infection." data-id="CD002253-fig-0098" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.3</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 3 Pelvic infection. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0098">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0099"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 4 nausea." data-id="CD002253-fig-0099" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.4</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 4 nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0099">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0100"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 5 Diarrhoea." data-id="CD002253-fig-0100" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.5</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 5 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0100">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0101"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-020-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-020-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 6 Woman's satisfaction." data-id="CD002253-fig-0101" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 20.6</div> <div class="figure-caption"> <p>Comparison 20 Mifepristone + vaginal misoprostol versus vaginal misoprostol alone, Outcome 6 Woman's satisfaction. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0101">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-020-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0102"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-021-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-021-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0102" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.1</div> <div class="figure-caption"> <p>Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0102">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0103"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-021-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-021-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 2 Death or serious complications (uterine perforation)." data-id="CD002253-fig-0103" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.2</div> <div class="figure-caption"> <p>Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 2 Death or serious complications (uterine perforation). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0103">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0104"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-021-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-021-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 3 Nausea." data-id="CD002253-fig-0104" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 21.3</div> <div class="figure-caption"> <p>Comparison 21 Vaginal gemeprost versus surgical evacuation of uterus, Outcome 3 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0104">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-021-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0105"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0105" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.1</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0105">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0106"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 2 Nausea." data-id="CD002253-fig-0106" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.2</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 2 Nausea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0106">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0107"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 3 Vomiting." data-id="CD002253-fig-0107" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.3</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 3 Vomiting. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0107">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0108"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 4 Diarrhoea." data-id="CD002253-fig-0108" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.4</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 4 Diarrhoea. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0108">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0109"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 5 Pain (use of analgesics)." data-id="CD002253-fig-0109" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.5</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 5 Pain (use of analgesics). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0109">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0110"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-022-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-022-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 6 Time to expulsion." data-id="CD002253-fig-0110" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 22.6</div> <div class="figure-caption"> <p>Comparison 22 Misoprostol intravaginal extraamniotic versus vaginal misoprostol, Outcome 6 Time to expulsion. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0110">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-022-06.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0111"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-01" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-01.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 1 Complete miscarriage." data-id="CD002253-fig-0111" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-01.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.1</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 1 Complete miscarriage. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0111">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-01.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0112"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-02" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-02.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 2 Nausea." data-id="CD002253-fig-0112" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-02.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.2</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 2 Nausea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0112">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-02.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0113"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-03" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-03.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 3 Vomiting." data-id="CD002253-fig-0113" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-03.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.3</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 3 Vomiting.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0113">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-03.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0114"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-04" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-04.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 4 Diarrhoea." data-id="CD002253-fig-0114" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-04.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.4</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 4 Diarrhoea.</p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0114">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-04.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0115"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-05" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-05.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 5 Pain (use of analgesics)." data-id="CD002253-fig-0115" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-05.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.5</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 5 Pain (use of analgesics). </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0115">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-05.png" target="_blank">Open in new tab</a></div> </div> <div class="figure" id="CD002253-fig-0116"> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/urn:x-wiley:14651858:media:CD002253:CD002253-CMP-023-06" target="_blank"><b></b></a></p> </div> <div> <p><a class="external" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_t/tCD002253-CMP-023-06.xxx" target="_blank"><b></b></a></p> </div><img alt="Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 6 Woman's satisfaction with treatment." data-id="CD002253-fig-0116" src="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-06.png"/> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="figure-viewer-caption"> <div class="figure-label">Analysis 23.6</div> <div class="figure-caption"> <p>Comparison 23 Vaginal misoprostol with versus without extended course, Outcome 6 Woman's satisfaction with treatment. </p> </div> </div> <div class="tools"><a class="scolaris-systematic-reviews" href="https://training.cochrane.org/essentials/module-4-understanding-using-systematic-reviews" target="_blank">Using systematic reviews (free)</a><a class="figureList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-fig-0116">Navigate to figure in review</a><button class="print-figure" href="#">Print figure</button><a class="figure-viewer-isolate" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/media/CDSR/CD002253/image_n/nCD002253-CMP-023-06.png" target="_blank">Open in new tab</a></div> </div> </div> <div class="tables-list"> <div class="table"> <table class="summary-of-findings framed" data-id="CD002253-tbl-0001"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> early fetal death (less than 24 weeks)<br/> <b>Setting:</b> worldwide<br/> <b>Intervention:</b> vaginal misoprostol<br/> <b>Comparison:</b> placebo </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with placebo</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complete miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 4.23<br/> (3.01 to 5.94) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>305 women<br/> (5 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>There were differences in timing of outcome measurement: after 24 hours (2 studies), after 48 hours (2 studies) or after 7 days (1 study). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>189 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1.000<br/> (569 to 1.000) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pelvic infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>not estimable</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>(studies)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.38<br/> (0.43 to 4.40) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 women<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>93 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>128 per 1.000<br/> (40 to 409) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 2.21<br/> (0.35 to 14.06) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>88 women<br/> (2 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>23 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>51 per 1.000<br/> (8 to 327) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blood loss: haemoglobin difference &gt; 10 g/L</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.25<br/> (0.38 to 4.12) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>50 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<br/> VERY LOW <sup>5 6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>160 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>200 per 1.000<br/> (61 to 659) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain (opiate use)</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 5.00<br/> (0.25 to 101.11) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>84 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊝⊝⊝<sup>4 6</sup> </p> <p>VERY LOW</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000<br/> (0 to 0) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Woman’s satisfaction/acceptability of method</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.17<br/> (0.83 to 1.64) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>32 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>750 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>878 per 1.000<br/> (622 to 1.000) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Serious indirectness: differences in medication regimens used between the included studies. However: very strong association; dose‐response relation (‐1). </p> <p><sup>2</sup> Serious risk of bias: problems with blinding in various studies, downgraded because of limitation in study design (‐1). </p> <p><sup>3</sup> Serious imprecision: only two studies with relatively few patients (‐1). </p> <p><sup>4</sup> Serious risk of bias: unclear allocation concealment (‐1). </p> <p><sup>5</sup> Serious risk of indirect evidence: haematocrit difference was used to estimate the amount of blood loss (‐1). </p> <p><sup>6</sup> Serious imprecision: only one study included, wide confidence interval (‐2). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings for the main comparison.</span> <span class="table-title">Vaginal misoprostol compared to placebo for early fetal death (less than 24 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-tbl-0001">Navigate to table in review</a></div> </div> <div class="table"> <table class="summary-of-findings framed" data-id="CD002253-tbl-0002"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</span></div> <tbody> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="7" rowspan="1" valign="top"> <p><b>Patient or population:</b> early fetal death (less than 24 weeks)<br/> <b>Setting:</b> worldwide<br/> <b>Intervention:</b> vaginal misoprostol<br/> <b>Comparison:</b> surgical evacuation of uterus </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Outcomes</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p><b>Anticipated absolute effects<sup>*</sup> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Relative effect<br/> (95% CI)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>№ of participants<br/> (studies)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Certainty of the evidence<br/> (GRADE)</b> </p> </td> <td align="left" class="table-header" colspan="1" rowspan="2" valign="top"> <p><b>Comments</b> </p> </td> </tr> <tr class="table-header separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with surgical evacuation of uterus</b> </p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p><b>Risk with vaginal misoprostol</b> </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Complete miscarriage</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.40<br/> (0.32 to 0.50) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>943 women<br/> (6 RCTs) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>1 2</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Blinding of patients and treating personnel was impossible due to the nature of the interventions. All studies used the same dosage of misoprostol (800 mcg). </p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>921 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>368 per 1.000<br/> (295 to 460) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pelvic infection</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.73<br/> (0.39 to 1.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>618 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Only 1 study included but with relatively large patient numbers.</p> </td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>71 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>52 per 1.000<br/> (28 to 97) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Nausea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 21.85<br/> (1.31 to 364.37) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>22 per 1.000<br/> (1 to 364) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Diarrhoea</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 40.85<br/> (2.52 to 662.57) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>0 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>41 per 1.000<br/> (3 to 663) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>Blood loss: post‐treatment haematocrit (%)</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>The mean blood loss: post‐treatment haematocrit (%) was 35.5</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>mean 1.40 lower<br/> (3.51 lower to 0.71 higher) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>‐</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>50 women<br/> (1 RCT) </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>3 4</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="1" valign="top"></td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Pain relief</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 1.42 (0.82 t0 2.46)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>154 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>4 5</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>213 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>303 per 1.000<br/> (175 to 525) </p> </td> </tr> <tr class="separated"> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>Woman’s satisfaction/acceptability of method</p> </td> <td align="left" class="table-tint table-highlight" colspan="2" rowspan="1" valign="top"> <p>Study population</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>RR 0.67 (0.40 to 1.11)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>45 women</p> <p>(1 RCT)</p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"> <p>⊕⊕⊝⊝<br/> LOW <sup>6 7</sup> </p> </td> <td align="left" bgcolor="#ffffff" colspan="1" rowspan="2" valign="top"></td> </tr> <tr class="separated"> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>800 per 1.000</p> </td> <td align="left" class="table-tint table-highlight" colspan="1" rowspan="1" valign="top"> <p>536 per 1.000<br/> (320 to 888) </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p>*<b>The risk in the intervention group</b> (and its 95% confidence interval) is based on the assumed risk in the comparison group and the <b>relative effect</b> of the intervention (and its 95% CI).<br/> <br/> <b>CI:</b> Confidence interval; <b>RR:</b> Risk ratio. </p> </td> </tr> <tr class="separated"> <td align="" bgcolor="#ffffff" colspan="7" rowspan="1" valign=""> <p><b>GRADE Working Group grades of evidence</b> <br/> <b>High certainty:</b> We are very confident that the true effect lies close to that of the estimate of the effect<br/> <b>Moderate certainty:</b> We are moderately confident in the effect estimate: The true effect is likely to be close to the estimate of the effect, but there is a possibility that it is substantially different<br/> <b>Low certainty:</b> Our confidence in the effect estimate is limited: The true effect may be substantially different from the estimate of the effect<br/> <b>Very low certainty:</b> We have very little confidence in the effect estimate: The true effect is likely to be substantially different from the estimate of effect </p> </td> </tr> </tbody> <tfoot> <tr> <td colspan="7"> <div class="table-footnote"> <p><sup>1</sup> Serious risk of bias: only one study blinded the outcome assessors. All other studies were not blinded (‐1). </p> <p><sup>2</sup> Serious inconsistency: varied sampling, different medication regimes, I<sup>2</sup> = 46% (‐1). </p> <p><sup>3</sup> Serious risk of bias: no blinding of outcome assessors (‐1). </p> <p><sup>4</sup> Serious imprecision: only one study with relatively few patients, small number of events and wide confidence intervals (‐1). </p> <p><sup>5</sup> Serious risk of bias: high risk of selective reporting and unclear allocation concealment (‐1). </p> <p><sup>6</sup> Serious risk of bias: high risk of bias for blinding and attrition (‐1). </p> <p><sup>7</sup> Serious imprecision: only one study with relatively few patients (‐1). </p> </div> </td> </tr> </tfoot> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Summary of findings 2.</span> <span class="table-title">Vaginal misoprostol compared to surgical evacuation of uterus for early fetal death (less than 24 weeks)</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/full#CD002253-tbl-0002">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0003"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vaginal misoprostol versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>305</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.23 [3.01, 5.94]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complete miscarriage &lt; 1 day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.73 [2.70, 8.28]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Complete miscarriage &lt; 2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.74 [2.70, 12.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Complete miscarriage &lt; 7 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>83</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.99 [1.80, 4.99]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or serious complications: uterine perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.33 [0.01, 7.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Blood loss: haemoglobin difference &gt; 10 g/L <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [0.38, 4.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Days of bleeding: vaginal bleeding 2 weeks after treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.41, 2.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.43, 4.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>88</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.21 [0.35, 14.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Pain (opiate use) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>84</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.25, 101.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Woman's satisfaction with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>32</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.17 [0.83, 1.64]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 1.</span> <span class="table-title">Vaginal misoprostol versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0003">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0004"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vaginal misoprostol versus expectant management</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>614</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.25 [1.09, 1.45]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>8.05 [1.87, 34.72]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 2.</span> <span class="table-title">Vaginal misoprostol versus expectant management</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0004">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0005"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vaginal misoprostol versus surgical evacuation of uterus</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>6</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>943</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.32, 0.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Uterine perforation <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.32 [0.01, 7.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Blood loss: post‐treatment haematocrit (%) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.40 [‐3.51, 0.71]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain relief <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.42 [0.82, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>618</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.39, 1.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>21.85 [1.31, 364.37]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>154</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>40.85 [2.52, 662.57]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Woman's satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>45</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.40, 1.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 3.</span> <span class="table-title">Vaginal misoprostol versus surgical evacuation of uterus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0005">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0006"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vaginal misoprostol versus vaginal dinoprostone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>125</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.83 [1.37, 2.46]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>6.07 [0.30, 121.33]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>65</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.03 [0.28, 3.78]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Duration of hospital stay (days) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>60</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐2.38 [‐3.36, ‐1.40]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 4.</span> <span class="table-title">Vaginal misoprostol versus vaginal dinoprostone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0006">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0007"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Vaginal misoprostol lower versus higher‐dose regimens</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage &lt; 13 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>397</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.82 [0.58, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Complete miscarriage 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.87, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.67 [0.31, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>214</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.15, 1.91]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 5.</span> <span class="table-title">Vaginal misoprostol lower versus higher‐dose regimens</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0007">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0008"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vaginal misoprostol wet versus dry vaginal preparations</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>320</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.90, 1.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complete miscarriage &lt; 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.85, 1.54]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Complete miscarriage &lt; 8 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.04 [0.84, 1.29]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Complete miscarriage &lt; 15 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.92 [0.78, 1.10]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Complete miscarriage &lt; 30 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.79, 1.14]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.75 [0.89, 3.42]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.93 [0.33, 2.62]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Acceptability of method: would wish/probably wish same treatment in future nonviable pregnancy <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>73</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.93, 1.49]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 6.</span> <span class="table-title">Vaginal misoprostol wet versus dry vaginal preparations</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0008">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0009"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Vaginal misoprostol + methotrexate versus vaginal misoprostol alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.13 [0.85, 1.50]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Haemorrhage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.31 [0.10, 50.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain relief <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>21</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.25, 2.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 7.</span> <span class="table-title">Vaginal misoprostol + methotrexate versus vaginal misoprostol alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0009">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0010"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>76</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.82, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complete miscarriage &lt; 1 day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.90 [0.65, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Complete miscarriage &lt; 2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>38</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.88, 1.29]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 8.</span> <span class="table-title">Vaginal misoprostol plus laminaria tents versus vaginal misoprostol alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0010">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0011"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vaginal misoprostol versus sublingual misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage &lt; 13 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>5</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>513</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.61, 1.16]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Complete miscarriage 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>9</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.13, 2.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Blood loss: excessive (&gt; menstruation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>340</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.54 [0.15, 1.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>392</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.58 [0.46, 0.74]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>302</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.42 [0.12, 1.44]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.46, 1.26]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>472</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.54, 0.92]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 9.</span> <span class="table-title">Vaginal misoprostol versus sublingual misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0011">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0012"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Vaginal misoprostol versus intravenous oxytocin</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [0.96, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Blood loss: excessive <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.05, 5.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation 15‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>85</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.56 [0.05, 5.97]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 10.</span> <span class="table-title">Vaginal misoprostol versus intravenous oxytocin</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0012">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0013"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Vaginal misoprostol versus vaginal gemeprost</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.24 [0.90, 1.70]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Opiates for pain relief <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.0 [0.0, 0.0]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.13, 70.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>50</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.14 [0.01, 2.63]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 11.</span> <span class="table-title">Vaginal misoprostol versus vaginal gemeprost</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0013">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0014"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Sublingual misoprostol versus oral misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.07 [0.88, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.36, 1.67]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 400 mcg sublingual misoprostol 4hourly versus 400 mcg oral misoprostol 4hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.14 [0.88, 1.48]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.2 200 mg mifepristone + 600 mcg sublingual misoprostol versus 200 mg mifepristone + 600 mcg oral misoprostol </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.38, 0.72]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea and/or vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>338</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.59 [0.41, 0.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Nausea and/or vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.11, 3.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.2 Nausea</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.65 [0.41, 1.05]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.3 Vomiting</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.5 [0.27, 0.92]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>238</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.85 [0.60, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 400 mcg sublingual misoprostol 4 hourly versus 400 mcg oral misoprostol 4 hourly</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>138</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.83 [0.29, 2.35]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.2 200 mg mifepristone + 600 mcg sublingual misoprostol versus 200 mg mifepristone + 600 mcg oral misoprostol </p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.86 [0.59, 1.25]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Woman's satisfaction with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.28 [1.06, 1.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 12.</span> <span class="table-title">Sublingual misoprostol versus oral misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0014">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0015"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Sublingual powdery versus sublingual compact misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.66, 1.41]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nausea/vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.16, 7.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>54</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.44, 2.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 13.</span> <span class="table-title">Sublingual powdery versus sublingual compact misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0015">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0016"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Sublingual misoprostol with versus without extended course</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.93, 1.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.38 [0.72, 2.65]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.12 [0.96, 1.31]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.60, 41.95]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.0 [1.25, 3.19]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 14.</span> <span class="table-title">Sublingual misoprostol with versus without extended course</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0016">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0017"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Sublingual + vaginal misoprostol versus only vaginal misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.85, 1.18]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Blood loss: haemoglobin level <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.10 [‐0.38, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.2 [0.80, 1.79]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.78 [0.32, 1.88]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.55 [1.48, 4.38]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>80</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.75 [0.29, 1.97]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Woman's satisfaction with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>77</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.99 [0.79, 1.25]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 15.</span> <span class="table-title">Sublingual + vaginal misoprostol versus only vaginal misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0017">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0018"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Oral misoprostol versus vaginal misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage &lt; 13 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>418</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.68 [0.45, 1.03]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Complete miscarriage &gt; 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.0 [0.92, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Blood loss: excessive <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>100</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.0 [0.32, 27.87]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain (visual analogue scale) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>18</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐1.90 [‐4.82, 1.02]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>200</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.6 [1.01, 2.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>290</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.73 [0.11, 4.89]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">7 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>220</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.93, 1.48]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">8 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>4</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>410</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.06 [0.72, 1.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">9 Woman's satisfaction with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>198</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.86, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 16.</span> <span class="table-title">Oral misoprostol versus vaginal misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0018">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0019"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Oral misoprostol + mifepristone versus expectant management</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.08 [0.90, 1.30]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Blood loss (severe) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.34 [0.01, 8.29]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Days of bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.70 [‐0.43, 1.83]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>4.10 [‐5.92, 14.12]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.52 [0.05, 5.55]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Woman's satisfaction with treatment (visual analogue scale day 14) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>122</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.40 [‐5.54, 12.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 17.</span> <span class="table-title">Oral misoprostol + mifepristone versus expectant management</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0019">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0020"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Buccal misoprostol lower versus higher‐dose regimen</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage 13‐23 weeks <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>270</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.71 [0.58, 0.86]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complete miscarriage &lt; 1 day</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.64 [0.46, 0.89]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Complete miscarriage &lt; 2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.76 [0.60, 0.96]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.28, 1.34]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>2.1 Gestation 14‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.61 [0.28, 1.34]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.12, 0.76]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>3.1 Gestation 14‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.12, 0.76]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.19, 0.82]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>4.1 Gestation 14‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.40 [0.19, 0.82]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>5.1 Gestation 14‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.96 [0.87, 1.06]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Woman's satisfaction with treatment (satisfied or very satisfied) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>6.1 Gestation 14‐24 weeks</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.95 [0.78, 1.17]</p> </td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 18.</span> <span class="table-title">Buccal misoprostol lower versus higher‐dose regimen</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0020">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0021"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Mifepristone versus placebo</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""></td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Subtotals only</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.1 Complete miscarriage &lt; 2 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>5.0 [0.25, 98.75]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.2 Complete miscarriage &lt; 3 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>19.0 [1.17, 308.40]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.3 Complete miscarriage &lt; 4 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>14.0 [2.00, 97.88]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>1.4 Complete miscarriage &lt; 5 days</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>46</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>9.5 [2.49, 36.19]</p> </td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Days of bleeding <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.92 [1.89, 8.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pain <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>44</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>2.19 [0.93, 5.17]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 19.</span> <span class="table-title">Mifepristone versus placebo</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0021">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0022"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Mifepristone + vaginal misoprostol versus vaginal misoprostol alone</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>3</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>447</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.95, 1.47]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Blood transfusion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>3.04 [0.32, 28.90]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Pelvic infection <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.14, 7.10]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.76, 1.36]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>300</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.94 [0.66, 1.35]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Woman's satisfaction <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>135</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Random, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.36 [1.06, 1.75]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 20.</span> <span class="table-title">Mifepristone + vaginal misoprostol versus vaginal misoprostol alone</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0022">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0023"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Vaginal gemeprost versus surgical evacuation of uterus</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.80 [0.67, 0.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Death or serious complications (uterine perforation) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.05 [0.97, 1.13]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>87</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.79 [0.56, 5.68]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 21.</span> <span class="table-title">Vaginal gemeprost versus surgical evacuation of uterus</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0023">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0024"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Misoprostol intravaginal extraamniotic versus vaginal misoprostol</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.10 [1.00, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.57 [1.33, 1.85]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.25 [0.05, 1.14]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.2 [0.01, 4.11]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain (use of analgesics) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.30 [0.16, 0.58]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Time to expulsion <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>180</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Mean Difference (IV, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>‐4.81 [‐5.66, ‐3.96]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 22.</span> <span class="table-title">Misoprostol intravaginal extraamniotic versus vaginal misoprostol</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0024">Navigate to table in review</a></div> </div> <div class="table"> <table class="comparison" data-id="CD002253-tbl-0025"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Vaginal misoprostol with versus without extended course</span></div> <thead> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p>Outcome or subgroup title</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>No. of studies</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>No. of participants</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Statistical method</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>Effect size</p> </td> </tr> </thead> <tbody> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">1 Complete miscarriage <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.92, 1.09]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">2 Nausea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.81 [0.63, 1.04]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">3 Vomiting <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.18 [0.68, 2.06]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">4 Diarrhoea <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>2</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>351</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.00 [0.82, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">5 Pain (use of analgesics) <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>0.84 [0.71, 1.00]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> <tr> <td align="" bgcolor="#ffffff" colspan="1" data-title="Outcome or subgroup title" rowspan="1" valign=""> <p class="subgroupTitle">6 Woman's satisfaction with treatment <span class="subgroupLink"><b class="text-toggle-control">Show forest plot</b><i aria-hidden="true" class="fa fa-caret-down"></i></span></p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of studies" rowspan="1" valign=""> <p>1</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="No. of participants" rowspan="1" valign=""> <p>171</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Statistical method" rowspan="1" valign=""> <p>Risk Ratio (M‐H, Fixed, 95% CI)</p> </td> <td align="" bgcolor="#ffffff" colspan="1" data-title="Effect size" rowspan="1" valign=""> <p>1.01 [0.84, 1.22]</p> </td> </tr> <tr class="figure-image"> <td colspan="5"></td> </tr> </tbody> </table> <div class="scolaris-modal-title">Figures and Tables - </div> <div class="table-viewer-caption"> <div class="table-heading"><span class="table-label">Comparison 23.</span> <span class="table-title">Vaginal misoprostol with versus without extended course</span></div> </div> <div class="tools"><a class="tableList" href="/cdsr/doi/10.1002/14651858.CD002253.pub4/references#CD002253-tbl-0025">Navigate to table in review</a></div> </div> </div> <noscript> <img height="1" src="/scolaris-auth/report/nonjs/fulltexthtmlreg?doi=10.1002%2F14651858.CD002253.pub4&amp;rf=&amp;articleType=CDSR" style="display:none" width="1"> </img></noscript> <section class="translation-notes-modal" data-modal-class="translation-notes" data-modal-title="Translation notes" data-ok-btn-selector=".ok-btn" style="display: none"> <div class="translation-notes"> <div class="section-language-toggles"> <nav class="section-languages"> <ul> <li class="section-languages-legend">Available in</li> <li class="section-language"> <a class="" href="de#CD002253-note-0004">Deutsch</a> </li> <li class="section-language"> <a class="" href="es#CD002253-note-0003">Español</a> </li> <li class="section-language"> <a class="" href="fa#CD002253-note-0005">فارسی</a> </li> <li class="section-language"> <a class="" href="fr#CD002253-note-0002">Français</a> </li> <li class="section-language"> <a class="" href="ja#CD002253-note-0008">日本語</a> </li> <li class="section-language"> <a class="" href="ms#CD002253-note-0007">Bahasa Malaysia</a> </li> <li class="section-language"> <a class="" href="th#CD002253-note-0006">ภาษาไทย</a> </li> <li class="section-language"> <a class="" href="zh_HANS#CD002253-note-0001">简体中文</a> </li> <li class="section-language"> <a class="" href="zh_HANT#CD002253-note-0014">繁體中文</a> </li> </ul> </nav> </div> <section class="translation-notes-content"> </section> <button class="btn primary ok-btn pull-right" type="button">Close</button> </div> </section></article> </div> <div class="citation-modal" style="display: none"> <div class="export-citation-header"> <p class="inset-message" data-load-error="Unable to load citation data" id="citeProcText"></p> </div> <div class="export-citation-body row-fluid"> <div class="span12"> <div class="addthis_toolbox addthis_default_style addthis_16x16_style"> <nav class="inline-nav-list is-bordered"> <li> <h4 class="heading">Save citation to:</h4> </li> <li><a class="citation-btn-refworks at300b btn btn-link" href="#" id="refWorksCitationBtn"><span class="citation-icon refworks"></span>RefWorks</a></li> <li><a class="citation-btn-sciwheel at300b btn btn-link disabled" href="#" id="sciWheelCitationBtn" target="_blank"><span class="citation-icon sciwheel"></span>SciWheel</a></li> </nav> </div> </div> </div> <div class="row-fluid"> <div class="span12"> <div class="citation-format"> <h4>Copy or download citation</h4> <a href="/en/help/exporting-search-results" rel="noopener noreferrer" target="_blank">Export help</a> </div> <nav class="inline-nav-list has-dividers"> <li class="citation-option" data-option="plain"><button class="btn btn-link" type="button">Plain text</button></li> <li class="citation-option" data-option="endnote"><button class="btn btn-link" type="button">EndNote</button></li> <li class="citation-option" data-option="refmanager"><button class="btn btn-link" type="button">Reference Manager</button></li> <li class="citation-option" data-option="procite"><button class="btn btn-link" type="button">ProCite</button></li> <li class="citation-option" data-option="bibtex"><button class="btn btn-link" type="button">BibteX</button></li> <li class="citation-option" data-option="csv"><button class="btn btn-link" type="button">CSV (Excel)</button></li> </nav> <div class="citation-content"> <pre data-load-error="Unable to load citation data" id="citationContent" tabindex="0"></pre> </div> <div class="clearfix"> <form class="download-citation-form" data-citation-citeproc-url="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=citation-citeproc&amp;p_p_cacheability=cacheLevelPage&amp;p_p_col_id=column-1&amp;p_p_col_count=1" method="GET" target="citation-download-iframe"> <input id="siteId" name="siteId" type="hidden" value=""> <input id="downloadType" name="downloadType" type="hidden" value=""> <input id="style" name="style" type="hidden" value=""> <input id="articleId" name="articleId" type="hidden" value=""> <input name="p_p_id" type="hidden" value="scolariscontentdisplay_WAR_scolariscontentdisplay"><input name="p_p_lifecycle" type="hidden" value="2"><input name="p_p_state" type="hidden" value="normal"><input name="p_p_mode" type="hidden" value="view"/><input name="p_p_resource_id" type="hidden" value="citation-download"/><input name="p_p_cacheability" type="hidden" value="cacheLevelPage"/><input name="p_p_col_id" type="hidden" value="column-1"/><input name="p_p_col_count" type="hidden" value="1"/> <button class="btn primary wide pull-right" type="submit">Download</button> <div class="inline-checkbox pull-right"> <label title=" for=" withabstract"=""> <input checked="" class="checkbox" name="withAbstract" type="checkbox"/> <span class="checkbox-label">Include abstract</span> </label> </div> </input></input></input></input></input></input></input></form> <iframe aria-hidden="true" name="citation-download-iframe" src="" style="display: none; visibility: hidden" title="Citation download frame"></iframe> </div> </div> </div> </div> <div class="print-modal" data-modal-title="Print this review" style="display: none;"> <div class="print-options-wrapper"> <p><strong>All sections are selected by default</strong>, please select the sections you do not wish to print or use the select or deselect all button to add or remove sections.</p> <div class="print-options-controls"> <input checked="checked" class="print-options-select-all" title="Select/deselect all" type="checkbox"/> <span class="checkbox-label">Select/deselect all</span> </div> <ul class="print-options checkbox-list"> </ul> <button class="btn primary print-article pull-right"><i aria-hidden="true" class="fa fa-print"></i> Print</button> </div> </div> <div class="download-stats-data-modal" data-modal-title="Download data package" style="display: none;"> <div> <p> The data available are protected by copyright and may only be used in accordance with the <a class="external" href="/about/data-download" target="_blank">Terms and Conditions.</a> </p> <div class="hide-for-zip"> <p> <a class="external" href="https://revman.cochrane.org/#/rm5Converter" target="_blank">RevMan 5 files</a> can be converted to a <a class="external" href="https://links.cochrane.org/review-datapack-userguide" target="_blank">data package.</a> </p> </div> <p> Files in the data package can be imported to <a class="external" href="https://revman.cochrane.org/info" target="_blank">Review Manager software</a> or opened in other tools that support CSV and RIS. </p> <form class="download-stats-data-form" method="GET" target="_blank"> <input name="content-disposition" type="hidden" value="attachment"/> <input name="mime-type" type="hidden" value="application/octet-stream"/> <p class="print-options-controls"> <input aria-label="I agree to these terms and conditions" class="download-stats-data-toc-check-box" type="checkbox"/> <span aria-hidden="true" class="checkbox-label">I agree to these terms and conditions</span> <button class="btn primary download-stats-data pull-right" disabled=""><i aria-hidden="true" class="fa fa-download"></i> Download data</button> </p> </form> </div> </div> <div class="share-modal" data-modal-title="Share this review" style="display:none;"> </div> <div class="viewer-thumbnail-pane-html" style="display:none;"> <div class="figure-viewer-options"> <nav class="inline-nav-list"> <li class="figure-options-btn-container"><button class="btn btn-link" id="figureOptionBtn" type="button">Figures</button></li> <li class="table-options-btn-container"><button class="btn btn-link" id="tableOptionBtn" type="button">Tables</button></li> </nav> </div> <div class="figure-viewer-thumbnails"> <div class="figure-thumbnails is-visible" id="figureThumbnails"></div> <div class="table-thumbnails" id="tableThumbnails"></div> </div> </div> <div class="utilities-html" style="display:none;"> <div class="figure-viewer-utilities"> <a class="figure-viewer-menu-toggle" href="#"> <i class="fa fa-chevron-left"></i><span class="toggle-label" data-figure-hide-text="Hide thumbnails" data-figure-show-text="Show thumbnails" data-table-hide-text="Hide table list" data-table-show-text="Show table list">Hide thumbnails</span> </a> <a class="figure-viewer-navigateback" href="#"> <i class="fa fa-chevron-left"></i> </a> <a class="figure-viewer-rotate" href="#"> <i class="fa fa-undo"></i> </a> <a class="figure-viewer-download" href="#"> <i class="fa fa-download"></i> </a> <a class="figure-viewer-share" href="#"> <i class="fa fa-share-alt"></i> </a> <a class="figure-viewer-zoomin" href="#"> <i class="fa fa-plus"></i><span>zoom in</span> </a> <a class="figure-viewer-zoomout" href="#"> <i class="fa fa-minus"></i><span>zoom out</span> </a> </div> </div> <div class="controls-html" style="display:none;"> <div class="figure-viewer-navigation"> <a class="figure-viewer-nav previous" href="#"> <i class="fa fa-chevron-left"></i><span>left</span> </a> <a class="figure-viewer-nav next" href="#"> <i class="fa fa-chevron-right"></i><span>right</span> </a> </div> </div> <div class="mobile-thumbnail-selector-html" style="display:none;"> <div class="figure-viewer-mobile-thumbnails"> <select class="figure-selection"> <option>Figures</option> </select> <select class="table-selection"> <option>Tables</option> </select> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div>
<div class="portlet-boundary portlet-boundary_1_WAR_kaleodesignerportlet_ portlet-static portlet-static-end kaleo-designer-portlet" id="p_p_id_1_WAR_kaleodesignerportlet_">
<span id="p_1_WAR_kaleodesignerportlet"></span>
</div>
<form action="#" id="hrefFm" method="post" name="hrefFm">
<span></span>
</form>
</div>
<footer class="footer">
<div class="main-footer">
<div class="main-footer-wrapper container">
<div class="brand">
<p class="brand-name">Cochrane</p>
<a href="http://www.cochrane.org/" title="Cochrane logo">
<img alt="Cochrane logo" class="footer-logo logo-part-1" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-1.png"> <img alt="" class="footer-logo logo-part-2" src="https://www.cochranelibrary.com/cochrane-theme/images/footer-logo-part-2.png"> </img></img></a> </div> </div> </div> <div class="aux-footer"> <div class="aux-footer-nav-container container"> <nav class="aux-footer-nav"> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse Publications</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/">Browse by Subject</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/advertisers">Advertisers &amp; Agents</a></li> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Contact Us</a></li> </ul> <ul class="aux-footer-nav-list"> <li><a class="aux-footer-nav-link" href="https://hub.wiley.com/community/support/cochrane-library">Help &amp; Support</a></li> <li><a class="aux-footer-nav-link" href="https://onlinelibrary.wiley.com/terms-and-conditions">Terms &amp; Conditions</a></li> </ul> </nav> </div> <div class="brand"> <div class="brand-container container"> <p class="copyright"> Copyright © 2000 - 2025 by <a class="" href="http://www.wiley.com">John Wiley &amp; Sons, Inc.</a> All Rights Reserved <br> Review our <a href="https://www.wiley.com/privacy"><strong>Privacy Policy</strong></a> <a href="https://www.wiley.com/cookies"><strong>Cookie Policy</strong></a> <a href="#" onclick="Osano.cm.showDrawer('osano-cm-dom-info-dialog-open')"><strong>Cookie Preferences</strong></a> </br></p> <a href="http://eu.wiley.com/"><img alt="Wiley logo" class="logo" src="https://www.cochranelibrary.com/cochrane-theme/images/en-US_wiley-footer-logo.png"/></a> </div> </div> <span class="wiley-semi-circle"></span> </div> <!--BEGIN QUALTRICS WEBSITE FEEDBACK SNIPPET--> <script type="text/javascript"> (function(){var g=function(e,h,f,g){ this.get=function(a){for(var a=a+"=",c=document.cookie.split(";"),b=0,e=c.length;b<e;b++){for(var d=c[b];" "==d.charAt(0);)d=d.substring(1,d.length);if(0==d.indexOf(a))return d.substring(a.length,d.length)}return null}; this.set=function(a,c){var b="",b=new Date;b.setTime(b.getTime()+6048E5);b="; expires="+b.toGMTString();document.cookie=a+"="+c+b+"; path=/; "}; this.check=function(){var a=this.get(f);if(a)a=a.split(":");else if(100!=e)"v"==h&&(e=Math.random()>=e/100?0:100),a=[h,e,0],this.set(f,a.join(":"));else return!0;var c=a[1];if(100==c)return!0;switch(a[0]){case "v":return!1;case "r":return c=a[2]%Math.floor(100/c),a[2]++,this.set(f,a.join(":")),!c}return!0}; this.go=function(){if(this.check()){var a=document.createElement("script");a.type="text/javascript";a.src=g;document.body&&document.body.appendChild(a)}}; this.start=function(){var t=this;"complete"!==document.readyState?window.addEventListener?window.addEventListener("load",function(){t.go()},!1):window.attachEvent&&window.attachEvent("onload",function(){t.go()}):t.go()};}; try{(new g(100,"r","QSI_S_ZN_cGCHHvWNpnJb1zf","https://zncgchhvwnpnjb1zf-wiley.siteintercept.qualtrics.com/SIE/?Q_ZID=ZN_cGCHHvWNpnJb1zf")).start()}catch(i){}})(); </script><div id="ZN_cGCHHvWNpnJb1zf"><!--DO NOT REMOVE-CONTENTS PLACED HERE--></div> <!--END WEBSITE FEEDBACK SNIPPET--> </footer> <div class="scolaris-modal-overlay"></div> <div class="scolaris-modal"> <div class="scolaris-modal-titlebar clearfix"> <p class="scolaris-modal-title"></p> <a class="scolaris-modal-close" href="#"><span>close</span><span class="icon fa fa-times"></span></a> <div class="scolaris-modal-ui"></div> </div> <!-- Static injection of addtoAny as dynamic injection not working properly--> <div class="scolaris-share-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"> <div class="a2a_kit a2a_kit_size_32 a2a_default_style"> <a class="a2a_button_facebook share-button">  Facebook</a> <a class="a2a_button_x share-button">  X(Twitter)</a> <a class="a2a_button_whatsapp share-button">  WhatsApp</a> <a class="a2a_dd share-button">  View more</a> </div> </div> </div> <div class="scolaris-modal-content clearfix"> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="scolaris-modal-ui clearfix"></div> </div> <div class="english-only-modal-wrapper" data-modal-class="english-only-modal" data-modal-title="Feature in English only" style="display: none"> <div class="english-only-modal"> <p class="message"></p> <button class="btn primary ok-btn pull-right" type="button">OK</button> <button class="btn primary border-only cancel-btn pull-right" type="button">Cancel</button> </div> </div> <!--[if gte IE 9]><!--> <script src="/cochrane-theme/vendor/ie9.js?t=1738734739000" type="text/javascript"></script> <!--<![endif]--> <script src="https://www.cochranelibrary.com/cochrane-theme/js/theme.js?t=1738734739000" type="text/javascript"></script> <script src="https://content.readcube.com/cochrane/checkout.js"></script> <script src="https://content.readcube.com/cochrane/epdf_linker.js" type="text/javascript"></script> <script src="https://crossmark-cdn.crossref.org/widget/v2.0/widget.js" type="text/javascript"></script> <script src="https://d1bxh8uas1mnw7.cloudfront.net/assets/embed.js" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/hit-highlighting.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/topics-lookup.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/institution.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/api-manager.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/pico.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/reference-linking.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/rightsLink.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.submit.failed.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.comment.form.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/safety-alerts.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/ui.translation-notes-modal.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-content-display/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/notifications-portlet/notifications/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-search/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773542000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-topics/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773465000" type="text/javascript"></script> <script src="https://www.cochranelibrary.com/scolaris-language-portlet/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1739773471000" type="text/javascript"></script> <script type="text/javascript">Liferay.Util.addInputFocus();</script> <script type="text/javascript">Liferay.Portlet.register("scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header_",portletId:"scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_header\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002253\x2epub4"});Liferay.Portlet.register("scolariscontentdisplay_WAR_scolariscontentdisplay");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_",portletId:"scolariscontentdisplay_WAR_scolariscontentdisplay",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentdisplay_WAR_scolariscontentdisplay\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dcolumn-1\x26p_p_col_pos\x3d0\x26p_p_col_count\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D"});Liferay.provide(Liferay.Util,"openKaleoDesignerPortlet",function(c){var b=AUI();var e=Liferay.PortletURL.createURL("https://www.cochranelibrary.com/en/content?p_p_id=2_WAR_kaleodesignerportlet&p_p_lifecycle=0");e.setParameter("mvcPath","/designer/edit_kaleo_draft_definition.jsp");e.setParameter("availableFields",c.availableFields);e.setParameter("availablePropertyModels",c.availablePropertyModels);e.setParameter("ddmStructureId",c.ddmStructureId);e.setParameter("draftVersion",c.draftVersion);e.setParameter("kaleoProcessId",c.kaleoProcessId);e.setParameter("name",c.name);e.setParameter("openerWindowName",c.openerWindowName);e.setParameter("portletResourceNamespace",c.portletResourceNamespace);e.setParameter("propertiesSaveCallback",c.propertiesSaveCallback);e.setParameter("refreshOpenerOnClose",c.refreshOpenerOnClose);e.setParameter("saveCallback",c.saveCallback);e.setParameter("version",c.version);e.setWindowState("pop_up");c.uri=e.toString();var d=c.dialog;if(!d){var f=b.one(Liferay.Util.getOpener()).get("region");d={destroyOnHide:true};c.dialog=d}if(!("align" in d)){d.align=Liferay.Util.Window.ALIGN_CENTER}var a=c.dialogIframe;if(!a){a={closeOnEscape:false};c.dialogIframe=a}Liferay.Util.openWindow(c)},["liferay-portlet-url"]);Liferay.Portlet.register("1_WAR_kaleodesignerportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_1_WAR_kaleodesignerportlet_",portletId:"1_WAR_kaleodesignerportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3d1_WAR_kaleodesignerportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002253\x2epub4"});Liferay.Portlet.register("scolarissearchportlet_WAR_scolarissearch");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolarissearchportlet_WAR_scolarissearch_",portletId:"scolarissearchportlet_WAR_scolarissearch",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolarissearchportlet_WAR_scolarissearch\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002253\x2epub4"});Liferay.Portlet.register("scolariscontentlanguagebanner_WAR_scolarislanguageportlet");Liferay.Portlet.onLoad({canEditTitle:false,columnPos:0,isStatic:"end",namespacedId:"p_p_id_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_",portletId:"scolariscontentlanguagebanner_WAR_scolarislanguageportlet",refreshURL:"\x2fen\x2fc\x2fportal\x2frender_portlet\x3fp_l_id\x3d20757\x26p_p_id\x3dscolariscontentlanguagebanner_WAR_scolarislanguageportlet\x26p_p_lifecycle\x3d0\x26p_t_lifecycle\x3d0\x26p_p_state\x3dnormal\x26p_p_mode\x3dview\x26p_p_col_id\x3dnull\x26p_p_col_pos\x3dnull\x26p_p_col_count\x3dnull\x26p_p_static\x3d1\x26p_p_isolated\x3d1\x26currentURL\x3d\x252Fweb\x252Fcochrane\x252Fcontent\x253FtemplateType\x253Dfull\x2526urlTitle\x253D\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526doi\x253D10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x2526type\x253Dcdsr\x2526contentLanguage\x253D\x26templateType\x3dfull\x26urlTitle\x3d\x252Fcdsr\x252Fdoi\x252F10\x2e1002\x252F14651858\x2eCD002253\x2epub4\x26contentLanguage\x3d\x26type\x3dcdsr\x26doi\x3d10\x2e1002\x252F14651858\x2eCD002253\x2epub4"});AUI().use("aui-base","liferay-menu","liferay-notice","liferay-poller","liferay-session",function(a){(function(){Liferay.Util.addInputType();Liferay.Portlet.ready(function(b,c){Liferay.Util.addInputType(c)});if(a.UA.mobile){Liferay.Util.addInputCancel()}})();(function(){new Liferay.Menu();var b=Liferay.Data.notices;for(var c=1;c<b.length;c++){new Liferay.Notice(b[c])}})();(function(){Liferay.Session=new Liferay.SessionBase({autoExtend:true,sessionLength:1800,redirectOnExpire:false,redirectUrl:"https\x3a\x2f\x2fwww\x2ecochranelibrary\x2ecom\x2fweb\x2fcochrane",warningLength:0})})()});</script> <script src="https://www.cochranelibrary.com/cochrane-theme/js/main.js?browserId=other&amp;minifierType=js&amp;languageId=en_US&amp;b=6210&amp;t=1738734739000" type="text/javascript"></script> <script type="text/javascript"></script> <div class="mobile-righthand-nav"> <a class="rh-nav-close-btn" href="#"> <span>Close</span> <span class="fa fa-chevron-down"></span> </a> <div class="wrapper"> </div> <a class="rh-nav-open-btn" href="#"> <span>Review tools &amp; navigation</span> </a> </div> <iframe aria-hidden="true" id="printframe" name="printframe" style="position: absolute; left: -2000px; top: 0;" title="Print frame"></iframe> <iframe aria-hidden="true" id="citationExportFrame" name="citationExportFrame" style="position: absolute; left: -2000px; top: 0;" title="scolaris.citation.export.frame"></iframe> <nav> <div class="mobile-navigation"> <div class="close-container"> <a aria-label="Navigate back" class="main-nav-back-btn" href="#"><i class="fa fa-chevron-left"></i></a> <a class="main-nav-close-btn" href="#" title="Close menu">Close menu <i class="fa fa-times"></i></a> </div> <div class="mobile-search basic-search-container"> <div class="portlet-boundary portlet-boundary_scolarissearchportlet_WAR_scolarissearch_ portlet-static portlet-static-end" id="p_p_id_scolarissearchportlet_WAR_scolarissearch_"> <span id="p_scolarissearchportlet_WAR_scolarissearch"></span> <section class="portlet" id="portlet_scolarissearchportlet_WAR_scolarissearch"> <header class="portlet-topper"> <h1 class="portlet-title"> <span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Search\x20Portlet')"> <img alt="" id="ymag__null__null" src="/scolaris-search/icon.png"> <span class="taglib-text hide-accessible">Scolaris Search Portlet</span> </img></span> <span class="portlet-title-text">Scolaris Search Portlet</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarissearchportlet_WAR_scolarissearch" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="header-search"> <form action="https://www.cochranelibrary.com/en/content?p_auth=EBp84H4P&amp;p_p_id=scolarissearchportlet_WAR_scolarissearch&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolarissearchportlet_WAR_scolarissearch_scolarisAction=redirectSearchResult" method="post"> <input name="searchType" type="hidden" value="basic"> <input name="facetDisplayName" type="hidden" value=""> <input name="facetQueryTerm" type="hidden" value=""/> <input name="facetQueryField" type="hidden" value=""/> <input name="facetCategory" type="hidden" value=""/> <fieldset class="fieldset"> <legend class="sr-only">Basic Search</legend> <div class="select search-by"> <select aria-label="Search by options" class="custom-select-enabled search-type" name="searchBy" title="Search by options"> <option value="1">Title Abstract Keyword</option> <option value="2">Record Title</option> <option value="3">Abstract</option> <option value="4">Author</option> <option value="5">Keyword</option> <option value="6">All Text</option> <option value="7">Publication Type</option> <option value="8">Source</option> <option value="9">DOI</option> <option value="14">Language</option> <option value="10">Accession Number</option> <option value="11">Trial Registry Number</option> <option value="12">Cochrane Group</option> <option value="13">Cochrane Topic</option> </select> </div> <div class="search-select-crg-container select" style="display: none;"> <select class="search-select-crg-list"></select> </div> <div class="search-select-topic-container select" data-topic-list-url="https://www.cochranelibrary.com/en/content?p_p_id=scolaristopics_WAR_scolaristopics&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=topics-list&amp;p_p_cacheability=cacheLevelPage" style="display: none;"> <select class="search-select-topic-list"></select> </div> <div class="search-select-cl-container select" style="display: none;"> <select class="search-select-cl-list"></select> </div> <div class="search-text-container"> <div class="control-group control-group-inline search-input-wrapper"> <input aria-label="Enter search term" class="field browser-search search-text ui-autocomplete-input" id="searchText" name="searchText" placeholder="Search" size="30" type="text" value=""/>
<div id="autocomplete-results"></div>
</div>
<div class="control-group control-group-inline search-button-wrapper">
<button aria-label="Search" class="searchByBtn" type="submit">
<i aria-hidden="true" class="fa fa-search"></i>
</button>
</div>
</div>
</fieldset>
</input></input></form>
</div>
<script>
    window.displayResultURL = 'https://www.cochranelibrary.com/en/content?p_p_id=scolarissearchportlet_WAR_scolarissearch&p_p_lifecycle=2&p_p_state=normal&p_p_mode=view&p_p_resource_id=getSuggestions&p_p_cacheability=cacheLevelPage&_scolarissearchportlet_WAR_scolarissearch_templateType=full&_scolarissearchportlet_WAR_scolarissearch_urlTitle=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002253.pub4&_scolarissearchportlet_WAR_scolarissearch_contentLanguage=&_scolarissearchportlet_WAR_scolarissearch_type=cdsr&_scolarissearchportlet_WAR_scolarissearch_doi=10.1002%2F14651858.CD002253.pub4';
    window.searchByOption = '';
</script>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<a class="btn secondary" href="/en/browse-by-topic">Browse </a>
<a class="btn secondary advanced-search-button" href="/en/advanced-search">Advanced search</a>
</div>
<div class="menu-items parent">
<div>
<div class="nav-root-item parent">
<a class="language-selection-title-link" href="#" title="Select language">
<span class="mobile-nav-language-title">Select your preferred language </span></a> <span class="icon fa fa-caret-down"></span>
<div class="mob-child">
<div class="portlet-boundary portlet-boundary_scolarislanguageselector_WAR_scolarislanguageportlet_ portlet-static portlet-static-end" id="p_p_id_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav_">
<span id="p_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav"></span>
<section class="portlet" id="portlet_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Language\x20Selector')">
<img alt="" id="fdkn__null__null" src="/scolaris-language-portlet/icon.png"> <span class="taglib-text hide-accessible">Scolaris Language Selector</span> </img></span> <span class="portlet-title-text">Scolaris Language Selector</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolarislanguageselector_WAR_scolarislanguageportlet_INSTANCE_mobilenav" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="language-display" data-content-languages="[de, en, es, fa, fr, hi, hr, id, ja, ko, hu, ms, nl, pl, pt, ru, ro, ta, th, zh_HANT, zh_HANS]"> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-file-text"></i> English </a> <a class="language-select-mobile" href="#" title="Select your preferred language"> <i class="fa fa-globe"></i> English </a> </div> <div class="form-content language-selector-modal child"> <div class="row-fluid"> <h3><i class="fa fa-file-text"></i> Cochrane review language</h3> <p>Select your preferred language for Cochrane reviews and other content. Sections without translation will be in English.</p> <div class="dropdown-trigger" id="active-content-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="content-language-selector" data-languagecode="de" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=de">Deutsch</a> <a class="content-language-selector is-active" data-languagecode="en" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=en">English</a> <a class="content-language-selector" data-languagecode="es" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=es">Español</a> <a class="content-language-selector" data-languagecode="fa" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fa">فارسی</a> <a class="content-language-selector" data-languagecode="fr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=fr">Français</a> <a class="content-language-selector" data-languagecode="hi" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hi">हिन्दी</a> <a class="content-language-selector" data-languagecode="hr" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hr">Hrvatski</a> <a class="content-language-selector" data-languagecode="id" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=id">Bahasa Indonesia</a> <a class="content-language-selector" data-languagecode="ja" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ja">日本語</a> <a class="content-language-selector" data-languagecode="ko" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ko">한국어</a> <a class="content-language-selector" data-languagecode="hu" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=hu">Magyar</a> <a class="content-language-selector" data-languagecode="ms" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ms">Bahasa Malaysia</a> <a class="content-language-selector" data-languagecode="nl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=nl">Nederlands</a> <a class="content-language-selector" data-languagecode="pl" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pl">Polski</a> <a class="content-language-selector" data-languagecode="pt" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=pt">Português</a> <a class="content-language-selector" data-languagecode="ru" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ru">Русский</a> <a class="content-language-selector" data-languagecode="ro" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ro">Română</a> <a class="content-language-selector" data-languagecode="ta" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=ta">தமிழ்</a> <a class="content-language-selector" data-languagecode="th" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=th">ภาษาไทย</a> <a class="content-language-selector" data-languagecode="zh_HANT" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANT">繁體中文</a> <a class="content-language-selector" data-languagecode="zh_HANS" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage&amp;_scolariscontentlanguagebanner_WAR_scolarislanguageportlet_contentLanguage=zh_HANS">简体中文</a> </div> </div> <div class="row-fluid"> <h3 class="portal-language-header"><i class="fa fa-globe"></i> Website language</h3> <p>Select your preferred language for the Cochrane Library website.</p> <div class="dropdown-trigger" id="active-portal-language"> <span>English</span> <i aria-hidden="true" class="fa fa-caret-down"></i> </div> <div class="language-selector-dropdown"> <a class="portal-language-selector is-active" data-portallanguage="en" href="/en/cdsr/doi/10.1002/14651858.CD002253.pub4/full/en">English</a> <a class="portal-language-selector" data-portallanguage="es" href="/es/cdsr/doi/10.1002/14651858.CD002253.pub4/full/es">Español</a> </div> </div> <a class="btn secondary ok-btn pull-right" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentlanguagebanner_WAR_scolarislanguageportlet&amp;p_p_lifecycle=2&amp;p_p_state=normal&amp;p_p_mode=view&amp;p_p_resource_id=set-content-language&amp;p_p_cacheability=cacheLevelPage">Save</a> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
<div class="parent">
<a class="mobile-link signin" data-redirect="false" href="https://www.cochranelibrary.com/c/portal/login?p_l_id=20757&amp;redirect=%2Fcdsr%2Fdoi%2F10.1002%2F14651858.CD002253.pub4%2Ffull" rel="nofollow">
                        Sign In
                    </a>
</div>
</div>
<div class="menu-items-footer">
<div class="utility-links">
<a class="cochrane-link" href="http://www.cochrane.org/" target="_blank">Visit Cochrane.org</a>
</div>
</div>
</div>
<div class="menu-items child"></div>
</div>
</nav><div class="basic-login-form-content" data-modal-title="Sign in" style="display: none;">
<div class="form-content">
<div class="row-fluid">
<div class="span12">
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_MODAL_">
<span id="p_58_INSTANCE_MODAL"></span>
<section class="portlet" id="portlet_58_INSTANCE_MODAL">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="dbam__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_MODAL" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_MODAL&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_MODAL_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_MODAL_fm" method="post" name="_58_INSTANCE_MODAL_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_MODAL_formDate" type="hidden" value="1740728804625"> <input class="field" id="_58_INSTANCE_MODAL_saveLastPath" name="_58_INSTANCE_MODAL_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_MODAL_redirect" name="_58_INSTANCE_MODAL_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002253.pub4/full"> <input class="field" id="_58_INSTANCE_MODAL_doActionAfterLogin" name="_58_INSTANCE_MODAL_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_login"> Email Address </label> <input class="field clearable" id="_58_INSTANCE_MODAL_login" name="_58_INSTANCE_MODAL_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_MODAL_password"> Password </label> <input class="field" id="_58_INSTANCE_MODAL_password" name="_58_INSTANCE_MODAL_password" type="password" value=""/> </div> <span id="_58_INSTANCE_MODAL_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="clearfix"> <div class="checkbox-list pull-left"> <div class="checkbox-list-item"> <div class="control-group form-inline input-checkbox-wrapper"> <label for="_58_INSTANCE_MODAL_rememberMeCheckbox"> <input id="_58_INSTANCE_MODAL_rememberMe" name="_58_INSTANCE_MODAL_rememberMe" type="hidden" value="true"/> <input checked="" class="field" id="_58_INSTANCE_MODAL_rememberMeCheckbox" name="_58_INSTANCE_MODAL_rememberMeCheckbox" onclick="Liferay.Util.updateCheckboxValue(this); " type="checkbox" value="true"/> Remember Me </label> </div> </div> </div> <div class="pull-right"> <a href="https://onlinelibrary.wiley.com/user/forgottenpassword" target="_blank">Forgotten password?</a> </div> </div> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> <a class="btn secondary" href="https://onlinelibrary.wiley.com/user-registration" target="_blank">Register</a> </div> <div class="pull-right"> <a class="institutional-login-form-button" href="https://www.cochranelibrary.com/en/content?p_p_id=scolariscontentdisplay_WAR_scolariscontentdisplay&amp;p_p_lifecycle=0&amp;p_p_state=normal&amp;p_p_mode=view&amp;_scolariscontentdisplay_WAR_scolariscontentdisplay_action=institution-access">Institutional login</a> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div></div>
<div class="institution-login-form-content" data-modal-title="Institutional login" style="display: none;">
<div class="form-content">
<div class="row-fluid access-content-wrapper">
<div class="span12">
<div class="section">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="obft__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_combinedloginform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="access-content-section"> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/>
</div>
<button class="btn primary" name="button" type="submit">Go</button>
</div>
<div class="message error" id="institutionLookupErrorDiv" style="display:none">
                        '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access.
                    </div>
</div>
<input id="entityId" name="entityId" type="hidden" value=""/>
</form>
<h4>Previously accessed institutions</h4>
<ul class="plain" id="previousInstitutions">
<li>(none)</li>
</ul>
</div>
<div class="section-content">
<div class="open-athens-login">
                Login using <a href="/openathens">OpenAthens</a>
</div>
</div>
</div>
</div>
</div>
</div>
<div style="display:none">
<input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
<div class="portlet-boundary portlet-boundary_58_ portlet-static portlet-static-end portlet-login" id="p_p_id_58_INSTANCE_4_">
<span id="p_58_INSTANCE_4"></span>
<section class="portlet" id="portlet_58_INSTANCE_4">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Sign\x20In')">
<img alt="" id="joiu__null__null" src="https://www.cochranelibrary.com/cochrane-theme/images/spacer.png" style="background-image: url('https://www.cochranelibrary.com/sprite/html/icons/_sprite.png'); background-position: 50% -592px; background-repeat: no-repeat; height: 16px; width: 16px;"> <span class="taglib-text hide-accessible">Sign In</span> </img></span> <span class="portlet-title-text">Sign In</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_58_INSTANCE_4" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <p>If you have a <strong>Wiley Online Library</strong> institutional username and password, enter them here.</p> <form action="https://www.cochranelibrary.com/en/content?p_p_id=58_INSTANCE_4&amp;p_p_lifecycle=1&amp;p_p_state=normal&amp;p_p_mode=view&amp;_58_INSTANCE_4_struts_action=%2Flogin%2Flogin" autocomplete="on" class="form sign-in-form" id="_58_INSTANCE_4_fm" method="post" name="_58_INSTANCE_4_fm"> <fieldset class="input-container" disabled="disabled"> <legend class="sr-only">Cochrane Login</legend> <input name="_58_INSTANCE_4_formDate" type="hidden" value="1740728804629"> <input class="field" id="_58_INSTANCE_4_saveLastPath" name="_58_INSTANCE_4_saveLastPath" type="hidden" value="false"> <input class="field" id="_58_INSTANCE_4_redirect" name="_58_INSTANCE_4_redirect" type="hidden" value="/cdsr/doi/10.1002/14651858.CD002253.pub4/full"> <input class="field" id="_58_INSTANCE_4_doActionAfterLogin" name="_58_INSTANCE_4_doActionAfterLogin" type="hidden" value="false"> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_login"> Username </label> <input class="field clearable" id="_58_INSTANCE_4_login" name="_58_INSTANCE_4_login" type="text" value=""> </input></div> <div class="control-group input-text-wrapper"> <label class="control-label" for="_58_INSTANCE_4_password"> Password </label> <input class="field" id="_58_INSTANCE_4_password" name="_58_INSTANCE_4_password" type="password" value=""> </input></div> <input class="field" id="_58_INSTANCE_4_institutionalLogin" name="_58_INSTANCE_4_institutionalLogin" type="hidden" value="true"/> <span id="_58_INSTANCE_4_passwordCapsLockSpan" style="display: none;"> Caps Lock is on. </span> <div class="login-form-footer clearfix"> <div class="pull-left"> <button class="btn primary" type="submit">Sign in</button> </div> </div> </input></input></input></input></fieldset> </form> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/>
<input id="openlabel" name="openlabel" type="hidden" value="Open access"/>
</div>
</section>
</div>
</div>
</div>
</div>
</div></div>
<div class="get-access-form-content" data-modal-title="Unlock gold-standard Cochrane evidence" style="display: none;">
<div class="portlet-boundary portlet-boundary_scolariscontentdisplay_WAR_scolariscontentdisplay_ portlet-static portlet-static-end scolaris-content-display-portlet" id="p_p_id_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform_">
<span id="p_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform"></span>
<section class="portlet" id="portlet_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform">
<header class="portlet-topper">
<h1 class="portlet-title">
<span class="" onmouseover="Liferay.Portal.ToolTip.show(this, 'Scolaris\x20Content\x20Display')">
<img alt="" id="wpdq__null__null" src="/scolaris-content-display/icon.png"> <span class="taglib-text hide-accessible">Scolaris Content Display</span> </img></span> <span class="portlet-title-text">Scolaris Content Display</span> </h1> <menu class="portlet-topper-toolbar" id="portlet-topper-toolbar_scolariscontentdisplay_WAR_scolariscontentdisplay_INSTANCE_getaccessform" type="toolbar"> </menu> </header> <div class="portlet-content"> <div class="portlet-content-container"> <div class="portlet-body"> <div class="readcube-checkout-container-outer"> <div class="row-fluid access-content-wrapper"> <div class="span6 access-left-content"> <div class="section"> <div class="section-content"> <p>Improve your health decisions with access to trusted, independent evidence from the Cochrane Library. Unlock this review for uninterrupted access.</p> <p>Still deciding? <a href="https://m.info.wiley.com/webApp/cochranenewsletter"> Sign up to our newsletter to learn more </a> </p> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title">Institutional users</h3> <div class="section-content"> <p>Search for your institution's name below to login via Shibboleth</p> <form action="/shibboleth" id="institutionLoginForm" method="post"> <div class="fieldset"> <div class="form-group access-input-wrapper"> <div class="ui-widget ui-front"> <label class="sr-only" for="institutionName">Institution name</label> <input class="field" id="institutionName" name="institutionName" type="text" value=""/> </div> <button class="btn primary" name="button" type="submit">Go</button> </div> <div class="message error" id="institutionLookupErrorDiv" style="display:none"> '<span id="enteredInstitionNameSpan"></span>' is not set up for this type of access on Wiley Online Library. Please contact your institution's administrator to ask about access. </div> </div> <input id="entityId" name="entityId" type="hidden" value=""/> </form> <h4>Previously accessed institutions</h4> <ul class="plain" id="previousInstitutions"> <li>(none)</li> </ul> </div> <div class="section-content"> <div class="open-athens-login"> Login using <a href="/openathens">OpenAthens</a> </div> </div> </div> </div> <div class="section"> <div class="access-content-section"> <h3 class="title"> Other access options </h3> <div class="section-content"> <ul class="plain"> <li> <a class="get-access-individual-login-button" href="/c/portal/login"> Individual access - via Wiley Online Library </a> </li> </ul> </div> </div> </div> </div> <div class="span6 access-right-content readcube-checkout-container"> <div class="section"> </div> </div> </div> </div> </div> </div> </div> <div style="display:none"> <input id="freelabel" name="freelabel" type="hidden" value="Free access"/> <input id="openlabel" name="openlabel" type="hidden" value="Open access"/> </div> </section> </div> </div> <!-- Scolaris Version: --> <script type="text/javascript">if(window._satellite){_satellite.pageBottom()};</script> </div> <script>(function(){function c(){var b=a.contentDocument||a.contentWindow.document;if(b){var d=b.createElement('script');d.innerHTML="window.__CF$cv$params={r:'918ecd6b9ccef56f',t:'MTc0MDcyODgwNS4wMDAwMDA='};var a=document.createElement('script');a.nonce='';a.src='/cdn-cgi/challenge-platform/scripts/jsd/main.js';document.getElementsByTagName('head')[0].appendChild(a);";b.getElementsByTagName('head')[0].appendChild(d)}}if(document.body){var a=document.createElement('iframe');a.height=1;a.width=1;a.style.position='absolute';a.style.top=0;a.style.left=0;a.style.border='none';a.style.visibility='hidden';document.body.appendChild(a);if('loading'!==document.readyState)c();else if(window.addEventListener)document.addEventListener('DOMContentLoaded',c);else{var e=document.onreadystatechange||function(){};document.onreadystatechange=function(b){e(b);'loading'!==document.readyState&&(document.onreadystatechange=e,c())}}}})();</script></body> </html> 